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Zusammenfassung 
 
Mit dem CRISPR-Cas System wurde ein adaptives Immunsystem identifiziert, mit dem sich 
sowohl Archaen also auch Bakterien gegen fremde Nukleinsäuren zur Wehr setzen können. 
Dabei wird die Komplementarität einer kleinen RNA (crRNA) zur eindringenden Nukleinsäure 
ausgenutzt um diese abzubauen. Namensgebend für dieses System ist der CRISPR-Array 
oder Lokus, welcher sich aus sich wiederholenden DNA-Sequenzen (Repeats) und 
einzigartigen Elementen zwischen den Repeats (Spacer) zusammensetzt. Diese 
Spacersequenzen können aus vorausgegangenen Infektionen von Viren stammen und 
vermitteln, als Teil der kleinen crRNA, die nötige Komplementarität im Falle einer 
Neuinfektion. 
Im Zuge der Co-Evolution von Prokaryoten und ihren Viren hat sich eine hohe Diversität von 
verschiedenen CRISPR-Cas Systemen entwickelt. Es wird zwischen drei Haupttypen 
unterschieden, welche in weitere Subtypen unterteilt werden können. 
Die vorliegende Arbeit zeigt die erste Charakterisierung eines Subtyp I-B CRISPR-Cas 
Systems. Die in vivo Aktivität dieses CRISPR-Cas Systems wurde mittels RNA 
Sequenzierung in Methanococcus maripaludis C5 bestätigt. Die in den RNA-Seq Daten 
identifizierten crRNAs bestehen jeweils aus einer kompletten Spacersequenz und einer 
konservierten 8 Nukleotid Sequenz am 5' Terminus sowie einer 2 Nukleotid Sequenz am 3' 
Terminus. 
Es wurden 8 cas Gene identifiziert. Von den Cas-Proteinen wurden mit Cas8b und einem 
zunächst nur mit hypothetischer Funktion annotierten Protein zwei subtypisch spezifische 
Vertreter genauer analysiert. Für das letzte Protein wurde eine Endoribonuclease-Aktivität 
identifiziert und das Protein als Cas6b bezeichnet. Cas6b ist ein “single-turnover” Enzym, 
welches die längeren Vorläufer crRNAs in kleine reife crRNAs prozessiert. Dabei wurde 
bewiesen, dass Cas6b für die 8 Nukleotid Repeatsequenz am 5' Terminus der reifen crRNAs 
verantwortlich ist. Trotz einer sehr geringen Sequenzidentität von nur 11%, zeigte eine 
Modellierung der Cas6b Struktur eine hohe Ähnlichkeit zur Kristallstruktur des in Pyrococcus 
furiosus identifizierten Cas6 Enzyms. Mit Hilfe von eingefügten Punktmutationen konnten vier 
Aminosäurereste des katalytischen Zentrums von Cas6b identifiziert werden: Lysin (K30), 
Histidin (H38), Histidin (H40) und Tyrosin (Y47). Analysen der RNA-Bindefähigkeit von 
Cas6b haben gezeigt, dass Cas6b nach erfolgter Substratbindung in der Lage ist 
Dimerstrukturen zu formen. Weitere Untersuchungen mittels „RNA-Crosslinking“ gefolgt von 
massenspektrometrischen Analysen haben ein Methionrest (M185) identifiziert, welcher eng 
mit einem Uridin (U15) der Repeatsequenz koordiniert ist. Cas6b Aktivitäts-Assays mit 
Repeatvarianten von M. maripaludis sowie der Repeatsequenz von Clostridium 
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thermocellum konnten belegen, dass die Prozessierung von Vorläufer crRNA durch Cas6b 
unabhängig von möglichen Sekundärstrukturen in der RNA stattfindet. 
Neben dem Vorhandensein von reifen crRNAs geht aus den RNA-Seq Daten auch eine 
hoche Variabilität der crRNA Häufigtkeit hervor. Um die identifizierten crRNA Mengen zu 
bewerten, wurde ein experimentaler Ablauf entworfen, mit welchem der Einfluss jeder 
einzelnen Spacersequenz auf a) die Prozessierung durch Cas6b und b) die Stabilität der 
crRNAs analysiert werden konnte. Mit Hilfe dieses globalen Analyseansatzes wurden 
geringe Einflüsse der Spacerlänge sowie Spacersequenz auf die in vitro Prozessierung und 
Stabilität beobachtet. In diesem Zusammenhang werden zukünftige Experimente auch den 
Einfluss des Cas-Protein Interferenzkomplexes (Cascade) sowie mögliche regulatorische 
Effekte auf die Häufigkeit der crRNAs betrachten. 
Die Charakterisierung des subtypspezifischen Cas8b ergab eine Spaltung des rekombinaten 
Proteins in zwei definierte Fragmente. Mittels Edman-Sequenzierung wurde die Schnittstelle 
innerhalb der Proteinsequenz identifiziert. In anderen CRISPR-Cas Subtypen sind zwei 
Proteine vorhanden, welche als große und kleine Untereinheit des Interferenzkomplexes 
Cascade beschrieben werden. Im Subtyp I-B hingegen ist Cas8b als einziges äquivalent zu 
den beiden Proteinen zu finden und es wurde postuliert das seine mögliche autokatalytische 
Spaltung die kleine und große Cascade-Untereinheit generiert. Die biochemische 
Charakterisierung von Cas8b und dessen mögliche Rolle innerhalb der Interferenzantwort 
ergab eine unspezifische Bindefähigkeit zu Nukleinsäuren und konnte keine nukleolytische 
Aktivität zeigen. Mögliche Funktionen von Cas8b werden diskutiert und in zukünftigen 
Studien sollen diese im Kontext des Interferenzkomplexes Cascade weiterführend untersucht 
werden. 
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Summary 
 
The CRISPR-Cas system is an adaptive immune system found in archaea and bacteria to 
defend themselves against mobile genetic elements (e.g. phages). The system employs 
base complementarity of small RNA species (crRNAs) to target the foreign nucleic acids for 
degradation. The hallmark of the system is the CRISPR array or locus, which is composed of 
repetitive DNA sequences (repeats) that are interspersed by unique sequences (spacers). 
Spacer sequences can be derived from earlier encounters with viruses and, as part of the 
crRNAs, confer the base complementarity during a reoccurring attack. During the ongoing 
battle between prokaryotes and viruses diverse CRISPR-Cas systems evolved into three 
main types that are further subdivided. 
This thesis shows the first characterization of a subtype I-B CRISPR-Cas system. RNA-Seq 
data proved the in vivo activity of this CRISPR-Cas system in Methanococcus maripaludis 
C5. The data further revealed that the crRNAs are always composed of a complete spacer 
sequence flanked by an 8 nt 5' repeat tag and a 2 nt 3' repeat tag. 
Eigth cas genes were identified for M. maripaludis. Two Cas proteins, Cas8b and an 
annotated hypothetical protein were characterized in more detail. The hypothetical protein 
was shown to be the endoribonuclease responsible for the single-turnover catalysis of 
precursor crRNA into mature crRNA and was termed Cas6b. The reaction performed by 
Cas6b yields the 8 nt 5' terminal tag of the mature crRNAs. Despite sharing only low 
sequence identity of 11 %, the two Cas6 proteins of M. maripaludis and Pyrococcus furiosus 
could be well aligned using a structural model of Cas6b and the crystal structure of P. 
furiosus Cas6. Cas6b mutant analysis was used to determine four amino acid residues 
(lysine 30, histidine 38, histidine 40 and tyrosine 47) that comprise the catalytic site of Cas6b. 
The RNA binding properties of Cas6b were determined and showed a dimerization upon 
binding to a non-cleavable substrate. Further analyses including RNA crosslinking 
experiments followed by mass spectrometry identified a methionine residue (M185) that 
tightly coordinated to a uridine (U15) of the repeat sequence. Cas6b activity assays 
employing differently structured repeat variants of M. maripaludis and a 37 nt repeat 
sequence of Clostridium thermocellum could show, that the processing reaction performed 
by Cas6b does not recognize a secondary structure of the substrate. 
In addition to the verification to the in vivo activity of the CRISPR-Cas system, the RNA-Seq 
data also revealed a varying abundance pattern of crRNAs. To assess the crRNA abundance 
a experimental procedure was designed, which was aimed to analyse the influence of spacer 
sequences on a) the processing by Cas6 and b) the stability of crRNAs. With the help of this 
global approach influences of the spacer length and spacer sequence on the crRNA 
maturation and in vitro stability were recognized. In this context, future experiments will also 
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determine further possible influences on crRNA abundance including i) crRNA loading into 
the Cas protein interference complex (Cascade) and ii) possible regulatory effects in terms of 
crRNA utilization dependent regulation. 
The characterization of the subtype-specific protein Cas8b revealed a splitting of the 
recombinant protein into two defined fragments. The exact point of cleavage was determined 
by Edman sequencing and provides evidence for a proteolytic cleavage of the full-length 
protein (either autocatalytically or by a protease). Other CRISPR-Cas subtypes were 
reported to contain two proteins serving as small and big subunit of the interference complex 
Cascade. For subtype I-B on the other hand Cas8b was found to be the only equivalent to 
these two proteins and it was proposed that the identified cleavage generates the large and 
small Cascade subunit. A biochemical analysis of Cas8b with respect to its putative roles 
during CRISPR-Cas immunity showed an unspecific binding to nucleic acids while no 
nucleolytic cleavage was observed. Possible functions of Cas8b are discussed and future 
studies will focus on the analysis of the protein functions in the context of a complete 
Cascade. 
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Introduction 
 
In an evolutionary arms race between viruses on one side and Bacteria and Archaea on the 
other side, the latter ones created a remarkable arsenal of defense mechanisms. In the first 
line of defense prokaryotes developed various systems to block penetrators using 
extracellular polymeric substances (e.g. capsules) (Abedon, 2012; Hyman & Abedon, 2010; 
Labrie et al, 2010). Further defense systems include (i) the alteration or bare absence of 
receptors for phage adsorption (Labrie et al, 2010), (ii) the blocking of phage movement to 
prevent the penetration of the cytoplasm in case of successful adsorption or (iii) the 
recognition of phage particles via prophage endoced proteins during an infection event, 
which leads to repressed phage proliferation and prevents superinfection of the cell (Raivio, 
2011). A different strategy is the abortive infect, in which the community is protected by the 
death of an individual infected cell to prevent phage proliferation (Hyman & Abedon, 2010; 
Labrie et al, 2010). Additional specificity in the response to invaders is achieved by 
restriction-modification systems that use enzymes targeting special sequence motifs to 
degrade the alien DNA (Arber & Linn, 1969; Enikeeva et al, 2010). Very recently, an adaptive 
immune system was discovered in Archaea and Bacteria. This CRISPR-Cas (clustered 
regularly interspaced short palindromic repeats – CRISPR associated) immune system acts 
via complementary base pairing of small RNA species, CRISPR RNA (crRNA), that target 
and degrade invading nucleic acids. 
Originally thought to be a DNA repair system, the CRISPR-Cas system was later identified to 
constitute a prokaryotic immune system (Barrangou et al, 2007; Brouns et al, 2008). 
Hallmark of the system is the CRISPR array or locus, which contains repeated DNA 
elements (repeats) that are interspersed by unique DNA sequences (spacers) (Fig. 1). These 
sequences can be derived from an invading nucleic acid (e.g. virus DNA/RNA) and, as part 
of the small interfering RNA (crRNA), spacers confer the immunity during a reoccurring 
attack of a particular virus via base complementarity. Spacer sequences can be added or 
removed from a given CRISPR array and entire CRISPR clusters can be inherited. Hence, 
spacers define the adaptive character of the immune system. A leader sequence is located 
upstream of a CRISPR array, in which the regulatory elements and transcriptional start sites 
for the array are found. The leader also serves as the introduction site of new spacer 
sequences as newly adapted sequences are always found at the leader proximal end of the 
array. A set of Cas (CRISPR associated) genes, providing functionality of the system, is 
situated in close proximity of a CRISPR array, even though sometimes two or more CRISPR 
loci can share a set of cas genes (Barrangou & Horvath, 2011; Bolotin et al, 2005; Brouns et 
al, 2008; Deveau et al, 2010; Horvath & Barrangou, 2010; Marraffini & Sontheimer, 2010a; 
Sorek et al, 2008; Terns & Terns, 2011; van der Oost & Brouns, 2009). 
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Figure1. Schematic view of the function of Type-I CRISPR-Cas systems. CRISPR-Cas systems 
comprise i) a CRISPR array, composed of repeats (R) and spacer sequences (coloured blocks), ii) a 
leader sequence and iii) a set of cas genes coding for proteins involved in the functionality of the 
system. 
In clock-wise direction, the injection of phage DNA leads to recognition of the protospacer adjacent 
motif (PAM) (blue) by Cas proteins inluding Cas1 and Cas2 resulting in the Adaptation of a 
protospacer sequence (red) as a new spacer into the CRISPR array. Transcription of the array 
results in a long precursor crRNA, which is processed by a Cas6 enzyme producing mature crRNA. 
The crRNA (red) is bound by the CRISPR associated complex for antiviral defense (CASCADE) and 
subsequently binds the foreign DNA in case of a new infection guided by crRNA specific recognition of 
the target sequence. The recruitment of Cas3 leads to endonucleolytic decay of the invading nucleic 
acid. 
 
The functionality of CRISPR-Cas systems can be described in three major stages: i) the 
adaptation of new spacer sequences by Cascis (CRISPR associated complex for integration 
of spacer) (Cady & O'Toole, 2011; Datsenko et al, 2012; Erdmann & Garrett, 2012; Plagens 
et al, 2012; Shah et al, 2013; Swarts et al, 2012; Yosef et al, 2012), ii) the transcription of the 
array into a precursor crRNA (pre-crRNA) which is further processed into mature crRNA 
(Carte et al, 2008; Gesner et al, 2011; Haurwitz et al, 2010; Richter et al, 2012; Sashital et al, 
2011) and iii) the interference of a CRISPR associated complex for antiviral defense 
(Casade) or Cascade-like complexes (Jore et al, 2011b; Lintner et al, 2011a; Lintner et al, 
2011b; Sashital et al, 2012; Sinkunas et al, 2011; Sinkunas et al, 2013; Wiedenheft et al, 
2011a; Wiedenheft et al, 2011b) with the invading nucleic acid based on the base 
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complementarity of the crRNA (Fig. 1) (Barrangou & Horvath, 2011; Horvath & Barrangou, 
2010; Sorek et al, 2008; van der Oost & Brouns, 2009; Westra et al, 2012b). 
CRISPR-Cas systems share the same basic principles of functionality. However, while the 
adaptation process seems to be similar for different systems and two of the involved proteins 
(Cas1 and Cas2) are uniform, the detailed interference mechanisms with the foreign 
DNA/RNA show significant differences. Therefore, three major CRISPR-Cas types are 
described based on the presence of Cas3 (Type I), Cas9 (Type II) and Cas10 (Type III), 
which serve as the enzymes degrading the alien DNA or RNA species. The three types can 
be further classified into at least 10 additional subtypes based on subtype-specific proteins 
(e.g. Cas8b for subtype I-B) (Makarova et al, 2011b). 
Shortly after the system was discovered, the idea of exploiting its key players for biotechnical 
and bioengineering purposes arose (Makarova et al, 2006). As of today, the usage of 
CRISPR-Cas systems ranges from a simple identification of different bacterial strains based 
on the spacers of a CRISPR array (spoligotyping) (Kamerbeek et al, 1997) to gene silencing 
(CRISPRi) (Qi et al, 2013) and genome editing (RGEN) (Cong et al, 2013; Mali et al, 2013) 
on the basis of the interfering crRNA and the type II protein Cas9. The development of 
genome-editing tool based on Cas9 and a guide RNA, led to an increased interest in 
CRISPR-Cas systems. Unlike established genome-editing tools (e.g. transcription activator 
like effector nucleases (TALEN), zinc-finger nucleases (ZFN)), RGEN does not require a 
redesign of the used protein and therefore is less money- and time - consuming (recently 
reviewed in (Charpentier & Doudna, 2013; Horvath & Barrangou, 2013; Richter et al, 
2013b)). Future application proposals (Makarova et al, 2006) include the use of engineered 
CRISPR systems to protect bacteria utilized in industrial processes (e.g. wine and dairy 
industry).  
While most uses of CRISPR-Cas in industrial processes refer to Bacteria, Archaea also 
possess some interesting aspects regarding their CRISPR-Cas systems. While only about 
40% of the sequenced bacteria have a CRISPR-Cas system, roughly 90 % of all sequenced 
archaea use CRISPR-Cas (Grissa et al, 2007a; Grissa et al, 2007b; Kunin et al, 2007). In 
some archaea the CRISPR arrays can make up to 1 % of the genome and as many as 18 
CRISPR loci have been identified in one species (Methanocaldococcus sp. FS406-22). Other 
archaea accumulated huge amounts of up to 47 cas genes (e.g. Pyrococcus yayanosii) 
(numbers taken from CRISPI data base). Given that most prokaryotes try to keep their 
genome as compact and small as possible it is remarkable that some organisms maintain a 
large variety of the CRISPR-Cas systems, while others do not possess any CRISPR loci. 
Archaea were proposed to constitute a third domain of life in 1977 (Woese & Fox, 1977), 
next to the already established domains Eukarya and Bacteria, and were accepted as such 
in the 1990’s (Woese et al, 1990).  
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Members of the Archaea are known to strive under extreme conditions (e.g. high/low pH, 
high temperature) (Whitman et al, 1999) but were later found to be as ubiquitous as Bacteria 
(Miller & Wolin, 1982). With the recent advances in the growth and maintenance of archaeal 
strains and the development of genetic tools for archaeal model organisms (Albers et al, 
2006; Berkner et al, 2007; Berkner et al, 2010; Blank et al, 1995; Gardner & Whitman, 1999; 
Sandbeck & Leigh, 1991) it became possible to survey some fundamental problems of 
biology: How do the extremophiles abide the harsh conditions? What drives the co-evolution 
of organisms from the three domains? Especially the methanogenic archaea got into focus 
as reserves of fossil fuels are decreasing and these organisms could provide a new source 
of bio-methane (Weiland, 2010). Methanococcus maripaludis is one exemplary organism, 
which produces methane during methanogenesis. It is a coccoidal, methanogenic archeon 
growing under mesophilic and strictly anaerobic conditions with a hydrogen/carbondioxide 
atmosphere and a 2 bar over-pressure (Jones et al, 1987; Jones et al, 1983). Isolated from 
the marshlands in Georgia (US), several further strains (Keswani et al, 1996) were found and 
sequenced of which some do and some do not have a CRISPR-Cas system. M. maripaludis 
C5, as a representative strain possessing a single subtype I-B system, serves as a perfect 
model organism to not only characterize the CRISPR-Cas system of this archaeon but also 
to investigate the evolutionary aspects of strains with and without a CRISPR-Cas system. M. 
maripaludis became an archael model organism due to the ability to grow and maintain this 
organism in an artificial environment and due to the availability of a fully sequenced genome 
and genetic tools (Gardner & Whitman, 1999; Sandbeck & Leigh, 1991). The single subtype 
I-B CRISPR-Cas system (Fig. 2) of M. maripaludis C5 is composed of a CRISPR locus with 
28 direct repeats of 37 nt length and 27 spacers of 34 – 40 nt length, which do not match to 
any known virus. Located adjacent to the CRISPR array are two operons of cas genes 
coding for the adaptation proteins Cas1, Cas2 and Cas4, for the interference proteins Cas3, 
Cas5, Cas7 and the subtype-specific protein Cas8b. In addition, the gene for the pre-­‐crRNA 
processing enzyme Cas6b is located here (Richter et al, 2012). 
 
 
Figure 2. Genetic organization of the subtype I-B CRISPR-Cas system of M. maripaludis C5. 
The system is comprised of i) a CRISPR array (black arrow) with 28 direct repeats of 37 nt length and 
27 unique spacers, ii) a leader sequence containing the transcriptional start site (grey shaded block) 
and iii) a set of 8 cas genes coded in two operons (grey arrows) (Richter et al, 2012). 
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The aim of the work presented in this thesis was to biochemically characterize the previously 
undescribed CRISPR-Cas subtype I-B based on the system identified in M. maripaludis. 
During the work all 8 cas genes were cloned and the proteins expressed. Of these, Cas2, 
Cas6b, Cas7 and Cas8b turned out to be soluble while the remaining four proteins yielded 
insoluble inclusion bodies. Therefore, the work focused on the biochemical characterization 
of the subtype-specific proteins Cas6b and Cas8b. Initial experiments included the 
verification of in vivo transcription and processing and the analysis of mature crRNA 
abundance and sequence of the CRISPR-Cas system of M. maripaludis. The pre-crRNA 
processing enzyme Cas6b was identified and characterized regarding its RNA binding and 
cleavage properties, including mutagenesis of important amino acid residues to determine a 
putative active site and binding domain. It was shown that Cas6b contains four amino acids: 
K30, the two interchangeable residues H38 and H40 and Y47 that play a major role for the 
pre-crRNA processing activity. This study also shows a possible dimerization of Cas6b 
during the processing step and reveals a methionine (M185) residue that is important for 
repeat recognition. A global in vitro analysis of crRNA processing and stability shows 
possible influences of spacer sequence and length on crRNA abundance. Analysis of the 37 
nt repeat sequence indicated that the sequence seems to be more important for processing 
than the structure of the repeat sequence. The results further indicate an interchangeability 
of repeat sequences of different I-B subtypes. 
The subtype-specific Cas8b protein was investigated considering its putative role within the 
interfering complex Cascade with focus on RNA and DNA binding and RNA and DNA 
cleavage properties. Cas8b of a bacterial and an archaeal subtype I-B system proved to co-
purify as two fragments, which suggests a possible self-cleavage of the protein. Further 
studies of Cas8b regarding its possible role in Cascade using R-loop mimicking structures 
showed that Cas8b does not cleave DNA or RNA and revealed unspecific binding to nucleic 
acids. Possible functions within the full Cascade assemble will be tested in future studies.  
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Abstract 
 
The CRISPR arrays found in many bacteria and most archaea are transcribed into a long 
precursor RNA that is processed into small clustered regularly interspaced short palindromic 
repeats (CRISPR) RNAs (crRNAs). These RNA molecules can contain fragments of viral 
genomes and mediate, together with a set of CRISPR-associated (Cas) proteins, the 
prokaryotic immunity against viral attacks. CRISPR/Cas systems are diverse and the Cas6 
enzymes that process crRNAs vary between different subtypes. We analysed CRISPR/Cas 
subtype I-B and present the identification of novel Cas6 enzymes from the bacterial and 
archaeal model organisms Clostridium thermocellum and Methanococcus maripaludis C5. 
Methanococcus maripaludis Cas6b in vitro activity and specificity was determined. Two 
complementary catalytic histidine residues were identified. RNA-Seq analyses revealed in 
vivo crRNA processing sites, crRNA abundance and orientation of CRISPR transcription 
within these two organisms. Individual spacer sequences were identified with strong effects 
on transcription and processing patterns of a CRISPR cluster. These effects will need to be 
considered for the application of CRISPR clusters that are designed to produce synthetic 
crRNAs. 
 
Introduction 
 
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated 
(cas) genes define an anti-viral defence system in Archaea and Bacteria. CRISPR loci are 
composed of repeat sequences with an average length of 24 – 47nt, which alternate with 
unique spacer sequences derived from previous encounters with foreign nucleic acids (i.e. 
viruses, plasmids) (Barrangou et al, 2007; Bolotin et al, 2005; Sorek et al, 2008; van der Oost 
et al, 2009). CRISPR loci are transcribed and processed to generate the small interfering 
crRNAs. Diverse sets of cas genes are often found adjacent to a CRISPR locus and encode 
proteins that are involved in the three phases of CRISPR/Cas activity: acquisition of new 
spacers, processing of crRNAs and interference with foreign nucleic acid (Barrangou & 
Horvath, 2011; Cui et al, 2008; Horvath & Barrangou, 2010; Koonin & Makarova, 2009; Terns 
& Terns, 2011). Although there is little information available for the process of new spacer 
acquisition, recent progress has led to a better understanding of the other two phases. The 
maturation of precursor crRNA into small crRNAs is performed by diverse Cas 
endonucleases that belong to a protein family termed Cas6 (Carte et al, 2010; Carte et al, 
2008; Gesner et al, 2011; Haurwitz et al, 2010; Sashital et al, 2011; Wang et al, 2011; Wang 
et al, 2012). In CRISPR/Cas Type-I the interference step is mediated by a complex of 
different Cas proteins (Cas complex for antiviral defence: Cascade) bound to crRNAs that 
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target the invading nucleic acid through base complementarity which ultimately results in the 
inactivation or degradation of foreign DNA by Cas3 (Howard et al, 2011; Jore et al, 2011b; 
Lintner et al, 2011b; Mulepati & Bailey, 2011; Plagens et al, 2012; Semenova et al, 2011; 
Sinkunas et al, 2011; Westra et al, 2012c). Type-II CRISPR/Cas systems use the single 
Cas9 protein for interference (Sapranauskas et al, 2011) and Type-III systems use a multi 
Cas protein complex that is distinct from Cascade (Cocozaki et al, 2012; Zhang et al, 2012). 
Computational analyses of these defence systems identified a surprising diversity of different 
CRISPR/Cas types and subtypes, which are spread throughout archaeal and bacterial 
kingdoms. 
This classification has defined three major types which can be further divided into at least 10 
CRISPR/Cas subtypes (Makarova et al, 2011b). The subtype I-B, found, e.g. in Clostridia, 
methanogens and halophiles, is defined by the subtype- specific protein Cas8b. In 
Clostridium thermocellum and Methanococcus maripaludis the minimal subtype I-B Cas 
protein organization consists of the universal Cas1, Cas2 and Cas4 proteins that are 
proposed to mediate the integration of spacers as well as Cas3, Cas5, Cas7 and Cas8b, 
which are proposed to form the Cascade complex of this subtype. Finally, a Cas6 protein is 
required for the processing of crRNA (Carte et al, 2010; Carte et al, 2008; Gesner et al, 
2011; Haurwitz et al, 2010; Sashital et al, 2011; Wang et al, 2011; Wang et al, 2012). 
A Cas6 protein was first described for CRISPR/Cas subtype III-B in Pyrococcus furiosus as a 
metal-independent endonuclease involved in the processing of precursor crRNA into mature 
crRNA (Carte et al, 2010; Carte et al, 2008; Wang et al, 2011; Wang et al, 2012). Cas6 
enzymes were also characterized for CRISPR/Cas subtype I-F in Pseudomonas aeruginosa 
(Cas6f, also termed Csy4) (Haurwitz et al, 2010) and CRISPR/Cas subtype I-E in Thermus 
thermophilus and Escherichia coli (Cas6e, also termed Cse3) (Gesner et al, 2011; Sashital et 
al, 2011). The amino acid sequence similarity of these Cas6 proteins is limited, yet they 
share ferredoxin-like folds and perform analogous reactions in the different CRISPR/Cas 
systems. These Cas6 proteins do not only differ in substrate specificity, but also in the 
composition of their active sites. For example P. furiosus Cas6 (Pf Cas6) interacts with 
single-stranded RNA while Cas6e and Cas6f seem to specifically bind to hairpin structures 
formed by the repeats (Carte et al, 2010; Carte et al, 2008; Gesner et al, 2011; Haurwitz et 
al, 2010; Sashital et al, 2011; Wang et al, 2011; Wang et al, 2012). Further differences can 
be found in the catalytic site of the Cas6 proteins. Pf Cas6 uses a catalytic triad composed of 
tyrosine, histidine and lysine residues (Carte et al, 2010; Wang et al, 2011), while in Cas6f a 
catalytic dyad of a histidine and a serine residue proved to be important for protein activity 
(Haurwitz et al, 2010; Haurwitz et al, 2012). Activity of Cas6e relies on a tyrosine and a 
histidine residue (Gesner et al, 2011; Sashital et al, 2011). Although there are variations in 
their active site composition and the recognition of RNA substrates, the different Cas6 
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cleavage reactions always generate crRNAs that consist of a spacer unit that is flanked by 8 
nt of the repeat sequence as a 5'-terminal tag and a 3'-terminal repeat tag (Carte et al, 2008; 
Gesner et al, 2011; Haurwitz et al, 2010). Finally, Cas6 was shown to deliver the mature 
crRNA to the Cascade complex (Jore et al, 2011b; Wiedenheft et al, 2011b). 
In this study, we provide the first analysis of crRNA processing for CRISPR/Cas subtype I-B 
for one bacterial model organism, C. thermocellum and one archaeal model organism, M. 
maripaludis (detailed information of CRISPR loci and gene organization can be found in 
Supplementary Figure S1). The abundance and processing of crRNAs were analysed in vivo 
by RNA-Seq methodology. In addition, the Cas6 enzymes of this CRISPR/Cas subtype 
(termed Cas6b) were identified and M. maripaludis Cas6b (Mm Cas6b) was analysed for 
crRNA processing in vitro. 
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Material and Methods 
 
Growth of E. coli, M. maripaludis C5 and C. thermocellum cells 
 
Methanococcus maripaludis C5 cells were a kind gift of W.B. Whitman (Georgia). Clostridium 
thermocellum (DSM1237) cells were obtained from DSMZ (German collection of micro-
organisms and cell cultures). All E. coli cells were grown in LB-media with appropriate 
antibiotics at 37 °C and shaking at 200 rpm. 
Methanococcus maripaludis C5 was grown at 37 °C in complex medium for methanococci 
(McC) (Jones et al, 1987) with H2/CO2 atmosphere (80%/20%) and one bar (15 psi) 
overpressure. Clostridium thermocellum cells were incubated in complex medium (Lynd & 
Grethlein, 1987) at 60 °C with an anaerobic atmosphere (N2). 
 
Production of Cas6 and mutants 
 
The cas6 genes MmarC5_0767, Cthe_3205 and Cthe_2303 were amplified from genomic 
DNA of M. maripaludis C5 or C. thermocellum ATCC 27405 and cloned into the vector pET-
20b to facilitate protein expression with a C-terminal His-tag. Oligonucleotides for site-
directed mutagenesis were designed using Agilents QuickChange Primer Design tool and 
cas6 mutants were created using the QuickChange site-directed mutagenesis (Stratagene) 
according to the manufacturer’s instructions. Mutations were confirmed by sequencing 
(MWG Eurofins). 
All Cas6 variants were produced in E. coli (Rosetta2 DE3) cells. Induction of protein 
expression was performed by addition of isopropylthio-b-D-galactoside (IPTG) to a final 
concentration of 0.5 mM after growing the cells to an OD578 of 0.6. Four hours after induction 
the cells were harvested, the pelleted cells re-suspended in lysis buffer (10 mM Tris–HCl 
[pH8.0], 300 mM NaCl, 10 % glycerol and 0.5 mM DTT) and incubated on ice with lysozyme 
(1 mg/g cell pellet) for 30 min. Cell disruption was performed using sonication (8 x 30 s; 
Branson Sonifier 250). Clearing of the lysate was achieved by centrifugation (20000 rpm, 30 
min, 4 °C) and the supernatant was applied to a Ni–NTA–Sepharose Column (GE- 
Healthcare) and purified using a FPLC Äkta- Purification system (GE-Healthcare). Elution of 
the proteins was performed by a linear imidazole gradient (0 - 500 mM). Purity of the proteins 
was determined by sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS–
PAGE) and Coomassie Blue staining. The protein was dialysed into lysis buffer and the 
protein concentration was determined by Bradford Assay (BioRad). 
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Generation of RNA substrates 
 
The spacer2–repeat–spacer3 and repeat–spacer27–repeat RNA substrates were generated 
by in vitro run-off transcription using T7 RNA polymerase and internally labelled using [α-32P] 
adenosine triphosphate (ATP) (5000 ci/mmol, Hartman Analytic) (Sampson & Uhlenbeck, 
1988). The repeat RNAs and repeat RNAs with a substitution of the first unprocessed 
nucleotide against a dexoy nucleotide were synthesized by Eurofins MWG Operon. End 
labelling of these substrates was performed using T4 polynucleotide kinase (Ambion) and 
[γ-32P] ATP (5000 ci/mmol) according to the manufacturer’s instructions. 
Templates for in vitro transcription were obtained by cloning of the pre-crRNA sequences 
with an upstream T7 RNA polymerase promotor sequence into pUC19 vector. After 
linearization of the plasmid with HindIII, in vitro transcription was performed in a final volume 
of 20 µl [40 mM HEPES–KOH (pH8.0); 22 mM MgCl2; 5 mM DTT; 1 mM spermidine; 4 mM 
UTP, CTP, GTP and 2 mM ATP; 20 U RNase inhibitor; 1 µg T7 RNA polymerase; 1 µg 
linearized plasmid] at 37 °C for 1 h. End labelling of synthesized RNA was done in a 20 µl 
reaction volume: 10 µl of the RNA was labelled using 2 µl T4 Polynucleotide Kinase (PNK) 
buffer (New England Biolabs (NEB)) and 25 U T4 PNK (Ambion) at 37 °C for 30 min. 
The RNAs were separated by denaturing PAGE (8 M urea; 1 x TBE; 10% polyacrylamide), 
and afterwards respective bands were cut out using sterile scalpels in reference to brief 
autoradiographic exposure. The RNA was eluted from the gel piece using 500 µl RNA elution 
buffer [250 mM NaOAc, 20 mM Tris–HCl (pH 7.5), 1 mM ethylenediaminetetraacetic acid 
(EDTA) (pH8.0), 0.25 % SDS] and overnight incubation on ice. Precipitation of RNA was 
performed by adding two volumes EtOH (100 %; ice cold) and 1/100 glycogen for 1 h 
at -20°C and subsequent washing with 70 % EtOH of pelleted RNA. 
 
Endonuclease assay 
 
Different indicated concentrations of purified Cas6 enzyme were incubated with radio 
labelled RNA substrates and buffer [250 mM KCl, 1.875 mM MgCl2, 1 mM DTT, 20 mM 
HEPES–KOH (pH 8.0)]. The reaction mix was incubated for 10 min at 37 °C and then 
immediately mixed with 2x formamide buffer [95 % formamide; 5 mM EDTA (pH 8.0); 2.5 mg 
bromophenol blue; 2.5 mg xylene cyanol] and incubated at 95 °C for 5 min to stop the 
cleavage reaction. The reaction was applied to a denaturing 12–15 % polyacrylamide gel 
running in 1 x TBE with 12 W for 1.5 h. Visualization was achieved by phosphorimaging. 
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RNA-sequencing 
 
RNA and DNA were extracted from cell lysates with phenol/chloroform (1:1; phenol pH 5 for 
RNA and pH 8 for DNA) (Randau et al, 2005b). A Proteinase K and 55 °C heat shock 
treatment preceded the phenol/chloroform step. Small RNAs (<200 nt) were purified from 
total RNA using the mirVana RNA extraction kit (Ambion). Three micrograms of isolated 
small RNA from either M. maripaludis C5 or C. thermocellum were treated with T4 PNK to 
ensure proper termini for ligation. A protocol for the dephosphorylation of 2'-, 3'-cyclic 
phosphate termini was modified from (Schurer et al, 2002): 1 µg of RNA was incubated at 
37°C for 6 h with 10 U T4 PNK and 10 µl 5x T4PNK buffer (NEB) in a total volume of 50 µl. 
Subsequently, 1 mM ATP was added and the reaction mixture was incubated for 1 h at 37 °C 
to generate monophosphorylated 5'-termini. RNA libraries were prepared with an Illumina 
TruSeq RNA Sample Prep Kit and sequencing on an Illumina HiSeq2000 sequencer was 
performed at the Max-Planck Genomecentre Cologne. 
 
Identification of crRNA abundance 
 
Sequencing reads were trimmed [(i) removal of Illumina TruSeq linkers and poly-A tails and 
(ii) removal of sequences using a quality score limit of 0.05] and mapped to the reference 
genomes (GenBank: CP000568 and CP000609) with CLC Genomics Workbench 5.0 (CLC 
Bio, Aarhus, Denmark). The following mapping parameters were used (mismatch cost: 2, 
insertion cost: 3, deletion cost: 3, length fraction: 0.5, similarity: 0.8). Reads <15 nt were 
removed. Initial crRNA identification was obtained from crisprdb (Grissa et al, 2007a) and 
gene annotations were obtained from Genbank. 
 
Modelling of M. maripaludis Cas6b 
 
A model of the Mm Cas6b (MmarC5_0767) protein structure was built with the I-TASSER 
platform (Roy et al, 2010). The program identified P. furiosus Cas6 (pdb ID 3PKM) as the top 
template for structure prediction. The protein model was compared with the Pf Cas6 crystal 
structure using the program DaliLite (Holm & Park, 2000) and their alignment revealed two 
homologous structures (Z-score 19.7, RMSD 2.5 Å). Cas6b sequences were aligned with 
ClustalW2 (Larkin et al, 2007). 
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Results 
 
crRNA processing for CRISPR/Cas subtype I-B 
 
The processing of crRNAs of the CRISPR/Cas subtype I-B was analysed by RNA-Seq for M. 
maripaludis C5 and for C. thermocellum ATCC 27 405. The isolated total small RNAs were 
modified with T4 polynucleotide kinase to allow proper adapter ligation and were sequenced 
through Illumina HiSeq2000 RNA-Seq methodology. Over 14 million individual sequence 
reads were mapped to the corresponding reference genomes and elucidated the abundance 
and processing patterns of the CRISPR arrays of these two organisms. M. maripaludis C5 
possesses a single CRISPR cluster with 28 repeats of 37-nt length that are interspersed by 
27 unique spacers. The CRISPR region is constitutively transcribed and processed into small 
crRNAs (Figure 1). The crRNAs contain a clearly defined 5'-terminal 8-nt tag with the 
sequence 5'-AUUGAAAC-3'. The 3'-termini are gradually shortened and most often contain a 
minimal 2-nt tag with the repeat nucleotides 5'-CU-3'. The abundance of crRNAs declines 
gradually from the leader proximal to the leader distant region with the crRNA containing the 
highly AT-rich (30 A or T out of 34 nt) spacer 3 being underrepresented. 
 
 
Figure 1. crRNA processing in M. maripaludis. Illumina HiSeq2000 sequencing reads mapped to 
the M. maripaludis C5 reference genome highlight the abundance of crRNAs. Processing occurs 
within the repeat elements, generating crRNAs with a 5'-terminal AUUGAAAC 8-nt tag (boxed) and 
more variably trimmed 3'-terminal tags. Cleavage sites are indicated and a possible hairpin structure 
was predicted by RNAfold (Zuker & Stiegler, 1981). 
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crRNA processing patterns in C. thermocellum reveal long-range influence of spacer 
sequences 
 
RNA-Seq analysis of the small RNAs of C. thermocellum revealed five constitutively 
transcribed and processed CRISPR clusters. Two of these CRISPR/Cas subtype I-B 
systems are very similar to the one found in M. maripaludis and contain 37-nt repeat 
elements. The other three CRISPR clusters have 30-nt repeat sequences. Processing of 
both C. thermocellum CRISPR repeat sequences into mature crRNAs yields the same 5'-
terminal 8-nt (5'- AUUGAAAC-3') tag that is also found for M. maripaludis crRNAs (Figure 2 
and Supplementary Figure S2). The 3'-termini are trimmed leaving mostly short tags. The 
abundance of crRNAs follows the pattern found in M. maripaludis and described for other 
CRISPR/Cas subtypes with one notable exception. The CRISPR locus 3 contains an internal 
signal to promote crRNA transcription within the CRISPR array (Figure 2A and 
Supplementary Table S1). The overall crRNA abundance gradually declines from Spacer 1 
to Spacer 103 before crRNA production peaks again starting with the crRNA containing 
spacer number 104. Interestingly, the 8-nt repeat tags are not identical for the crRNAs from 
this CRISPR locus 3 as at Spacer 116 the final U base of the 5'-terminal tag is changed to 
the commonly found base C (Figure 2A and Supplementary Table S1). Close analysis of this 
sudden spike of internal crRNA abundance revealed a transcription start site at the A residue 
at Position 29 within Spacer 103. Our data suggest that this spacer is sufficient to promote 
transcription within the CRISPR region and that the 28-nt upstream of the transcription start 
within the spacer provide the necessary promoter elements in the context of the flanking 
repeats. Although it is difficult to pinpoint the pribnow box, the extreme AT-richness of the 
spacer (26 out of 28 nt upstream of the transcription start site are A and T residues) suggests 
relaxed strand separation. DNA sequencing of the genomic region upstream of Spacer 104 
excluded errors in the initial genome assembly during whole-genome sequencing. In addition 
to internal promotion, we observed several cases of bidirectional transcript production for the 
CRISPR arrays. Anti-crRNA transcripts can start at the region opposite of the leader 
(CRISPR loci 1,2,5) or internally (CRISPR locus 4) (Figure 2B and Supplementary Figure 
S2). Although the amount of these anti-crRNA transcripts is usually very small in comparison 
to the abundance of crRNAs, individual anti-crRNAs show a conserved processing pattern 
within the repeats that yields RNAs with complete reverse complementary spacer 
sequences. These anti-crRNAs usually contain 18-nt 5'-tags and 15-nt 3'-tags for CRISPR 
loci 1 and 2 and 22-nt 5'-tags for CRISPR loci 4 and 5 (Supplementary Figure S3). The 
presence of processed anti-crRNAs can correlate with the reduced abundance of the 
respective sense crRNA (Figure 2B and Supplementary Figure S2). 
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Figure 2. crRNA processing in C. thermocellum. Illumina HiSeq2000 sequencing reads were 
mapped to the C. thermocellum ATCC 27405 reference genome and selected CRISPR regions are 
displayed. Conserved 5'-terminal crRNA cleavage sites and variably trimmed 3'-termini are indicated 
within the repeat sequence. A possible hairpin structure was predicted by RNAfold (Zuker & Stiegler, 
1981). All C. thermocellum CRISPR mappings are found in Supplementary Figure S2. (A) CRISPR 
locus 3 reveals internal promotion of crRNA transcription at Spacer 104. (B) CRISPR locus 4 
exemplifies bidirectional CRISPR transcription. Forward and reverse reads were separated to highlight 
the occurrence of processed anti-crRNAs that can correlate with reduced crRNA abundance. 
 
Identification of Cas6 I-B enzymes that generate crRNAs 
 
To identify the enzyme that generates crRNAs for CRISPR/Cas subtype I-B, we analysed the 
cas genes of M. maripaludis and C. thermocellum. A set of only eight cas genes was 
identified in the genome of M. maripaludis C5. One of these potential cas gene products 
(MmarC5_0767, Mm Cas6b) showed 12 % amino acid identity to Pf Cas6 which identified it 
as a Cas6b candidate for CRISPR/Cas subtype I-B. As the protein shares limited sequence 
identity with Cas6 proteins of other CRISPR/Cas subtypes (Carte et al, 2008; Gesner et al, 
2011; Haurwitz et al, 2010), the structure of Mm Cas6b was modelled with I-Tasser (Roy et 
al, 2010; Zhang, 2008). Pf Cas6 was identified as the closest structural homologue and 
shares a very similar overall architecture [Dali-Lite Z-score 19.7, RMSD 2.5 Å, (Holm & Park, 
2000)] (Figure 3). The structural alignment of the Mm Cas6b model and Pf Cas6 also reveals 
a conserved histidine residue of Mm Cas6b in close proximity to the catalytic histidine of Pf 
Cas6. The comparison of different Cas6b homologues of CRISPR subtype I-B (Figure 3) 
indicates high sequence similarity and conserved residues. Clostridium thermocellum 
contains one Cas6b homologue (Cthe_3205) associated with the 37-nt repeat sequences 
and a potential second Cas6 enzyme (Cthe_2303) associated with the 30-nt repeat 
sequences. Classification of Cthe_2303 is not unambiguously possible as the neighbouring 
cas genes do not clearly fit into the commonly used 10 CRISPR/Cas subtypes. 
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Figure 3. Structural model of Cas6b shows high similarity to Pf Cas6. (A) A structure model (I-
Tasser) of M. maripaludis Cas6b was aligned to Pf Cas6 (DaliLite). The catalytic site of Pf Cas6 is 
indicated and a histdine at Position 38 in Cas6b is located in close proximity to the catalytic histdine in 
P. furiosus. (B) An alignment of Cas6b homologues (ClustalW) of subtype I-B shows conserved amino 
acid residues (black coloured residues) and reveals putative catalytic residues (black bars). 
 
Repeat specific endonucleolytic activity of subtype I-B Cas6 homologues 
 
The genes for Cas6 enzymes from M. mariplaudis and C. thermocellum were cloned and the 
recombinant enzymes were produced. Clostridium thermocellum Cas6b (Cthe_3205) 
production yielded only insoluble protein, but the two other Cas6 proteins were obtained in 
soluble form and allowed the analysis of their involvement in crRNA processing. Size 
exclusion separation of Mm Cas6b revealed a monomeric structure of the protein. The 
purified Cas6 candidates (Mm Cas6b and Cthe_2303) showed in vitro endonuclease activity 
and processed repeat RNA sequences from M. maripaludis and C. thermocellum, 
respectively (Figure 4). Therefore, the unclassified Cthe_2303 provided a good control for 
crRNA processing specificity of Mm Cas6b, as both enzymes specifically recognized only the 
repeats from their associated CRISPR clusters. Addition of bivalent metal ions did not 
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influence the activity of Mm Cas6b. To define the cleavage site, a repeat RNA was 
synthesized with a deoxy nucleotide substitution at the proposed processing position that 
generates the 8-nt crRNA 5'-tag observed in vivo. This substitution resulted in the loss of Mm 
Cas6b and Cthe_2303 processing. 
 
Figure 4. Cas6b of M. maripaludis (MM C5) and C. thermocellum Cthe_2303 (CT) cleave their 
specific repeat structure. Cas6b endonuclease assay were performed with 5'-terminal radioactively 
labelled repeat RNA and the respective deoxy variants (indicated at the bottom, -1 displaying the first 
base upstream of the 5'-tag) of M. maripaludis and C. thermocellum. Cas6b processes the 37-nt 
repeat into the smaller 29-nt fragment, while the deoxy variant (d-1) and the 30-nt repeat RNA of C. 
thermocellum are not cleaved. Cthe_2303 is specific for its 30-nt repeat RNA. 
 
A single repeat structure is sufficient for Mm Cas6b in vitro processing 
 
To test the influence of different RNA substrates (Supplementary Table S2) for Mm Cas6b 
activity, cleavage assays were performed with (i) repeat RNA, (ii) repeat - spacer - repeat 
RNA and (iii) spacer - repeat - spacer RNA using repeat and spacer sequences of the M. 
maripaludis CRISPR. For all three substrates, product formation was observed that 
corresponds with Mm Cas6b processing at the cleavage site determined by the deoxy 
nucleotide substitution within the repeat (Figure 4). This cleavage site determines that the 
conversion of the repeat (37 nt) results in a 29-nt fragment, while the 
repeat - spacer27 - repeat structure (131 nt) is processed into three fragments (74, 38 and 
19 nt) and the spacer2 - repeat - spacer3 substrate (110 nt) is cleaved into two fragments (67 
and 43nt) (Figure 5). Since all used substrates were cleaved in similar efficiency, the repeat 
RNA was used for further analysis of the catalytic site of Mm Cas6b. In order to test the 
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influence of the computationally predicted [RNAfold (Zuker & Stiegler, 1981)] short hairpin 
structure of the repeat (Figure 1), the mutation G16C was introduced that disrupts a G–C 
base pair within this hairpin. The mutated repeat was cleaved less effectively than wild-type 
repeats (Supplementary Figure S4). 
 
Figure 5. RNA substrates for Cas6b processing. The two ‘repeat - spacer27 - repeat’ and 
‘spacer2 - repeat - spacer3’ substrates were internally labelled by in vitro transcription and repeat RNA 
molecules were 5'-end labelled. The substrates were used in three independent cleavage assays 
using different concentrations of Cas6b (4, 2, 0.125 and 0.0625 µM). (A) A representative assay 
shows the ability of Cas6b to process all used substrates in similar manner and efficiency. (B) Product 
formation for three independent reactions was quantified. 
 
Mm Cas6b contains two catalytic histidine residues 
 
To deduce catalytic residues, potentially important amino acids were identified based on the 
structural model of Mm Cas6b and the observed conservation of amino acids in the 
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alignment of Cas6b homologues (Figure 3). Cas6 proteins of other CRISPR/Cas subtypes 
contain a single catalytic histidine residue. In Cas6b, there are two conserved histidine 
residues (H38 and H40), separated only by a single amino acid that could potentially fulfil this 
role. A set of Mm Cas6b mutants was produced (Supplementary Figure S5) of which two 
mutants (Y49A and Y47A/Y49A) yielded insoluble proteins. The other mutants were used in 
endonucleolytic cleavage assays testing the processing of the repeat RNA substrate in 
comparison to wild-type Mm Cas6b (Figure 6). The single histidine mutant H38A and the 
tyrosine mutant Y47A showed reduced processing activity compared with wild-type Mm 
Cas6b. The H40A mutation reduced Mm Cas6b activity by >50 %. Surprisingly, both single 
histidine mutants retained considerable cleavage activity. However, the mutation of both 
histidine residues into alanine (H38A/H40A) resulted in a drastic loss of substrate 
processing. Mutation of the lysines at Position 29 or 30 did not show any notable effect on 
endonucleolytic activity. 
 
Figure 6. Two histidine residues play a critical role for Cas6b activity. Cas6b endonuclease 
assays were performed with the indicated Cas6b variants and 5'-end-labelled repeat RNA substrates. 
(A) A representative assay shows the activities of the Cas6b variants. While mutation of two lysines at 
Position 29 and 30 did not show any influence on activity in comparison to wild-type (wt), a mutation of 
two histidines at Positions 38 and 40 as well as a mutation of tyrosine at Position 47 show reduced 
processing activity. (B) Product formation for three independent reactions was quantified.  
	   27	  
Discussion 
 
The observed crRNA processing and abundance patterns of CRISPR/Cas subtype I-B are in 
good agreement with crRNA maturation previously analysed for other CRISPR/Cas subtypes 
and substantiate that 8-nt 5'-terminal and trimmed 3'-terminal crRNA tags are an universal 
feature of many CRISPR/Cas subtypes. The surprising observation of a spacer sequence 
that promotes crRNA production internally in C. thermocellum exemplifies the effect that an 
individual spacer can have for the abundance of mature crRNAs and subsequently the 
efficiency of entire CRISPR regions. The exchange of 1 nt of the otherwise universal 
5'-terminal 8-nt tag of the crRNAs in the vicinity of the internal CRISPR transcription start site 
opens the possibility that two CRISPR elements might have been fused and subsequently 
portions of a leader element might have been incorporated into the repeat - spacer - repeat 
pattern. In addition, spacer elements were shown to promote transcripts of the reverse 
orientation. These anti-crRNAs were first described in Sulfolobus (Lillestol et al, 2009) and 
were also found in P. furiosus (Hale et al, 2012). However, they appear to be absent in most 
organisms. The occurrence of specific processing patterns for anti-crRNAs from different 
repeats of C. thermocellum CRISPR and the absence of anti-crRNAs in M. maripaludis 
indicate that this phenomenon might be specific for organisms with relaxed transcription start 
site definition rather than for the CRISPR/Cas subtype. Individual anti-crRNAs appear to be 
better suited for a conserved maturation process at their termini by a currently unknown 
mechanism. Reverse transcripts can form double-stranded RNA duplexes that might reduce 
the abundance and efficiency of crRNAs. Taken together these results highlight the effects 
that individual spacer sequences within a CRISPR region can have in both forward and 
reverse direction. These strong effects will need to be taken into consideration in the 
anticipated and proposed design of synthetic CRISPR regions for biotechnologically or 
medically important processes. We identified the Cas6b endonuclease responsible for crRNA 
maturation in the CRISPR/Cas subtype I-B. Cas6 enzymes are among the most diverse 
members in the sets of Cas protein of the different CRISPR/Cas subtypes and can be used 
to classify CRISPR/Cas systems. The similarity of repeat sequences and Cas6b enzymes 
between Bacteria (i.e. Clostridia) and Archaea (i.e. methanogens) hints at a horizontal 
transfer event for these CRISPR/Cas systems. Cas6 proteins might show this remarkable 
degree of divergence due to their individual adaptation to the given repeat sequence and/or 
structure. Evidence for this can also be found in the different principles of recognition for Pf 
Cas6, Cas6e and Cas6f. While Pf Cas6 binds to unstructured RNA, both Cas6e and Cas6f 
need a secondary structured RNA to bind and process in vitro (Haurwitz et al, 2010; Sashital 
et al, 2011; Wang et al, 2011). For Type II CRISPR systems, no Cas6 activity was reported. 
In these systems, the presence of a guide RNA (tracrRNA) recruits RNase III for the 
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processing of crRNAs (Deltcheva et al, 2011). These pathways exemplify the differences in 
crRNA maturation among organisms and CRISPR subtypes. The Cas6 enzymes Pf Cas6, 
Cas6e and Cas6f of different CRISPR/Cas subtypes were all shown to require a single 
conserved histidine residue for catalysis (Carte et al, 2010; Gesner et al, 2011; Haurwitz et 
al, 2010; Haurwitz et al, 2012; Sashital et al, 2011; Wang et al, 2011). In this study not one 
but two conserved histidine residues were identified for Mm Cas6b. Only the simultaneous 
mutation of both histidine residues resulted in a drastic loss of endonuclease activity. This 
implies that Cas6b exhibits the first example of a more flexible catalytic core in which both 
histidine residues are potentially representing the catalytic histidine and able to complement 
the loss of the other residue. Why did Cas6b evolve two catalytic histidine residues where 
this function can be fulfiled by a single histidine in other Cas6 enzymes? One possible 
explanation is the advantage such setup would have in coping with different substrates, e.g. 
with crRNA precursors that contain spacer of different length or structure. In Pf Cas6 a 
catalytic triad was described that provides a catalytic site for general acid/base catalysis 
(Carte et al, 2010; Wang et al, 2011). Mm Cas6b does not contain an identical catalytic triad 
but our observation of the importance of tyrosine 47 for Mm Cas6b activity and the 
occurrence of clustered amino acids that could provide general bases and acids might 
indicate more flexible active site architecture. 
In conclusion, we provide the first description of crRNA processing in vivo and in vitro for 
CRISPR/Cas subtype I-B. These analyses of Cas6b in a bacterial and an archaeal model 
organism highlight the similarities between different CRISPR/Cas subtypes and the 
differences in crRNA processing. Two interchangeable catalytic histidine residues in Cas6b 
and internal promotion of crRNA production in C. thermocellum exemplify two new concepts 
that were found for CRISPR/Cas I-B systems. 
 
Acknowledgements 
 
The authors thank Andreas Su for technical help and André Plagens for advice and 
discussions. The authors are very grateful to Michael Rother, Rolf Thauer and William B. 
Whitman for their help with the handling of Methanococcus maripaludis. 
  
	   29	  
Supplementary Material 
 
Supplementary Figures 
 
	  
 
Figure S1. Genomic context and gene organization of the CRISPR loci in C. thermocellum and 
M. maripaludis. Schematic view of the CRISPR loci organization in a) C. thermocellum and b) M. 
maripaludis. Indicated are the number of spacers and the repeat length. 
	   30	  
	  
 
Figure S2. CRISPR RNA processing in C. thermocellum. Illumina HiSeq2000 sequencing reads 
were mapped to the C. thermocellum ATCC 27405 reference genome and CRISPR loci 1, 2 and 5 are 
displayed. Forward and reverse reads highlight the occurrence of processed anti-crRNAs. 	  	  	  	  	  
	  
 
Figure S3. Processing patterns of crRNA and anti-crRNA transcript maturation in C. 
thermocellum. Examplary transcripts for CRISPR locus 1 (30 bp repeats) and CRISPR locus 4 (37 bp 
repeats) are shown. 5’ and 3’ terminal tags that display a conserved cleavage pattern are indicated by 
black boxes and gradually processed termini are indicated in grey. 
	   31	  
	  
Figure S4. Repeat structure influence on Mm Cas6b activity. Mm Cas6b endonuclease assays 
were performed using internally labelled spacer2 - repeat - spacer3 substrates containing a wild type 
repeat sequence and a repeat variant with a mutation of G16 to C (G16C) that eliminates a G-C 
basepair and the computationally predicted hairpin formation (RNAfold). Mm Cas6b processing of the 
mutated repeat structure is strongly impaired. 
 
 
	  
Figure S5. Purity of wild-type (wt) Cas6b and mutant variant preparations. 5 µg of the indicated 
purified protein samples were separated on a coomassie blue stained 15 % SDS-PAGE. 
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Supplementary tables 
 
Table S1 Abundance patterns of C. thermocellum crRNAs. The crRNA production of all 5 C. 
thermocellum CRISPR clusters is detailed.    
   
C. thermocellum  CRISPR 1                                                                         
genome position:  716798 - 720142                                                              
61 units 
GTTTGTATCGTACCTATGAGGAATTG
AAAC (30 bp)  
   
       spacer 
# 
start 
position 
end 
position spacer sequence (sense direction) # reads 5'tag comments 
              
1 716828 716864 
UAAAACAAAGGAGAAUUGUAAAUGGAAG
AGUAUUUGA  4366 AUUGAAAC   
2 716895 716930 
UCGAGAUUUUGGAACUUUGUUUCGCCAU
UCGUGUCU  11390 AUUGAAAC   
3 716961 716997 
UCCGCAAAAGAGAGAAUCAGAGCUGCCG
AACUUUUGG  16074 AUUGAAAC   
4 717028 717062 
CGUUUCAUGGAUUUGAUAAGUUCAAGCU
CUAUCUC  23737 AUUGAAAC   
5 717093 717128 
GAUUCAGAAUUGAACGAGUACGUCAAAA
GCGUUUUA  53779 AUUGAAAC   
6 717159 717195 
UAGAUGAAUCAAAUAGUUCUACUGGACU
UGGAGAUAC  17396 AUUGAAAC   
7 717226 717261 
AAAUAAAUCUAAAGGGUAUGCCACGGAA
ACGUUAUA  13672 AUUGAAAC   
8 717292 717327 
CCCAGUAUGGAAUGGCGGUGGAACUGU
CCGGCUGGC  15046 AUUGAAAC   
9 717358 717394 
GCUCUAACAGUAAUUCAAUUAUUUUUGU
AUUCAUUUG  34638 AUUGAAAC   
10 717425 717461 
CGGGCCGCGCCUAUUUGCGUGGGAACC
CUUAUAAUGG  2467 AUUGAAAC   
11 717492 717527 
CGGUACUGCUGUGGUUAUCGACGAGAU
UCAGACUUG  12496 AUUGAAAC   
12 717558 717593 
ACGGAAGAGAAAAAACAGCAGAUAAUACA
AAGCGUA  5756 AUUGAAAC   
13 717624 717660 
UCAUUUUUUUCACGACUAUACAAUAUAC
CAUUUGAAU  2599 AUUGAAAC   
14 717691 717725 
UGGCUGAAAGGUUAUAGGUUGAAAGGAA
AAGUCCC  6538 AUUGAAAC   
15 717756 717791 
UCUCGCCUUUUGGCGGUUCGACUUUUG
CCGCUUUCA  1286 AUUGAAAC   
16 717822 717859 
GAAUUGCCAUUAAGUCUUUGGUUUCUUG
UCUUGUCAUG  33989 AUUGAAAC   
17 717890 717928 
UACAGCCUCCUUCAUGCUUUCUCCUUUG
UCAGCUAACUC  201 AUUGAAAC   
18 717959 717994 
AAGGCUGGGGUGAGUGGGUUGAAGUAA
CUGAAGGUG  757 AUUGAAAC   
19 718025 718059 
UUAUUUUUAGUACAUCAUUAUUUGUGAU
UAUUCUA  1594 AUUGAAAC   
20 718090 718127 
UUUGCCCUCUCCUUUCUUUUCUUUUGUU
UGUUUUAGCG  675 AUUGAAAC   
21 718158 718193 
UCUACCUGUUGAGCUUCUGCCACUUGUU
CUAAUGUA  4869 AUUGAAAC   
22 718224 718260 
UUGUUCAGCCUCCUUUCUAAGCAAUGUA
AUAAUAAAA  566 AUUGAAAC   
23 718291 718328 
CUUCAUAAUCUUUAGGGGUUCUUUUCUU
CAUAUUGUCA  1925 AUUGAAAC   
24 718359 718396 
CAACACUCCUUUAUUAUUAUUAUUUUUC
CUGCCUUUGC  353 AUUGAAAC   
25 718427 718462 
UAGGCCAGCUCGAAAAAGCCGGCGCUAA
CACCGAAG  432 AUUGAAAC   
26 718493 718529 
AUGUGCCUCCGCCACGUCUUGUUAUAAU
UGCUUCUCC  200 AUUGAAAC   
27 718560 718595 
CAUUGUUGCCUAGUUGUUUUUUUGGUU
UUACUUCUC  671 AUUGAAAC   
28 718626 718663 
AUUGCCGGCGGCAAGUCUGAAGCGCCAA
GAAUUGACCG  942 AUUGAAAC   
29 718694 718729 
CCGACUGUUCGACGUAGACGUCGACAG
GAGGAAAGA  148 AUUGAAAC   
30 718760 718795 
CCUCAAUUUCAUUGUAUCACCGGAGCAG
UGGAGCGU  683 AUUGAAAC 
identical 
with spacer 
#34 
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31 718826 718861 
CAGAAAACUUGUGAACUACCGCCACUUA
UAGAAGUG  758 AUUGAAAC   
32 718892 718928 
UUGUUCUGCAACUUAUGUAAACAUGUAG
UCGAAAUCA  3153 AUUGAAAC   
33 718959 718994 
UCUAUCAUGUAAACGGUAAUGCAUCCCA
UACACGCU  970 AUUGAAAC   
34 719025 719060 
CCUCAAUUUCAUUGUAUCACCGGAGCAG
UGGAGCGU  672 AUUGAAAC 
identical 
with spacer 
# 30 
35 719091 719126 
CCCCAUUCAAGAAUAUUCACUGCUAUUC
ACCUUCUU  50 AUUGAAAC   
36 719157 719192 
AUAAUUCACAUAAUGCAAAUGUUGCACA
ACUUGUAU  325 AUUGAAAC   
37 719223 719258 
CCGAUAAGCUAAAUGUCAACGCUGAGAU
GAUGGUAA  1261 AUUGAAAC   
38 719289 719325 
AAUCCCGCCCAUUCGGCUGCCAAAUCAA
UUCCGCCUA  48 AUUGAAAC   
39 719356 719392 
UAUUGUGCCAAGUGUCAAUACUUUUGGU
ACAAUAUUU  115 AUUGAAAC   
40 719423 719458 
CAAAUAGGUCUGUAUACAUUCUAUUUUG
AUACAAGU  1486 AUUGAAAC   
41 719489 719524 
UUGUGGCGACAGAACGGCGGGAAUAGC
AGUGUUGCA  257 AUUGAAAC   
42 719555 719591 
AUGUAACCAGCCCAUGUCAUUUCUGCCU
UUUGCUCCA  90 AUUGAAAC   
43 719622 719658 
UGAGGAUAAAAUACAGCAGUACCUUGAA
CUAGAUGAG  790 AUUGAAAC   
44 719689 719725 
AUAAAACUAUUUAUUUUUUGUUCACAAU
UGUGUACAA  878 AUUGAAAC   
45 719756 719791 
AAAAAUGGCGAGCAGGCAGGGGGUUAG
GACCCACCC  180 AUUGAAAU   
46 719822 719859 
CGAUUUUGCAGACAGUCAAGAAGAUGCA
GAACGUAAAC  496 AUUGAAAU   
47 719890 719927 
AGCAAAUAUUUGAUUCAAAAAUAGAGCU
AGUAAAGAAU  1587 AUUGAAAC   
48 719958 719996 
UUUUUCAAACUUGCAGGGCUAGGCAGGA
AUCGAACCUGC  250 AUUGAAAC   
  
      
       
       
       
       
       
   
C. thermocellum  CRISPR 2                                                                         
genome position: 1712609 - 1719059  
97 units  
GUUUUUAUCGUACCUAUGAGGAAU
UGAAAC (30 bp)  
   
       spacer 
# 
start 
position 
end 
position spacer sequence (sense direction) # reads 5'tag comments 
              
1 1712639 1712672 
CUACAUUGAAACUGGCAAUGCUACAGAA
GCAGCA  8733 AUUGAAAC   
2 1712703 1712742 
CUAUCUUUGUCAAACAGCAACCACAUGA
AAGCGUCGGCAA  5358 AUUGAAAC   
3 1712773 1712811 
AAUCUACUAUAAGUCAGUAUGAAACAUG
CAAAAGAGAAC  13400 AUUGAAAC   
4 1712842 1712877 
GGCGGUGUUGGUGCACAUACAAAACUUC
CAAGCACA  8589 AUUGAAAC   
5 1712908 1712945 
CACCUCAUAUGUUCAGGCAUACAUUUGU
UUAUAUGGCA  2097 AUUGAAAC   
6 1712976 1713011 
UCUUCUUAGCCUGCCACUGCUCCCAUCU
GAAACCUU  97 AUUGAAAC   
7 1713042 1713078 
UAAAAAUAUCUUCGGUAAUUGCAUCCGU
UUUAAUUUC  12884 AUUGAAAC   
8 1713109 1713146 
AUUUUAAAAAACCCAUAUUAUAUCCUCCU
UUAGUUUUC  623 AUUGAAAC   
9 1713177 1713213 
UACUUUGCUUAAGUUUUCAUAAUUAUCA
GAUUUAUC  14114 AUUGAAAC   
10 1713244 1713279 
UUGUAACCGAGAAUGUCCCUCCAAUGUU
CUAACUUU  1050 AUUGAAAC   
11 1713310 1713346 
GUGAUUGCAGACCCUGUUAUUAUUCAAG
CCGCUGAAA  1205 AUUGAAAC   
12 1713377 1713414 
AAGCCGGAUUUAGUGAGGCUUUUGGUG
AGUCUAAUGUC  3164 AUUGAAAC   
13 1713445 1713483 
AUAAACCUCAGACAUAUGUCACAGCAAAA
GGCGUUUCCU  3405 AUUGAAAC   
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14 1713514 1713549 
GCCCAAAAGGUAGCUGUAGCUGUUGCU
GGCGCAAUU  3955 AUUGAAAC   
15 1713580 1713618 
UUUUCCCCAGGUGACUAAUUUCAGGAAC
UUUUGUUAAUG  978 AUUGAAAC   
16 1713649 1713683 
UCUUGAUAAAAUAAACAAUUUUUCUGUU
GUAGAUA  2660 AUUGAAAC   
17 1713714 1713749 
UGAUGUGACUGUUGUGGUUCUCUACUG
CUGCGCCUU  431 AUUGAAAC   
18 1713780 1713816 
AUUCAAGUCUCUUUUUUUUGGUGUUGU
GCUUGCGAGC  6008 AUUGAAAC   
19 1713847 1713885 
UUCUAUGGUCGGAGUGACUGGAUUUGA
ACCAGCGACCUC  4149 AUUGAAAC 
spacer 
sequence 
promotes 
anti-crRNA 
production 
20 1713916 1713952 
AAGGCGAAAUAGGUUAUAGAAAAAUAAG
UAAUAUAAC  1051 AUUGAAAC   
21 1713983 1714020 
AACAGGAGCAGGAAGACAAUGAAGCCAU
GCGCCAGGGC  3205 AUUGAAAC   
22 1714051 1714087 
CCAUAUCACCAAGUAAAUUUGUUUCAAC
UCCGGCACC  91 AUUGAAAC   
23 1714118 1714154 
AGAGAAGGGUUUGUAGAAGACGACUUUU
UUACUGUCA  1972 AUUGAAAC   
24 1714185 1714220 
CCGACGCUGACUUUGCCGAGUGUGAAG
AAUGGCUGA  814 AUUGAAAC   
25 1714251 1714288 
CUUCACGGGAAAGGUUCUUGCUGUAAUA
UUCGGCCAUA  1184 AUUGAAAC   
26 1714319 1714354 
AGGAACAGGACUUCAUACAACGUCACCG
UUGAAGUG  2562 AUUGAAAC   
27 1714385 1714421 
UAAGCCAUCGGGCAUGACGAACCAUUAU
CGCAUAAAC  1308 AUUGAAAC   
28 1714452 1714487 
AUCUCCAAUCCACCUCCGGUAUGCGGCU
GCGUCUGC  62 AUUGAAAC   
29 1714518 1714557 
UAAAGCUCUGGUCGGUAAAUGUGCGGAU
UGGUCGCUCUGC  102 AUUGAAAC   
30 1714588 1714624 
AACUCACCUUCUCCCCAUUUACCGGACA
AACUAACCG  50 AUUGAAAC   
31 1714655 1714692 
GGUCUAGCUGUGUACCAGAAAUACUGGC
ACAGCUUUUC  271 AUUGAAAC   
32 1714723 1714758 
GGACUGGCUGCAACCUUGAACAUAAACU
UGAGUAUG  188 AUUGAAAC   
33 1714789 1714823 
GAGAGGCCUUUUGGCCGGAGGAAGUUG
UGGAGGUG  249 AUUGAAAC   
34 1714854 1714891 
UCGCCAUAUCUACCACAUAACCAGCGGU
UGUUGCCAAU  31 AUUGAAAC   
35 1714922 1714958 
AUAGCAUUUCUUGAAAAAAACCGUAAAG
AGUGGGGAU  470 AUUGAAAC   
36 1714989 1715027 
UUUUUUUUGCAAUUCCUUGUAACCCUGC
UUUGCUACUCA  35 AUUGAAAC   
37 1715058 1715097 
UACCUUUAUUAGUCGAUACAACACUUAA
AGUCUAUGACAA  165 AUUGAAAC   
38 1715128 1715163 
CAUACAGCGAUGGUAGAAAGGUGAAUAU
UGCUUCCU  524 AUUGAAAC   
39 1715194 1715232 
UUGCCGCACUGCCCAAAACCAGCCCAAU
UUUUGAACCCA  18 AUUGAAAC   
40 1715263 1715303 
UUCGACGUAGAAAAUGCAAUAUCUAUCG
GGGAAUGGUACUU  610 AUUGAAAC   
41 1715334 1715370 
CCGAACAUUUUAUGCUCGUAGGGUACAU
CUUCGCAGA  172 AUUGAAAC   
42 1715401 1715437 
CACGGCAGCACAACCAGCCGCACGUCUG
CUUUGGCUU  47 AUUGAAAC   
43 1715468 1715502 
CCGUUUCCCACAUCUGAUUGAGUUGUUU
GUUGAUA  67 AUUGAAAC   
44 1715533 1715569 
UGCAAUGAUUUCGAAUUCUUUGUAACAU
UGACUUUGG  512 AUUGAAAC   
45 1715600 1715635 
AACCAUAAAAAAGUAAACUGAACCAUAAA
UGAUACA  60 AUUGAAAC   
46 1715666 1715702 
UGCCCCAUUCUUUUCUUCGCUCUCCUUC
GCCCAUUAG  10 AUUGAAAC   
47 1715733 1715771 
ACUUUUUGUCUUCACCUACCAUGUCCAU
AUUCGUCAUAA  32 AUUGAAAC   
48 1715802 1715839 
CUUUUAUAAAUUGAAAAGGAGGAUAAGU
AUGUCAAACA  316 AUUGAAAC   
49 1715870 1715905 
UACCAUCUGAGGGCUAUUUUGAAAGGUU
CGUCAGUG  47 AUUGAAAC   
50 1715936 1715973 
UCGGUAUGCACAAAGAAGUACAUACCGC
AAUAUCUCUC  41 AUUGAAAC   
51 1716004 1716038 
GCUGCCAUUUUGACAAUGGUGUUCUGC
UGAUCUGC  109 AUUGAAAC   
52 1716069 1716103 
UCUCGCUCGAAUAAAAUUGGUACAUCAU
AUUUUUC  39 AUUGAAAC   
53 1716134 1716172 
AAUAAAAAAUUUAGCAUACUUUAUAUUGA
CCUUGAAGCG  183 AUUGAAAC   
54 1716203 1716242 
UAGACAUGGAUUAUGUGAACGUUGUGGC
AGACCGGGAAAG  65 AUUGAAAC   
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55 1716273 1716308 
GACUAAGUCCUGCAUCAGAUGGCAAUGU
CGGUUCAG  63 AUUGAAAC   
56 1716339 1716374 
AAGAAAACUGACAAUGCAGAAGCACAAA
GAGAAAAG  55 AUUGAAAC   
57 1716405 1716440 
UUCACCUCCUUUUUUCAUGAACUUUGGU
CCUCCAAG  14 AUUGAAAC   
58 1716471 1716508 
AUCAUAUAUGAUUCAUGCAAUGGAUGUC
AAUAUGGAUG  174 AUUGAAAC   
59 1716539 1716575 
GGUUUAUAGGCUUUUAGUUCUCCGCUG
UGUAUCGCUC  94 AUUGAAAC   
60 1716606 1716643 
CCGGCUUCACCUAUCAUCGCGAGAGUCG
GAGCGUCUAC  69 AUUGAAAC   
61 1716674 1716709 
CCUGAAAAUCUUCAUUCAAUGCGGCUAU
GCCACUGC  16 AUUGAAAC   
62 1716740 1716775 
AAUAAAUUUUCCUUUUCCAUUUAUUUAC
CUCCUUUU  12 AUUGAAAC   
63 1716806 1716844 
UCAAGCAUUUCUUUCGGUAAUGGUUCGC
CGAAAUCAAUC  44 AUUGAAAC   
64 1716875 1716910 
AUUUUCCUCCUUUAUAUGUAUAAAAGAC
CUUUAUAA  20 AUUGAAAC   
65 1716941 1716980 
GCCAUAUAUACACCCCCUACAGGUAGCU
UGGGGCAAACUC  29 AUUGAAAC   
66 1717011 1717046 
AUCUAAACGAAGAACAAUUGCAAAAGCUA
AAUGACU  75 AUUGAAAC   
67 1717077 1717116 
CAUUGAAACCGAAUGGGUUGAAGAAGGC
GGUUUCUUUAGA  86 AUUGAAAC   
68 1717147 1717184 
UACUAUCUGUAAAAUACUUGUAGCCUUG
UCUUUUAAUU  36 AUUGAAAC   
69 1717215 1717251 
CCAAUCCAUUCUUUCCGCAUCUUGUACU
GCUGAUACC  5 AUUGAAAC   
70 1717282 1717317 
UUUGUAUAAAGUGAGGUAAAUAGUAAAU
AUAUAUGC  69 AUUGAAAC 
identical 
with spacer 
# 78  
71 1717348 1717386 
AAAUCAAAGAAUCGGCAAAAGGAAAGACA
UACGAAAUUG  128 AUUGAAAC   
72 1717417 1717453 
UGCCUGCAAUGUUCUCGAUGGCAUUGU
CGAAGAUGAG  91 AUUGAAAC   
73 1717484 1717520 
UCCUCCCCUUGCCAUGUUAUGGUUUCG
CCCACUCUUU  13 AUUGAAAC   
74 1717551 1717586 
UCACCGUUAGGAAAGUUGAUAGUGAACA
CGCUGUUA  238 AUUGAAAC   
75 1717617 1717652 
UACAAUAUACACAAGCAGAAUUCUUACAA
AUAAUAA  19 AUUGAAAC   
76 1717683 1717720 
CAAAAAGGAGGAGUAGUUCGUUUUGAGG
AAAUAGACGC  79 AUUGAAAC   
77 1717751 1717787 
AGUGUUCUAUAUGUAUUUGCUUUUCCUA
AGCUUUUUG  82 AUUGAAAC   
78 1717818 1717853 
UUUGUAUAAAGUGAGGUAAAUAGUAAAU
AUAUAUGC  66 AUUGAAAC 
identical 
with spacer 
# 70 
79 1717884 1717923 
CGCUUUUUGCUACUUUGAUUUACGCCAU
UUAUUAUUCAAU  19 AUUGAAAC   
80 1717954 1717992 
UGAACUGCACCUAUCCGCCAGUUUCCAG
UCAUACUGGAU  108 AUUGAAAC   
81 1718023 1718060 
UGAUUUUUAAUGUAUUGUAAUAUUUCCA
UUUCCUUUUU  35 AUUGAAAC 
identical 
with spacer 
# 82 
82 1718091 1718128 
UGAUUUUUAAUGUAUUGUAAUAUUUCCA
UUUCCUUUUU  52 AUUGAAAC 
identical 
with spacer 
# 81 
83 1718159 1718194 
GAGCCGGACGUGUGAAAAACUAUAUCCC
GGAAGAUC  398 AUUGAAAC   
84 1718225 1718261 
UAAUUAAUUAGCUUAAAUAAGCUAUAAUU
AAUAUUGA  42 AUUGAAAC   
85 1718292 1718327 
AAAUAAAAUUGUAAGAAUGAGUUAAGGG
GUUCAAAA  355 AUUGAAAC   
86 1718358 1718396 
UUUCCAGGCUCAAAAAUAAACCUAAUCA
UUGUUAAAACC  55 AUUGAAAC   
87 1718427 1718462 
UACGGACUUGCAACCGUCUAUAACUUGU
UGUUAUAG  174 AUUGAAAC   
88 1718493 1718528 
AAUCAAUUUUGCUUUUAAAUAGAGUUUA
AUGUAUAC  164 AUUGAAAC   
89 1718559 1718595 
GCAUGUUUUAAACUGUCAAGUAUUUUUA
CUUUACAGA  193 AUUGAAAC   
90 1718626 1718661 
CGGUGGAUUAAAUGAGCUUUAUAAUCUG
CUGGAUAA  24 AUUGAAAC   
91 1718692 1718727 
AUCAAACCCUGAUAAAUAGACGGCUAGA
UGCCAUUU  99 AUUGAAAC   
92 1718758 1718793 
UACUUGAGUCUGUCCUUGAAGGCAUGG
CUGAAUACU  31 AUUGAAAC   
93 1718824 1718859 
UAUAGCAAAGGACAACGAAGUAAAAGAAA
ACUGGAA  69 AUUGAAAC   
94 1718890 1718925 
UCAAAAAACACUGCGUAACUCAUUAUGC
AUAACUCC  44 AUUGAAAC   
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95 1718956 1718992 
GCAUCUGUCAAUUUAUCACGGAUUGCAG
UAUCGAUUU  154 AUUGAAAC   
96 1719023 1719059 
GUGAAUUCCGAUGCUGUUUCCCUUUCG
GGUAAGUUUU  27 AUUGAAAC   
       
       
       
       
   
C. thermocellum CRISPR 3                                                                       
Genome position: 2740990-2729773                                                               
170 units 
GUUUUUAUCGUACCUAUGAGGAAU
UGAAAC (30 bp) 
   
       spacer 
# 
start 
position 
end 
position spacer sequence (sense direction) # reads 5'tag comments 
              
1 2741020 2741051 
CAUCAUGCAUUGGCGCUGGCAGCAUCAA
GUUUGUCUUCC 4677 AUUGAAAU   
2 2740953 2740982 
UUCAAGCCGCUGAAAGAAAAAAAGUUAG
ACCACUCUA 7875 AUUGAAAU   
3 2740886 2740915 
AAGAGUUUGAAGCGUGCAAGCUUGAAUU
UGCUGUUGA 17490 AUUGAAAU   
4 2740821 2740848 
UUUGCAGCUUCGUUUUUGCAAGUUCUAC
UGCUGUC 8069 AUUGAAAU   
5 2740753 2740783 
AGGAAGCCUUUUGGCCGGAGGAAGUUG
UGAAAGAUAAG 6601 AUUGAAAU   
6 2740687 2740715 
CGAAAACAAUCUACCGGUUGAUAAUAAG
CCGGACCC 5604 AUUGAAAU   
7 2740620 2740649 
UUGGGGCAUUGGUAUUUGGCGGAAUCC
CUGCGUUUGC 2390 AUUGAAAU   
8 2740552 2740582 
UGCACAAUCCCAUAUUUUGCAUACAAGU
CUAUUGCUUC 8496 AUUGAAAU   
9 2740486 2740514 
UUCGGUUCAUUGGCACUGGGAAUCCCA
GCAUAUUUG 7118 AUUGAAAU   
10 2740417 2740448 
AACUAUAACGGCACAACUUAUGUUCCUC
UUCGUGCUAUU 1559 AUUGAAAU   
11 2740350 2740379 
AUAUAUUGGCUGAGCAAGAAAAGAAGUU
GCUUUCGAU 5109 AUUGAAAU   
12 2740285 2740312 
AUUACGAAGCAUUUAUAGAGAGUUAUGC
UAAUACA 1837 AUUGAAAU   
13 2740216 2740247 
AUCUCAGCUUCUCUUUUUGCUCUUUCGU
AAGCGUCGCCA 819 AUUGAAAU   
14 2740150 2740178 
UUUCUGAAUUCGCUGGAAAUUUGUCCGU
CGUACGAA 11942 AUUGAAAU   
15 2740082 2740112 
UGCCCCAUUCUUUUCUUCGCUCUCCUUC
GCCCAUUAGC 27 AUUGAAAU   
16 2740015 2740044 
ACUAAGAAAAUAGCAAGAAGACUCCCAC
CUCUUUAGG 2368 AUUGAAAU   
17 2739949 2739977 
GGAUCGUUGUUUGCUCCUCCGGAUUUU
GUCUUCAGA 459 AUUGAAAU   
18 2739880 2739911 
CUACAUUUGCAGGCAAUUUUUCAAUUCU
CUAUCUAAUGG 562 AUUGAAAU   
19 2739813 2739842 
UCUUCUGCUGUCUCAUCCCAUAUUUUUU
GACCUUCUU 33 AUUGAAAU   
20 2739746 2739775 
ACCUCUUGCUUCGUAACGAAUGUAACAC
UAGAACCAG 522 AUUGAAAU   
21 2739679 2739708 
CCCAAACUUUCAAUACUGGCUAAAAUAU
CACCAAACC 19 AUUGAAAU   
22 2739612 2739641 
UUUUGCAAUGUUCUGCUACAUAAUCAUA
UACAAUUUC 202 AUUGAAAU   
23 2739546 2739574 
GCAUAAUUCCUGUACCGGAAACGGUAGA
AAUUAGCU 1261 AUUGAAAU   
24 2739481 2739508 
CCAUAAAAAUCACAAGUGUAGUCAGGCC
AGCGUCC 350 AUUGAAAU   
25 2739412 2739443 
UCUACUAUUUGAGCUGGUAAUCCGCUAU
GAAUCUUACGU 840 AUUGAAAU   
26 2739344 2739374 
GCUGUUUUCUCGCUAUAACCAGCCCUUC
UUGCUGCUUC 61 AUUGAAAU   
27 2739277 2739306 
UUUCUGAAUUCGCUGGAAAUUCUUCCGU
CGUACGAAA 1869 AUUGAAAU   
28 2739207 2739239 
AAGGCUCACGCAGAUGCUAUAAGAACAG
AAAUAGAACAGC 191 AUUGAAAU   
29 2739138 2739169 
UCCAAAAUUAUUACGCAGAUGGACAAGC
UUGAAAACGAA 495 AUUGAAAU   
30 2739069 2739100 
UGAAACCUUUGUGUAAUCGUCCAGUGAU
ACAGUUAGGAA 1496 AUUGAAAU   
31 2739003 2739031 
UUGAUUUCAAUAUCAAACUGUAUAAACC
UGCUUCGU 2325 AUUGAAAU   
32 2738937 2738965 UACUUGAGUCUGUAGAAGGUACUGCUGC 453 AUUGAAAU   
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CCAAAACC 
33 2738869 2738899 
GGCAAGAAGUAGUAGAAGGUGUGAACCC
ACCCUAUCGA 792 AUUGAAAU   
34 2738802 2738831 
UGUUUUUCAAUGCUAUUUGUUCACCGAU
UGAAUCCAC 367 AUUGAAAU   
35 2738735 2738764 
CUGGAUUGCGUAGAGAUUUGUACUUUU
GAAUUUUAAG 1223 AUUGAAAU   
36 2738669 2738697 
UUCUUUUUGAAGUUCUUUAAGUUUGCUU
UGCCAUUC 289 AUUGAAAU   
37 2738602 2738631 
AGAAAUAGAAUUUGGUAUAGAGGAGACC
CAUCAGAGC 384 AUUGAAAU   
38 2738535 2738564 
CAUUUUGACCUAGCUUCUUUGGUUUUAC
UUCUCUAGC 382 AUUGAAAU   
39 2738468 2738497 
AUAGGUGAGUCAGAUGUAAAAAAACAGG
GGAGGUAAU 121 AUUGAAAU   
40 2738402 2738430 
UUGUCAACUAAGCAUGCGAACUGCUCCG
GGCCAUUG 237 AUUGAAAU   
41 2738335 2738364 
UGUUCCUUUGUCAAAUAAAGCUAUAUAC
UAUCUAAAA 281 AUUGAAAU   
42 2738269 2738297 
CGCCAAGUCUCCAAAGGAGCUACAGGAA
AAAGUAAA 497 AUUGAAAU   
43 2738201 2738231 
UGAAAACAACUUGCCAAUUGAUAAUAAG
CCAGACCCAC 62 AUUGAAAU   
44 2738131 2738163 
CAAAUAACAAAUAGUAAAUUGACCGUAG
CAGAAUGGUUUG 243 AUUGAAAU   
45 2738064 2738093 
CGUCCACGUCGAAUAGUCGGUAAUCCAU
CAGCACCGA 109 AUUGAAAU   
46 2737998 2738026 
AAUAAUUCUGCUAUUCCAGUAAUUUGUU
UAAGUCGG 663 AUUGAAAU   
47 2737930 2737960 
GACAGACAGAUGAAUAUGACGGAACCGU
UUUUUGUGUG 247 AUUGAAAU   
48 2737863 2737892 
AAGAUAAGGCUAACAAAAAGCUAUUGUG
GGAAAUUUU 377 AUUGAAAU   
49 2737794 2737825 
AUUGCUUCGUUGAUUCAGGAAGCAUAGC
AUAUUCUUUUU 279 AUUGAAAU   
50 2737726 2737756 
UACCGAAUCGCGCUUCUAUGAGUUGGAC
CUUGUCGUCC 94 AUUGAAAU   
51 2737660 2737688 
AUGCACUUGAUGAAGUAAUAUCCCAAUG
GAUAGAUG 262 AUUGAAAU   
52 2737593 2737622 
CGUUCGAUCACGAUGUAGUCUUCACCCA
GAAGAAUCA 1039 AUUGAAAU   
53 2737527 2737555 
UAUUGCCAGUGAUCACCAUAGUCGGCGG
AAUGCUGG 252 AUUGAAAU   
54 2737459 2737489 
ACGGGAACCUAUUCUGCACGAUCAGCAU
UCGCGACAAA 322 AUUGAAAU   
55 2737393 2737421 
CAGCCUGGAACAUUCCUGUUUCAGCGUC
CUUCAUCA 25 AUUGAAAU   
56 2737327 2737355 
CAUUCGGUACAAGAAAAAUCUUAUUGGC
AUUACAAA 317 AUUGAAAU   
57 2737264 2737289 
UUGUAGAUUUCAGCCUGCUCCUUCUUCA
GGCGU 84 AUUGAAAU   
58 2737198 2737226 
UCGCUGUGCGUGAAUUUCACUUUGUGU
GUCAUGGUU 440 AUUGAAAU   
59 2737129 2737160 
AGGAACCCUUCAAAGUAACCCUCAGACG
GUAUAAAUGCU 57 AUUGAAAU   
60 2737063 2737091 
AUCCUUGCAACCUCCAAGGCUUUUUCUU
CAUCAGUC 191 AUUGAAAU   
61 2736995 2737025 
UACCACCGUCUCUUACAUAACCGACAAG
UCCACCUAUA 2 AUUGAAAU   
62 2736928 2736957 
UACAUUUCAUCUCUGUCAAACCACCGUU
CAUUUUCUU 15 AUUGAAAU   
63 2736862 2736890 
UUUGUUGAUAGUCCAUGCAACUCUCCGG
AAUCGUUA 92 AUUGAAAU   
64 2736796 2736824 
CCUUGUUUUGACUUUGACGUAUCAAUGC
UUGUUGCA 52 AUUGAAAU   
65 2736726 2736758 
GAUCUUUCACUCCAAACUUUCGCUGUGU
GAAAUAUAUCAC 46 AUUGAAAU   
66 2736661 2736688 
CUAUGCGCCAAGUAAUUGGAUAUAUUGC
AGGGUGU 95 AUUGAAAU   
67 2736595 2736623 
GCAGGAAAGCCUAAGUUGUUCCAAACAG
AAGAUGCA 210 AUUGAAAU   
68 2736528 2736557 
ACUUAACAAUCGAAAAUGUUGAUUUUUG
GAGUCCGAA 93 AUUGAAAU   
69 2736457 2736490 
AUUUCAUCUCUUCAUACGGACUUUCAAA
AUCUUCCCAAUCG 32 AUUGAAAU   
70 2736388 2736419 
CUGAUAAUUACCCAAUAAUCGUAAACAU
CGGAAGGAAGA 110 AUUGAAAU   
71 2736320 2736350 
GCCAUCGGCAGCCACCUUCUCGCAAAUC
AAUCUUGUCU 3 AUUGAAAU   
72 2736254 2736282 
CUUGUUAGAUGAUUUCCGCUAACUUGUU
CGCAGAUU 132 AUUGAAAU   
73 2736185 2736216 
UACCAGAGAAACAUUCAGAUUGUAUAAA
CUGGCAUAUGC 51 AUUGAAAU   
74 2736119 2736147 
UUAGUUUUAUAGCCUUUAGGAAGGGCUU
CGCUUUCA 66 AUUGAAAU   
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75 2736051 2736081 
CGGAUAGCUUGGGGUUUCUUACGCAAC
CAAUUGAAAAC 95 AUUGAAAU   
76 2735983 2736013 
AUGAUAUAAAGGAAGCUUUAGACGAGAA
AUUUGCUUUU 26 AUUGAAAU   
77 2735914 2735945 
UUUGAUAGUGGAAAUUAUUUUGGAUAUG
AUAAAAGGUGC 39 AUUGAAAU   
78 2735844 2735876 
UAAUAUGGACCCGCUAGAGUUUCGCGAG
UAUGGUCUACAC 16 AUUGAAAU   
79 2735775 2735806 
GCAAGAGCACGAACCUCAAAUCGCCUGU
ACGGCUGUAUG 50 AUUGAAAU   
80 2735709 2735737 
GUUGCUAAAGAAGAAAAUAAUGAUAAUC
CUUCUCUA 56 AUUGAAAU   
81 2735643 2735671 
AGAGAUAAACAACAAGACAAUGGACUGC
AAUAUAUU 49 AUUGAAAU   
82 2735577 2735605 
CAAACGGUUUGAAGAACGUUGGAGCGAG
AAUCUCAA 111 AUUGAAAU   
83 2735508 2735539 
AGGGGCUGUUAUGCCCCUCUUAUUAGG
AACCUGAACCUG 3 AUUGAAAU   
84 2735442 2735470 
ACAAAAGUAACACAGCCAAAUAAAGUGAA
AGGUUCA 46 AUUGAAAU   
85 2735375 2735404 
ACGGUGAACUGUAUGUAUCACCAAGUUC
UAUAGGUCA 79 AUUGAAAU   
86 2735306 2735337 
GAUUGUUGGAAAAAGGAAAUAGACGCAU
UUUUUGAGUUG 44 AUUGAAAU   
87 2735238 2735268 
GUUCCUCAAGCUGUGCAUCCCUAUCUGC
AAUUUCUUUU 8 AUUGAAAU   
88 2735172 2735200 
CAAAGCAAAAAACUGAAGCUAUGCUACU
UUCAUCUG 22 AUUGAAAU   
89 2735104 2735134 
UUUAGUUCUUCCGGCGCAUCGUUCUUG
UAUUCAGGCAA 12 AUUGAAAU   
90 2735036 2735066 
AGGCCAACAACUGAACUAGUUUUGUUUG
UCAUUCUUAU 20 AUUGAAAU   
91 2734970 2734998 
CCUUUGGAGAAUAUGCAAGCCCUGAUUU
UGGCAGUA 53 AUUGAAAU   
92 2734904 2734932 
UAGAUUCAACAUUCGAUUCUCCAAAGGC
UUCGCUAA 73 AUUGAAAU   
93 2734837 2734866 
UCCGCAAAAGAGAGAAUCAGAGCUGCCG
AACUUUUGG 36 AUUGAAAU   
94 2734771 2734799 
ACUAUAUCAAGUGUUCCAAAUCCAAUAU
CAGAACUC 179 AUUGAAAU   
95 2734706 2734733 
UGGCACAGAACAAAGCUAUAAUGGCAAA
GUAUUCC 11 AUUGAAAU   
96 2734637 2734668 
CUGUAUCUGAAUGCGUCUAAUUCAGGUA
UAGCAUGUUCC 16 AUUGAAAU   
97 2734567 2734599 
GAGAAUUAUUCUGGUUCAUCGGCUGCCA
AAUAUAUUGUUG 132 AUUGAAAU   
98 2734502 2734529 
AAGUCUUAUUAUAGACAACAAAAACACG
GGUACCA 38 AUUGAAAU   
99 2734433 2734464 
AUCAUUCAAGACCACUGCCUGAAUACAA
GAACGAUGCGC 27 AUUGAAAU   
100 2734367 2734395 
CCAAUUCAUAGUACCUAGCCGUAGAAGG
AACAUAUA 153 AUUGAAAU   
101 2734301 2734329 
CCGAACCAUUGACCAAUACUAUAUCCUA
GAUUUUCA 49 AUUGAAAU   
102 2734234 2734263 
AGCCAAGAAGAGGGGUCAAACCACUCAA
AAUAGCCAU 119 AUUGAAAU   
103 2734167 2734196 
UGUAAUAAAAAUAUGUUAAUAUAUAUUUA
AGAGUAAU 775 AUUGAAAU 
spacer with 
potential 
promoter 
sequence 
104 2734099 2734129 
UUGACAAUGAAAAUUACACUGUCAAAGA
UGGAGAAGGA 41151 AUUGAAAU 
drastic read 
# increase 
105 2734033 2734061 
AAAUAUACUCUAUGGUAUCUGCUGGACG
CAAGUUGC 21552 AUUGAAAU   
106 2733967 2733995 
AAGGUAUUGUCAUUGGCUGUUGCAUAUU
UCAGUUUU 9585 AUUGAAAU   
107 2733899 2733929 
UCGAUUGGCUCUUUUGUGAUUUGAUAUA
UUUCUGCAGC 35845 AUUGAAAU   
108 2733831 2733861 
CCGCGGUUCCUGCGGUCCAAUUUGCUU
UCCCGACAAUA 2394 AUUGAAAU   
109 2733763 2733793 
UAAUAAUAUUCUAUUUCUUCUUUUAUCC
UGUUGAAUAU 10002 AUUGAAAU   
110 2733694 2733725 
CAAUACCUCCUUUCAAUACCGGCGGUAU
UUGUAAUCGCC 853 AUUGAAAU   
111 2733626 2733656 
AUAAUUCAAUGUUACUGUUUAUUUUUUU
AAAGUGCCAA 6202 AUUGAAAU   
112 2733558 2733588 
UUAAAUAAUUCAAUUGUUCCGUUUAUUC
CGCCCUUAAU 650 AUUGAAAU   
113 2733492 2733520 
UCCUCAAUCUCUUUUUCGGUAAACAUCC
ACCAUCAC 1514 AUUGAAAU   
114 2733426 2733454 
UCAGGUGUAAGAGGUUUUACUUUCGCCC
CUUGCGGC 2474 AUUGAAAU   
115 2733361 2733388 
AGGUGGAAGGCUCCCUGAGGGGAGCAC
CACCCUCC 792 AUUGAAAU 
U to C 
change in 
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5' tag 
116 2733295 2733323 
UGAUGUCGCGCCAGACAAAACGUAUGUA
AUCAAAGA 4534 AUUGAAAC   
117 2733230 2733257 
AAUUCUGCCAAGGCUCGCUCUCUGGCUU
CUUGAAG 825 AUUGAAAC   
118 2733160 2733192 
CUCAAGAACAGUUUGGUAAAUUGUUUGG
UAUUGUUAAAUC 4582 AUUGAAAC   
119 2733094 2733122 
CAAGGCUACCGAAUAUAUCAAUAAUGCC
UAAAUCUU 600 AUUGAAAC   
120 2733025 2733056 
UAUUCGUGAUGCUCCCAGCAAGCUGUG
GGUCUCCGCCCA 1261 AUUGAAAC   
121 2732960 2732987 
AAAUAAAACACGUUUCCAUCAAAUUCUCU
UUUUUC 1292 AUUGAAAC   
122 2732893 2732922 
ACAUAGUGAGUGCAUUGCCUUGGUUUG
UUUUUUCUGC 4186 AUUGAAAC   
123 2732823 2732855 
CACAAGCAGAGAGAGUGGGAGUACGUCA
AGCAGUAGCGUG 1937 AUUGAAAC   
124 2732753 2732785 
AGGCCGAACCAUAUGAUGUGAUUUCCAC
CUUGUUGCAAAU 1328 AUUGAAAC   
125 2732687 2732715 
UGAACUUUUUUCUUUUGUAAUAGAUUCC
AUCAGUUA 628 AUUGAAAC   
126 2732620 2732649 
CUUCAUCAAGUGCAUCAAAAGUAUCGCU
UUUUCUUUC 819 AUUGAAAC   
127 2732551 2732582 
UCUUCCAUCUAACCCCUCCCUAAUUCUA
CAUAUUCUCCG 28 AUUGAAAC   
128 2732484 2732513 
GUUUCAAAUUCACUGGACCAUUCACUGG
ACCAGUAUA 1697 AUUGAAAC   
129 2732417 2732446 
CUUGGAAGCGUAAUCGUUAGAAAAUCCU
GUUCAUUCU 1919 AUUGAAAC   
130 2732348 2732379 
ACAAUUCUGCAAAUUUUGAUUUACCGAG
UAGCUUUUCUA 472 AUUGAAAC   
131 2732279 2732310 
UACUCAACCGUAACUACUCUUUCAAAUU
CUACUUCUCCA 37 AUUGAAAC   
132 2732212 2732241 
CUGCUGACGAGGUGUUUUGAAGCCCAC
CUAUUGCUAU 299 AUUGAAAC   
133 2732147 2732174 
CCAAGCUGAAGGAUGGCAGGUACGUCAU
CAUUGUU 267 AUUGAAAC   
134 2732081 2732109 
CAGGCUGAGGAUGAGUAUAUAAAAUACA
UUCUUAAA 258 AUUGAAAC   
135 2732013 2732043 
AUAAUCCUUUCACCUUCAUAUCUCCCAU
UCAAGUUCCU 10 AUUGAAAC   
136 2731944 2731975 
GUUGUAUUCCUUUGAAUGAAAGAGCAAU
GCUUAAAGAAA 1679 AUUGAAAC   
137 2731874 2731906 
ACAAAAAUAUAGUUACCAUUGGCGAGUU
UCUUUGCGACAC 65 AUUGAAAC   
138 2731807 2731836 
CUCGGCACCGCUUGCCAUAUCACCAAGC
AAAUUUGUU 22 AUUGAAAC   
139 2731739 2731769 
ACAUCCACUGAGAAUCUCUUAGCGAAUA
AAAAUGCAUC 249 AUUGAAAC   
140 2731672 2731701 
UUGUUCAAAAUUGGGAUUCCAAGGCUAC
GAUAUCGUG 572 AUUGAAAC   
141 2731605 2731634 
CUUCUUUUUCGCUGUCGUAAUAUCCGAC
AAUGAAAGA 87 AUUGAAAC   
142 2731538 2731567 
ACUUAAUUGUUAACUUUGGUUGACGAAU
AGGUUUACA 53 AUUGAAAC   
143 2731469 2731500 
UUUGAGAAAUUCUGUUAUAUUAAAAUCA
AAAUGUACAGC 181 AUUGAAAC 
identical 
with spacer 
# 148 
144 2731402 2731431 
CUGAAGGGAGGGAGUGAUUUGAUAAAGA
UAAACGAAU 28 AUUGAAAC   
145 2731333 2731364 
AGAUUCAGGCGAAAAUCUGAACUUGAAG
GUCAGAUAUGC 438 AUUGAAAC   
146 2731267 2731295 
UCUUCCGUGUUGCCUGGGAGACGCCAG
GAUCUGUCU 230 AUUGAAAC   
147 2731200 2731229 
AUGAUGUAAAUAAUAAAAGUCUCGAUAAA
CUUAGGAA 576 AUUGAAAC   
148 2731131 2731162 
UUUGAGAAAUUCUGUUAUAUUAAAAUCA
AAAUGUACAGC 167 AUUGAAAC 
identical 
with spacer 
# 143 
149 2731062 2731093 
CCGUAUUGUAAACCCAAUUCUAAUAUUG
AUAAGCCGCUA 86 AUUGAAAC   
150 2730995 2731024 
AGGGCUUGGGUGCUAUAUCUGCAGAAG
UAUCUGAUGC 436 AUUGAAAC   
151 2730924 2730957 
AUGUUCCGGAUCAUGUUGUUGUCAUCAU
CCGGGAAUUGGGC 222 AUUGAAAC   
152 2730856 2730886 
UACCGAGCUUCUCAUGCAAUUCUCUUGC
GCUUACGACU 122 AUUGAAAC   
153 2730790 2730818 
AUCAUUUCCUGCAAAGCUAUGAACUGGU
UCAUUCCG 91 AUUGAAAC   
154 2730722 2730752 
UAGUAAGAACAAUAGUUCCGGAUGUAUC
UGAAUAUAUC 375 AUUGAAAC   
155 2730653 2730684 
AUCCUUAAAUUUGAGAUAUCUGAAUAAG
AUAUCUUUUUC 60 AUUGAAAC   
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156 2730587 2730615 
UGCCCUGUGGAGCCGGGAAGACAGAAAC
GGCAAUGG 62 AUUGAAAC   
157 2730521 2730549 
CUAUGUACUCAAUCUUUCUAUCAGCUAU
AGGUGUAA 121 AUUGAAAC   
158 2730451 2730483 
UCUAUUGGAAUUCUGUUUGCAAUAUACA
GUACCUUUAAGU 167 AUUGAAAC   
159 2730384 2730413 
AAUCUAACUGUUGUUGUUUCUGUAUAAG
UCAAUCCUU 144 AUUGAAAC   
160 2730318 2730346 
AAACUCAAUUGCGUUAUGCCGUUUUCUU
CUUUGUCA 184 AUUGAAAC   
161 2730250 2730280 
AAAAUAAUAUAUCGAAUUUUCCCCUUAU
UGGGUCCCAU 54 AUUGAAAC   
162 2730182 2730212 
AUCCCUGGUUUUUGAGCCACCGUAUAGC
AUUUGCAAUU 100 AUUGAAAC   
163 2730115 2730144 
UGCAGAUCGUCCAUUGUCAAAAAGCGAG
AAGGCGCAA 15 AUUGAAAC   
164 2730048 2730077 
CUUCGCAAUAAAUGUAAUCUAUAUCGUA
GUCGUCUUC 22 AUUGAAAC   
165 2729982 2730010 
CUUUGGAAACCAAGGGUUUCGGCUGUUA
UUCUCGCU 11 AUUGAAAC   
166 2729915 2729944 
CACUUUAAUUCAAGUAAUAAUCUUAAUU
GAUACUCAU 21 AUUGAAAC   
167 2729849 2729877 
GAUGGUGCGGAUUUGAAGGAUGUGCCG
UUCAAAUAC 0 AUUGAAAC   
168 2729781 2729811 
UAAAUUUUCAGGCAACUGUUUUCAAAAG
CUUUGAUAAA 0 AUUAAAAC   
169 2729714 2729743 
CGUUUAUUCUUUCCCUCUUCGUCAACUU
UCAAUAUCC 0 AUUGAACC   
       
       
       
       
       
   
C. thermocellum  CRISPR 4                                                                           
enome position: 3785203 - 3791022                                                                   
80 units 
GUUGAAGUGGUACUUCCAGUAAAA
CAAGGAUUGAAAC (37 bp)  
   
   
  
   spacer 
# 
start 
position 
end 
position spacer sequence (sense direction) # reads 5'tag comments 
              
1 3785240 3785275 
AUGUAGAUGAAUGAUUACGAUGUUGGAG
AAAUAUUU  56800 AUUGAAAC   
2 3785313 3785348 
CUGUAUCCGCAUGUCCUACAGCAGAUGU
CACAUCUG  3144 AUUGAAAC   
3 3785386 3785422 
AUCUUUUGUAUAUCAAAGGAAGCUACUU
CUGUAAUUA  64622 AUUGAAAC   
4 3785460 3785495 
AGUGCUGCAAACAUCACAGCAGUAUUCA
AUCAGGAA  43516 AUUGAAAC   
5 3785533 3785568 
UCGCAUUUUCUACAUCAAACAAAGUUGC
UCCGUCGU  5752 AUUGAAAC   
6 3785606 3785642 
CCUCCAAGUUUCAGUCUCCAUGAAGUAC
CAUUCCCCU  540 
ACAAGGAU
UGAAC   
7 3785680 3785716 
GUGAAACUUGCCGGUUUUUAUGGCGUA
UCUGUAGAUU  31097 AUUGAAAC   
8 3785754 3785789 
UCAAAGUGCACAAAUAAAAAGUGCUUGU
GUCAAUAC  22908 AUUGAAAC   
9 3785827 3785864 
CACAAGUUGCAAAUGAUGUAUUGCCGCC
GGUAAUUUCC  5477 AUUGAAAC   
10 3785902 3785936 
GCCAUCAGUGGCCGAUAGAUAAGGCACA
AUAUCUA  22137 AUUGAAAC   
11 3785974 3786009 
GUUGCUAUUCGAGCAGAAAGAAACCCAA
AAGUUAUC  27771 AUUGAAAC   
12 3786047 3786083 
GUGAUAUUAUAUUGAAUCUGUUUAAAUG
AGAUAUUCA  45648 AUUGAAAC   
13 3786121 3786157 
CCACUGUCUUCUGUCAAUUGUUAUUAUA
UCAUAUAUU  2905 AUUGAAAC   
14 3786195 3786229 
AUGUAUGUUCAAAUACAUCAUAAAUAUG
GUAAGGA  23146 AUUGAAAC   
15 3786267 3786305 
UUGAUAAUGUUCUUUUCAAUAGUGCCAA
GGUCUAAUCCU  2274 AUUGAAAC   
16 3786343 3786381 
UCCCCGCCGUGUUAAUCCGAUUGUAAAC
CUAUUCGUCAA  534 AUUGAAAC   
17 3786419 3786456 
ACUAAUUUGAUUUAUAAAAAUGACUUAAU
UACAAAUGA  4550 AUUGAAAC   
18 3786494 3786529 
CUAUAGAUAUGUAUGGAGUACCGAAAGG
CGACCCAU  18627 AUUGAAAC   
19 3786567 3786602 AAUACGGUGUCAGUGACGUUUUGAACCU 14523 AUUGAAAC   
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CAACCAAG  
20 3786640 3786674 
ACUCUCCCAUGUUCAUUCCUCCUCUUUU
CAAAUUU  368 AUUGAAAC   
21 3786712 3786747 
AGAUAGACGUACAUAUGACAGGAGGUUG
AAGUUAUU  5484 AUUGAAAC   
22 3786785 3786822 
GAAGCUAUGCCUUAUGUGGGUGGACGC
AGUUCUUCAGG  12913 AUUGAAAC   
23 3786860 3786897 
CUAUUUUGUAAUAAUCACUUUUAAUUUC
AUAACCUACA  1708 AUUGAAAC   
24 3786935 3786970 
AAAUAGUACAUAGGUGGAGAGCAGCAAA
CCCGCGAA  4685 AUUGAAAC   
25 3787008 3787044 
UUUGCAACGUUUCCGUUGCUGUUAACUA
CAUAGCAAG  3332 AUUGAAAC   
26 3787082 3787118 
ACGAUGAGCUUAAAAACGAUUACUAAAG
AGAGGAUGG  4869 AUUGAAAC   
27 3787156 3787191 
AUUUUUGCUUCUCUAGCUUGUCUUUUCG
UAUGUAUG  7242 AUUGAAAC   
28 3787229 3787264 
ACUGCUUUAGCGUGAUCCUUGUGACCG
UGCGAUACA  3394 AUUGAAAC   
29 3787302 3787337 
UGGACUUUGCUCAGGUCAUUGGCCCGG
AGAAACUGC  6830 AUUGAAAC   
30 3787375 3787409 
UCAUUCUUGCAAGCCUGAAUCAGCCCUU
UUAGAUA  1421 AUUGAAAC   
31 3787447 3787485 
GGUUCUAUGAUUUCGAUAUACGACCCGC
CUCUAUAUCCG  3131 AUUGAAAC   
32 3787523 3787558 
GUUUUCUUAAUUUCAAAUACUCUUUUUG
CCAUUUUU  17308 AUUGAAAC   
33 3787596 3787631 
AAUCCCAGCGAAGUCCUUUAGAGAACAG
AUUUUUGA  3571 AUUGAAAC   
34 3787669 3787706 
UUAAUUUUAAAGACUUAUUCCGCAAUGA
UAUAAAUAUG  2429 AUUGAAAC   
35 3787744 3787781 
ACUUUGCCUAAGAAGAAUAAAAGUAUUC
GUAGAAUAUU  11273 AUUGAAAC   
36 3787819 3787856 
CUAACAUUAUUCACACCUCCCAUCAACG
AACCUUUUUU  629 AUUGAAAC   
37 3787894 3787929 
ACUUAGCCGUUGCAGUGGGCUUACCUU
CUAAAAAUU  6222 AUUGAAAC   
38 3787967 3788002 
ACUUUCCUUGAUAUGUUUACCUGUAAAG
UAAAAAUA  4200 AUUGAAAC   
39 3788040 3788075 
CUUAUAUAUAGAACAUAAAUUUUUCUAUA
AUAUUAA  2283 AUUGAAAC   
40 3788113 3788147 
CCCUUACAGUGGCGAUAUUUGUGGAAUG
AGGCUGU  6055 AUUGAAAC   
41 3788185 3788221 
AUCUCUUGUAGAAUUUUCUCUGCCUUUU
CUAAGCUAC  7246 AUUGAAAC   
42 3788259 3788294 
ACAGUUAUCAUAGGCUAUCCUCCUUAUA
AAUGUUAA  2425 AUUGAAAC   
43 3788332 3788368 
AAUAAUCCAAAAGCAUUUCUACUGCUUU
UGGAAAUUU  2110 AUUGAAAC   
44 3788406 3788442 
AUAUUUACUCCGGCAUCCCUCAGCCGGC
GAAAAAGGU  1209 AUUGAAAC   
45 3788480 3788514 
AUAAUUCUUCUCGUUUUUGUUUUAAUUC
GUUUAUU  736 AUUGAAAC   
46 3788552 3788587 
GUAAUAAGCUGUCCAAUCACCUCCUAGU
UUUCCUGG  2758 AUUGAAAC   
47 3788625 3788662 
UAGAACUUGAAAGAGAAUCCUUCAGGGA
GAGUGGUACU  8239 AUUGAAAC   
48 3788700 3788736 
UAUCUUCAAAGUAAUAGCUGUUAUAUGU
GUCAAGUUC  9604 AUUGAAAC   
49 3788774 3788809 
UUAAUUCAUCGCCAUUUUUGCCUAUAAG
UCCAUAAA  953 AUUGAAAC   
50 3788847 3788882 
CUUCUUCGAAGCUACUAAAGGUGGCCGU
GCAGUAGU  4203 AUUGAAAC   
51 3788920 3788955 
AUAGAUAAGGCUAUUGCAAGAGUAGCGA
AUGUGCUA  12591 AUUGAAAC   
52 3788993 3789030 
CAAAUAUUUCAGAAGCUAUUGCGGAUAU
AUUUACUGUG  15333 AUUGAAAC   
53 3789068 3789106 
UUGAAUUCCUGCAAUGUGGCAGGCUUUU
CUCAACCUAGG  4407 AUUGAAAC   
54 3789144 3789181 
GUCCCUGUGAUUUCAGCCAAUUUAUCGC
AUUUUCAAUU  4918 AUUGAAAC   
55 3789219 3789257 
ACAUACAGUUCGGUGUUUUCAUCUAGUG
CUACAUUUAUU  9792 AUUGAAAC   
56 3789295 3789330 
CCAGCAGGUUGAGCGUUAGGCAGGUUU
CCCUGCCCG  8386 AUUGAAAC   
57 3789368 3789402 
GUGGAAGAUGCGUUGUUUAUGUCAGCAA
UUUCCGG  14203 AUUGAAAC   
58 3789440 3789475 
CAAAAUGGCAGGUGGUAAAACCACAGCU
AAUACAUC  2652 AUUGAAAC   
59 3789513 3789548 
GUUUCAUCAACAUCCAUCUCGUCUACAU
AGAACUCA  1719 AUUGAAAC   
60 3789586 3789622 
AUAACAUAUUUUAAAGCAAAAAGCAGAAA
AUCACUGG  2138 AUUGAAAC   
61 3789660 3789694 
UGAUUGUAAAGGAAUAUGUAUCCCCAAG
CCUUACA  4488 AUUGAAAC   
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62 3789732 3789769 
UGGAUAGUGCAAACAUAGAUGAAGCCUC
CGUAGGCCUU  2940 AUUGAAAC   
63 3789807 3789843 
UCUAUUUCAGCAACAAUAUAUUUGGCAG
CCGAUGAAU  1431 AUUGAAAC   
64 3789881 3789917 
AUCAUUGUAUAUAUCUUUGGAGUAACGU
AUAAUACCC  7666 AUUGAAAC   
65 3789955 3789991 
UUGAUAAUGUUCUUUUCAAUAGUGCCAA
GGUCUAAUC  2434 AUUGAAAC   
66 3790029 3790065 
ACAGGAACGUGCGUUCUCUGGACGAGG
UAACUAUCGU  10260 AUUGAAAC   
67 3790103 3790137 
UAGCACACAACAGCAAAAAAACAAAGAAA
AAAAGA  20001 AUUGAAAC   
68 3790175 3790210 
GCACCAACUUGUCUUUUUUGAUGAGGCU
UGCAACAA  3007 AUUGAAAC   
69 3790248 3790286 
AUAAUGUGCUGCUGGAUGCCCGUACAGU
CUUCCACUGUA  980 AUUGAAAC   
70 3790324 3790362 
UAGAUUGCGAAAAGCCUGCCACAUUGCA
GGUCACAAGGU  5804 AUUGAAAC   
71 3790400 3790434 
UUGUUUUUUCACUUAUAGACUUAAUUCA
GUGUGGC  4535 AUUGAAAC   
72 3790472 3790512 
CUUUCUCAAUGGCUGACUUCGAUGCGCC
CUGGGCAAGCAUU  807 AUUGAAAC   
73 3790550 3790585 
GUGCUGCUAUCUCGGCUAUUCUUUCAUC
UAUACUCA  1911 AUUGAAAC   
74 3790623 3790657 
UUUGCUCUUUAUCCGGUGCUCUUAUCUC
AUUCACA  209 AUUGAAAC   
75 3790695 3790730 
ACGAGAACGGGAAAGCAAUAUUGAGAAA
ACCCUUUG  2543 AUUGAAAC   
76 3790768 3790802 
UUGGCGGCAUAGCUUCUAUUAUAGAAAA
UUCUACU  2304 AUUGAAAC   
77 3790840 3790875 
UUAUAUCGAAGAAAAAAGAACAAAAGUGA
GGCGAUU  2043 AUUGAAAC   
78 3790913 3790951 
AUAAUUUCGGGAGUGUAGAAUUUCAACU
CGGCAAUAAGA  5674 AUUGAAAC   
79 3790950 3790987 
GAAUGAUUGAAUCAAUAACCAUUAUUGC
CUGCAAUUA 98 AUUGAAAC   
       
       
   
C. thermocellum  CRISPR 5                                                                        
genome position 3813209 - 3816348                                                                 
43 units 
GUUGAAGAGGUACUUCCAGUAAAA
CAAGGAUUGAAAC (37 bp) 
   
       spacer 
# 
start 
position 
end 
position spacer sequence (sense direction) # reads 5'tag comments 
              
1 3813246 3813281 
CUUUUUUUAUCUCGUUAUCUUCACCGUC
UGUGUAUC  4791 AUUGAAAC   
2 3813319 3813355 
AUUUCUCAUAUUCAAUUUUUACCUUUUC
CAUUUUUUA  1136 AUUGAAAC   
3 3813393 3813432 
AUCUUGGGGUGCAAGAGGUCGCUGGUU
CAAAUCCAGUCAC  13100 AUUGAAAC   
4 3813470 3813506 
AUGGGCAUGCUCAUAUGGUGUAUCCCUC
AACGCUAUA  11003 AUUGAAAC   
5 3813544 3813580 
CUAUCUGUUGCGAUUCUCCGCCACUGG
GAUUAUCACC  454 AUUGAAAC   
6 3813618 3813654 
AUUCACAAAAUCAGCACUCAAGAUGGGA
AGUGACUUG  4750 AUUGAAAC   
7 3813692 3813727 
AUCAUACUACCCAUAAAACCUUCUAAUU
GCUUUAGC  3000 AUUGAAAC   
8 3813765 3813801 
UUUUCCUUACAAUUGUUAAACAUCCAAA
UAUCGUCAU  9504 AUUGAAAC   
9 3813839 3813874 
CGCACAUUUCUAUCCCUAUACUGUUGCG
GUUGGUAA  7097 AUUGAAAC   
10 3813912 3813949 
UAUGUAUCAUAAUGCACGUGGCACUAAC
UGUAAGACUU  4800 AUUGAAAC   
11 3813987 3814022 
ACGACAACAUGAGAAGAAAAGGGGAUGA
AGCACAGA  1111 AUUGAAAC   
12 3814060 3814095 
UCUUCUCUUAAAGCACUACCAGUAUCUU
CUACUAUU  651 AUUGAAAC   
13 3814133 3814168 
UUGUAUGUAUUUUAUUAAUAUAGUGUGC
UUGUAAUU  4003 AUUGAAAC   
14 3814206 3814242 
GGAUUUGUCAAGUCUGCUAAAAUAGCGG
GCGGCAAAA  17648 AUUGAAAC   
15 3814280 3814315 
CCUUCUCCCCAUUUACCACCGGGCAAAU
UAACUGUA  142 AUUGAAAC   
16 3814353 3814388 
GUUAAUCCCAAAUUAUGCUCAAAAGAAAA
AAACCAA  3147 AUUGAAAC   
17 3814426 3814462 
AAUAUUGGAAUCCAAAAUAACCUUCAAUU
UUCCACCA  4212 AUUGAAAC   
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18 3814500 3814534 
GUGACGUUUUGGCGUCUAUUGAAAAUCU
AGGAUAU  7713 AUUGAAAC   
19 3814572 3814607 
UUUCACAUGCAUAAUAUGUGAAAUAGCG
ACCGAACA  5548 AUUGAAAC   
20 3814645 3814679 
AACCUCCUUUUUAUAUUUCUGGAUCAUC
AUCAUAA  1634 AUUGAAAC   
21 3814717 3814752 
CAGUAUUGCAUUGUUAUUCCUCGCUUUC
UUUUUGUU  1862 AUUGAAAC   
22 3814790 3814825 
AUACACUUCAAGAGAAUAAUGUCCAGUU
CGUGUCGG  2215 AUUGAAAC   
23 3814863 3814899 
AUGGUGAUGAAGUGAGGUAUGAAGCUG
GAAGCGGAGA  753 AUUGAAAC   
24 3814937 3814972 
UUUUAUAGUAGAUUAAGUUUUCUGCGUU
AAAAUAAU  3531 AUUGAAAC   
25 3815010 3815047 
AUUGUCUUGAACUCAGGGUCUAUAUACC
GCACCAAGCA  3584 AUUGAAAC   
26 3815085 3815122 
CUUCGGAUAAUCCGUCUUCUCGUUUAAU
UCUUAAGCCA  1117 AUUGAAAC   
27 3815160 3815196 
ACAUAUACGAAGGUUUAAACAGGACAGC
AGAGCAAAG  1491 AUUGAAAC   
28 3815234 3815271 
GACUACAUUCUUUUAAUUUUUAAAAAAG
AAAUAUUAAA  1009 AUUGAAAC   
29 3815309 3815347 
AAUCUUCUGCGAGCAGAAGGAGUUCGUU
UCUGUUGCAAC  12013 AUUGAAAC   
30 3815385 3815423 
CCCAAAGAAAGCGCAUGAUAGGGUCUUU
AGGUGGCUUCG  6504 AUUGAAAC   
31 3815461 3815495 
AUAUUACAGUAACAACUAAAGCAGGACA
UAAAAGU  1324 AUUGAAAC   
32 3815533 3815569 
UACAUGAUAUUACCUCCUAUUUUUAUUU
UUCUUCCAG  541 AUUGAAAC   
33 3815607 3815644 
AGCAUCCCUACUUAAAGAGACUGGGGGC
AUAUAACCCC  3765 AUUGAAAC   
34 3815682 3815722 
UUCAAUCGUGGCCUCCAGGGAACGGGC
GUAAAACAGUUCUU  2003 AUUGAAAC   
35 3815760 3815796 
AUAGAAGGGGCUUAAGCCCUUUUUAUUC
UGACCUGAA  2955 AUUGAAAC   
36 3815834 3815870 
AGGAAGCAGAGGAUUACGUACGUCAGAA
AACAGACUU  2279 AUUGAAAC   
37 3815908 3815942 
UUUUGUCAAGCCAUUGAUACAUCCUUUA
AUGUCUA  979 AUUGAAAC   
38 3815980 3816017 
GUAUAGCACAGGCCCAAGUAAAAGAAAG
GAGUUCAUCA  671 AUUGAAAC   
39 3816055 3816090 
CUACAGCUAUAGCUUGCUUGAAUACAAA
CUCAACGA  981 AUUGAAAC   
40 3816128 3816163 
GUCCCUCCUUAUGCUUCAACAUUGAUUG
CUACGCCU  305 AUUGAAAC   
41 3816201 3816238 
AACCUUACUAUGAUGUUAUAACAUACAAA
GGUUGUAAA  4603 AUUGAAAC   
42 3816276 3816311 
CUCAAACUCAGUGAUACUAAGUAUUUUA
AAAGAAAA  1090 AUUGAAAC   
 
 
Table S2 RNA substrates used for endonuclease cleavage assays. The repeat sequences are 
underlined and brackets indicate deoxy nucleotide substitutions. 
 
RNA substrate Sequence 5’ – 3’ 
M. maripaludis repeat CUAAAAGAAUAACUUGCAAAAUAACAAGCAUUGAAAC 
M. maripaludis d-1 repeat CUAAAAGAAUAACUUGCAAAAUAACAAG (dC) AUUGAAAC 
C. thermocellum repeat GUUUUUAUCGUACCUAUGAGGAAUUGAAAC 
C. thermocellum d-1 repeat GUUUUUAUCGUACCUAUGAGG (dA) AUUGAAAC 
repeat - spacer27 - repeat GAUUUCCGGCUAAAAGAAUAACUUGCAAAAUAACAAGCAUUGAA
ACCUGAUGAAACAAGCGAAACAAACAAUAAAAAAUCAAGCUAAAA
GAAUAACUUGCAAAAUAACAAGCAUUGAAACCGGGGCAAAGA 
spacer2 - repeat - spacer3 AUUAAUCCCAUAAUACUUUUCUAGGUCUGGGCGGAAUCUAAAAG
AAUAACUUGCAAAAUAACAAGCAUUGAAACUAAAAAAAGAAAAAA
GUUAAAAAAGCUAGAAUAAA 
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Abstract 
 
The prokaryotic antiviral defense systems CRISPR (clustered regularly interspaced short 
palindromic repeats)/Cas (CRISPR-associated) employs short crRNAs (CRISPR RNAs) to 
target invading viral nucleic acids. A short spacer sequence of these crRNAs can be derived 
from a viral genome and recognizes a reoccurring attack of a virus via base complementarity. 
We analyzed the effect of spacer sequences on the maturation of crRNAs of the subtype I-B 
Methanococcus maripaludis C5 CRISPR cluster. The responsible endonuclease, termed 
Cas6b, bound non-hydrolyzable repeat RNA as a dimer and mature crRNA as a monomer. 
Comparative analysis of Cas6b processing of individual spacer - repeat - spacer RNA 
substrates and crRNA stability revealed the potential influence of spacer sequence and 
length on these parameters. Correlation of these observations with the variable abundance 
of crRNAs visualized by deep-sequencing analyses is discussed. Finally, insertion of spacer 
and repeat sequences with archaeal poly-T termination signals is suggested to be prevented 
in archaeal CRISPR/Cas systems. 
Introduction 
The adaptive immune system CRISPR/Cas consists of an array of clustered, regularly 
interspaced, short palindromic repeats (CRISPR) and a set of CRISPR-associated (Cas) 
proteins. Spacer sequences that are present between the repeats can be derived from the 
genomes of mobile genetic elements (e.g., viruses) and are utilized to protect host organisms 
against recurring attacks from these elements. The activity of the CRISPR/Cas system within 
the cell is divided into three phases: (1) the adaptation of new spacers, (2) the maturation of 
small CRISPR RNAs (crRNAs) that contain a single spacer sequence and (3) the 
interference with foreign nucleic acids using crRNAs bound to a Cas protein interference 
complex (Barrangou et al, 2007; Barrangou & Horvath, 2011; Bolotin et al, 2005; Cui et al, 
2008; Horvath & Barrangou, 2010; Koonin & Makarova, 2009; Plagens et al, 2012; Sorek et 
al, 2008; Terns & Terns, 2011; van der Oost et al, 2009). 
The diverse CRISPR/Cas systems are divided into three major types and at least 10 
subtypes (Makarova et al, 2011b). In Clostridia, methanogens and halophiles, the subtype I-
B is present, which is defined by the subtype-specific protein Cas8b. Methanococcus 
maripaludis C5 possesses a single subtype I-B CRISPR/Cas system with a minimal Cas 
protein set composed of the universal proteins Cas1, Cas2 and Cas4 (proposed to mediate 
spacer acquisition), as well as Cas3, Cas5, Cas7 and Cas8b, which are presumed to form 
the interference complex Cascade (Cas complex for antiviral defense). Cas6b completes the 
set of Cas proteins and was shown to process pre-crRNA in M. maripaludis (Richter et al, 
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2012). Cas6b belongs to a diversified family of Cas6 endonucleases that is responsible for 
crRNA processing. The first characterized Cas6 enzyme belongs to the subtype III-B system 
present in Pyrococcus furiosus (Pf Cas6). Pf Cas6 was described as a metal-independent 
endonuclease involved in the processing of pre-crRNAs into mature crRNAs (Carte et al, 
2010; Carte et al, 2008; Wang et al, 2011; Wang et al, 2012). Different Cas6 enzymes were 
also characterized for subtype I-F (Cas6f, also known as Csy4 in Pseudomonas aerouginosa 
(Haurwitz et al, 2010; Haurwitz et al, 2012; Sternberg et al, 2012)) and subtype I-E (Cas6e or 
Cse3 in Escherichia coli and Thermus thermophilus (Gesner et al, 2011; Sashital et al, 
2011)). For the subtype I-C that lacks a Cas6 protein, Cas5d appears to compensate for the 
functions of both Cas6e and Cas5e (Garside et al, 2012; Nam et al, 2012). Investigated Cas6 
enzymes share a similar structure despite their low sequence similarities, feature a 
ferredoxin-like fold and operate in an analogous manner to create mature crRNA molecules. 
Nevertheless, significant differences in their catalytic site composition have been observed. 
In Pf Cas6, a catalytic triad formed by tyrosine, histidine and lysine residues can be found 
(Carte et al, 2010), while Cas6e utilizes a catalytic dyad of tyrosine and histidine residues 
(Haurwitz et al, 2012). Two adjacent conserved histidine residues play a major role for 
crRNA processing by Cas6b (Richter et al, 2012). Despite these differences in their active 
sites, all investigated Cas6 proteins generate crRNAs with a 5'-terminal 8 nt repeat tag 
(Carte et al, 2008; Gesner et al, 2011; Haurwitz et al, 2010; Richter et al, 2012; Sashital et al, 
2011), whereas Cas5d processing yields an 11 nt 5'-terminal tag (Nam et al, 2012). The 3' 
end of a crRNA contains the remaining repeat nucleotides, but is often subsequently trimmed 
by a currently unknown mechanism (Hale et al, 2008; Hale et al, 2009; Richter et al, 2012). It 
was shown that Cas6 enzymes bind their respective substrates as monomers (Carte et al, 
2010; Gesner et al, 2011; Haurwitz et al, 2010; Sashital et al, 2011; Sternberg et al, 2012; 
Wang et al, 2011) and are proposed to deliver the mature crRNA to the Cascade complex 
(Carte et al, 2010; Makarova et al, 2011b). However, a non-cleaving homolog of Pf Cas6 was 
observed to form dimers upon binding of unspecific RNA substrates (Wang et al, 2012). 
Monomeric Cas6 activity is in agreement with a proposed wrap-around mechanism for Pf 
Cas6, in which Cas6 was suggested to be bound to the pre-crRNA in a bead chain-like 
manner using the spacer sequences as guide elements for repeat binding (Wang et al, 
2011). The proposed wrap-around mechanism correlates with the regularly interspaced 
arrangement of a pre-crRNA as determined by the CRISPR array. The repeats of a CRISPR 
are nearly uniform for one particular array and the spacer sequences are most often unique 
(Barrangou et al, 2007; Horvath & Barrangou, 2010; Koonin & Makarova, 2009; Sorek et al, 
2008; Terns & Terns, 2011; van der Oost et al, 2009). The length of both spacers (26 - 72 nt) 
and repeats (24 - 47 nt) varies between different CRISPR systems (Grissa et al, 2007a; 
Sorek et al, 2008) and the arrays appear to follow restrictions regarding the preferred and 
	   47	  
allowed lengths of repeat and spacer sequences. Spacer acquisition studies in E. coli 
indicated a favored length of 32 - 33 nt for newly integrated spacers, which is consistent with 
the length of previously existing spacers of the particular array (Yosef et al, 2012). A 
Gaussian-like distribution of spacer length was found for the three CRISPR loci in 
Streptococcus thermophilus (Horvath et al, 2008) also showing a particular range of spacer 
lengths that is favored. In M. maripaludis, the spacer length varies between 34 - 40 nt (Table 
S1). Apart from their length, repeat sequences can differ in proposed secondary structures, 
which have been shown to be important for processing of some repeat sequences (Gesner 
et al, 2011; Haurwitz et al, 2010; Nam et al, 2012; Sashital et al, 2011). In other cases, the 
palindromic nature of repeats giving rise to small hairpin structures was shown to not be 
necessary for crRNA maturation (Carte et al, 2010; Carte et al, 2008; Wang et al, 2011). The 
position of the 5' processing site within the repeat was shown to influence the length of 
mature crRNA, as a ruler mechanism is applied to ensure a consistent length (Hatoum-Aslan 
et al, 2011). Based on their length, sequence and potential hairpin formation, 11 different 
repeat clusters were classified (Kunin et al, 2007). Deep sequencing analyses identified 
highly variable crRNA abundance patterns for different organisms. A general observed trend, 
e.g., for both CRISPR loci of N. equitans (Randau, 2012) and for the CRISPR locus of M. 
maripaludis (Table S1)(Richter et al, 2012), is a gradual decline in abundance of crRNAs 
from the first (closest to the promoter) to the last spacer. Newly acquired spacers are 
inserted closest to the promoter and this abundance pattern infers that the most recent 
interactions with viruses cause a Cascade-targeting system that might be most effective 
against these recently spotted viruses. However, it is puzzling why some crRNAs do not 
follow this trend and are found to be severely underrepresented in vivo. The analysis of the 
abundance of crRNAs bound to CMR complexes in Sulfolobus solfataricus identified a 
variable distribution of crRNAs that are loaded into the interfering complex (Zhang et al, 
2012). Similar results were obtained by RNA sequencing of a total RNA isolation of S. 
solfataricus, where the crRNA abundances were highly variable (Deng et al, 2012; Wurtzel et 
al, 2010). Both repeat and spacer sequences could affect crRNA abundance in the cell. To 
assess the variable crRNA abundance pattern of the single CRISPR system of M. 
maripaludis, we generated 26 spacer - repeat - spacer substrates and analyzed the influence 
of these spacer sequences on Cas6b cleavage activity in vitro. Possible influences of crRNA 
stability were monitored via in-line probing of crRNAs of M. maripaludis in the presence and 
absence of Cas6b. In addition, we observed dimerization of Cas6b upon binding of 
non-cleavable substrates while mature crRNA is bound by Cas6b monomers. 
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Material and Methods 
Production of Cas6b  
Production and purification of recombinant Cas6b via Ni-NTA chromatography was 
performed as described earlier (Richter et al, 2012). Oligomeric states of Cas6b were 
determined by size-exclusion chromatography. Ni-NTA purified Cas6b in lysis buffer [10 mM 
TRIS-HCl (pH 8.0); 300 mM NaCl; 10 % glycerol; 0.5 mM DTT] or Cas6b incubated with 
repeat RNA harboring a 2'-deoxy modification (see below) was applied to an analytical 
Superdex column (200 10/300 GL, GE-Healthcare) and fractionated using a FPLC 
Äkta-Purification system (GE-Healthcare). Proteins of collected fractions were precipitated by 
addition of one quarter volume 100 % TCA (trichloracetic acid) and 15 min incubation on ice. 
The precipitated proteins were washed twice with 200 µl acetone (100 %, ice-cold) and dried 
at 95 °C for 5 min before resuspension in SDS loading buffer. Molecular weight of the 
fractions was determined by comparison to a calibration of the column with molecular weight 
markers, as described in the manufacturer manual (Kit for Molecular Weights, 
Sigma-Aldrich). 
Generation of RNA substrates  
PCR reactions with genomic DNA, isolated from Methanococcus maripaludis C5 and 
containing forward primers encoding the T7 RNA polymerase (RNAP) promoter, yielded 
spacer(n) - repeat - spacer(n+1) templates for in vitro run-off transcription (Fig. 2). 
Transcriptions for unlabeled RNAs were performed for 1 h at 37 °C in a final volume of 20 µl 
[40 mM HEPES-KOH (pH 8.0); 22 mM MgCl2; 5 mM DTT; 1 mM spermidine; 4 mM UTP, 
CTP, GTP, ATP; 20 U RNase inhibitor, 1 µg T7 RNAP, 1 µg PCR product]. Radiolabeled 
spacer - repeat - spacer substrates were generated by in vitro run-off transcription reducing 
the amount of ATP to 2 mM and adding 25 µCi (α-32P) adenosine triphosphate (ATP) (5,000 
Ci/mmol, Hartman Analytic). For the production of crRNA substrates, unlabeled 
spacer-repeat-spacer RNAs were processed with 15 µM Cas6b and purified by 
phenol-chloroform extraction. The obtained crRNAs were 5'-end labeled using (γ-32P) ATP 
(5,000 Ci/mmol) and T4 polynucleotide kinase (PNK) in a volume of 20 µl [15 µl of purified 
RNA; 2 µl PNK buffer (New England Biolabs) and 25 U T4 PNK (Ambion)] for 1 h at 37 °C. 
Synthesis of repeat RNA with a deoxy substitution of the first unprocessed nucleotide was 
done by Eurofins MWG Operon. 5'-end labeling of the deoxy-modified repeat RNA was 
achieved as mentioned above. Labeled RNAs were separated by denaturing PAGE (8 M 
urea; 1 × TBE; 10% polyacrylamide) and visualized by autoradiography. Identified bands 
were excised from the gels and RNA species were eluted by overnight incubation on ice 
using 500 µl RNA elution buffer [250 mM NaOAc; 20 mM TRIS-HCl (pH 7.5); 1.5 mM 
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ehtylenediaminetetraacetic acid (EDTA) (pH 8.0); 0.25 % SDS]. After addition of two 
volumes, EtOH (100 %, ice cold) and 1/100 glycogen (Roche) the RNAs were precipitated for 
1 h at -20 °C. Subsequent washing with 70 % EtOH was followed by pelleting of the RNA. 
Endonuclease assay 
In endonucleolytic cleavage assays the indicated Cas6b concentrations were incubated for 
10 min at 37 °C together with the RNA substrates in cleavage buffer [250 mM KCl; 1.875 mM 
MgCl2; 1 mM DTT; 20 mM HEPES- KOH (pH 8.0)]. The reaction was quenched by adding 2 
x formamide buffer [95 % formamide; 5 mM EDTA (pH 8.0); 2.5 mg bromophenol blue; 2.5 
mg xylene cyanol] and incubation at 95 °C for 5 min. Separation of RNA species was 
achieved by a denaturing 12 - 20 % polyacrylamide gel running at 12 W. Visualization of 
RNA was done by autoradiography. In order to obtain full processing of precursor RNA to 
generate mature crRNAs suitable for 5' labeling with (γ-32P) ATP, the reaction time was 
increased to 1 h with 15 µM Cas6b. 
Electrophoretic mobility shift assay (EMSA) 
In EMSA reactions, indicated Cas6b concentrations were mixed with radiolabeled RNA 
substrates in binding buffer [10 mM TRIS-HCl (pH 8.0); 200 mM KCl; 5 % Glycerol; 0.5 mM 
DTT; 0.5 mM EDTA (pH 8.0); 1 µg BSA]. The reaction mix was incubated for 1 h at 37 °C 
and immediately mixed with 6 x DNA loading dye (4 g sucrose; 25 mg bromophenol blue; 25 
mg xylene cyanol in 10 ml H2O). Separation of the reaction was done with a 7 % native 
polyacrylamide gel running in 1 x TBE at 8 W for 2.5 h. Visualization was achieved by 
autoradiography. 
In-line probing  
Structural analysis of crRNAs was analyzed via in-line probing (Soukup & Breaker, 1999) 
incubating crRNA in probing buffer [5 mM TRIS-HCl (pH 8.5), 0.5 µg yeast RNA (Ambion), 
100 mM KCl, 20 mM MgCl2 ] for 16 h at room temperature. To test Cas6b influence on 
crRNA stability, 20 µM Cas6b was added to the probing reaction. The reaction was stopped 
by addition of 2 x formamide buffer and incubation at 95 °C for 5 min. Visualization was 
achieved by phosphorimaging after separation of RNA using 20 % denaturing polyacrylamide 
gels. 
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Results 
Cas6b forms dimers upon binding to non-cleavable repeat substrates 
Cas6b was previously identified to be the endonuclease responsible for the cleavage of 
repeat sequences of pre-crRNA molecules and for the generation of the crRNAs’ 5'-terminal 
8 nt tag (Richter et al, 2012). In this work, we analyzed the binding of the enzyme to a native 
repeat substrate. To prevent endonucleolytic cleavage of this repeat sequence during the 
performed binding assays, a non-cleavable variant of the repeat served as a substrate. This 
variant harbors a 2'-deoxy modification at the position of cleavage (Fig. 1A), which was 
shown to abolish nuclease activity (Haurwitz et al, 2010; Richter et al, 2012). Electrophoretic 
mobility shift assays (EMSA) were performed with varying concentrations of purified 
recombinant Cas6b. The EMSA assays revealed a band shift at low Cas6b concentrations 
that is fully converted to a distinct super shifted band with increasing Cas6b concentrations 
(Fig. 1B). This pattern of Cas6b repeat RNA binding is in accordance with the possible 
dimerization of the enzyme. Fractionation of a Cas6b-repeat complex via size-exclusion 
chromatography also supports Cas6b dimerization (Fig. S1). To prove that the observed 
Cas6b binding was specific, competition assays were performed. The addition of increasing 
concentrations of unlabeled 2'-deoxy-modified repeat RNA appears to preferentially diminish 
the occurrence of the super shift (Fig. 1C) and the total amount of unbound labeled RNA 
increased. The addition of up to 10 µg unlabeled yeast RNA did not influence the pattern of 
RNA shifts (Fig. 1C). Finally, we assayed the binding of a mature crRNA and observed a 
single band shift (Fig. 1D) that suggests the formation of a Cas6b monomer-crRNA complex 
after successful cleavage. 
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Figure 1. Cas6b-binding assays with non-cleavable native repeat RNA and mature crRNAs. (A) 
The employed RNA sequences are indicated. To prevent processing of the RNA repeat substrate, a 
deoxy substitution of the first base upstream of the 5' tag (boxed) was used in the binding assays. (B) 
Binding assays using decreasing concentrations of Cas6b (50 - 10 µM) and equal amounts of deoxy 
repeat RNA resulted in shift and super shift formation. The separation of samples was performed in 
native polyacrylamide gels (7 %). Bands were visualized by phosphorimaging. (C) Competition assays 
with unchanged Cas6b concentration (20 µM) and increasing concentrations of unlabeled deoxy 
repeat RNA (0 - 5 µM) and yeast RNA (10 - 1 µg) show specificity of Cas6b binding. (D) Only a single 
shift is observed for Cas6b binding (30 - 5 µM) with 5'-labeled crRNA substrate. 
 
Establishment of an experimental approach to assess crRNA processing in M. 
maripaludis  
To assess the previously reported highly variable abundance pattern of crRNAs isolated from 
M. maripaludis (Richter et al, 2012), we specifically designed an experimental setup to 
individually assay the influence of the two neighboring spacer sequences on Cas6b repeat 
RNA processing and crRNA stability in vitro (Fig. 2). Individual primer pairs were designed to 
amplify spacer-repeat-spacer sequences from M. maripaludis genomic DNA. One primer 
contained the T7 RNA polymerase promoter sequence. PCR products were generated for 
each spacer(n) - repeat - spacer(n+1) combination that were subsequently used as DNA 
templates for T7 RNA polymerase mediated in vitro run-off transcription. This approach 
allowed us to produce all individual RNA substrates. The addition of (α-32P)-ATP in the 
transcription mixture yielded radioactively labeled RNA substrates that were used for Cas6b 
endonuclease assays. In an alternative approach, we generated unlabeled RNA molecules, 
processed these with an excess amount of Cas6b to obtain mature crRNA, which then were 
radioactively labeled at their 5'-termini and used in in-line probing assays (Soukup & Breaker, 
1999) for structural analyses (Fig. 4). Even though the cleavage of spacer - repeat - spacer 
substrates yields two fragments, the T4 polynucleotide kinase labeling reaction strongly 
favored the crRNA product, which demonstrates the differences in the 5'-terminal 
phosphorylation state (5'-ppp vs. 5'-OH) of the two fragments. 
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Figure 2. Experimental setup to assess the influence of adjacent spacers on repeat RNA 
processing by Cas6b. Individual primers for each spacer(n) - repeat - spacer(n+1) combination were 
designed and each forward primer contained a T7 RNA polymerase promoter sequence. The primers 
were used in PCR reactions with genomic DNA to generate individual spacer - repeat - spacer 
templates for in vitro run-off transcription. Adding (α-32p)-ATP to the reaction yields radioactively 
labeled RNAs that were used for Cas6b endonuclease assays, whereas unlabeled RNAs were treated 
with Cas6b to generate mature crRNAs, which subsequently were labeled at the 5' tag and used for 
in-line probing reactions to evaluate crRNA stability. 
Spacer sequences influence crRNA maturation in vitro 
Three independent Cas6b endonuclease assays were performed with 26 consecutive 
spacer(n) - repeat - spacer(n+1) RNA substrates of the M. maripaludis CRISPR locus 
(spanning spacer 1 - 26) to screen for the influences of flanking spacer pairs on the efficiency 
of repeat RNA processing. Each RNA species was incubated with three different 
concentrations of Cas6b (10 µM, 1 µM and 0.1 µM) to evaluate and compare the cleavage 
efficiency for each substrate. All substrates displayed complete cleavage with 10 µM Cas6b. 
Some differences were observed for the other two concentrations that were quantified in 
triplicate (Fig. 3B). Cleavage assays with 1 µM Cas6b revealed that the two substrates 
containing spacer 8 (sp8) (60% and 70% substrate conversion, respectively) and the 
sp18 - repeat - sp19 (79% substrate conversion), as well as the sp25 - repeat - sp26 
pre-crRNAs (72% substrate conversion), were less efficiently processed (Fig. 3). The 
addition of 0.1 µM Cas6b showed further differences with reduced crRNA maturation for 
some of the substrates (e.g., sp3 - repeat - sp4, sp18 - repeat - sp19, sp25 - repeat - sp26) 
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while other substrates displayed a comparatively increased product formation (e.g., 
sp2 - repeat - sp3 or sp9 - repeat - sp10). 
Figure 3. The influence of spacer sequences on crRNA maturation. (A) In three independent 
endonucleolytic cleavage assays, each internally labeled spacer(n) - repeat - spacer(n+1) substrate 
was processed using 10 µM, 1 µM and 0.1 µM Cas6b (“c” indicates controls). The RNAs were 
separated in denaturing polyacrylamide gels (12 %) running at 12 W and visualized by 
autoradiography. (B) Quantification of product formation. In three independent cleavage assays, the 
intensities of formed products in relation to the total intensity of observed bands were determined. 
Minor differences of crRNA stability were observed in vitro  
To analyze other possible factors that might influence the abundance of crRNA in M. 
maripaludis in vivo, the stability of the individual crRNAs was compared in in-line probing 
assays (Fig. 4). In these assays, the natural instability of crRNA is observed over time (16 h) 
to achieve partial digestion of the RNA, which can be slowed down or prevented by the 
formation of RNA secondary structures (Soukup & Breaker, 1999). In a second assay, Cas6b 
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was added to the reaction in order to investigate potential stabilizing or destabilizing effects 
of the endonuclease binding to mature crRNAs. The probing assays for most of the crRNAs 
of the M. maripaludis CRISPR locus showed no obvious differences in crRNA stability since 
all reactions resulted in uniform laddered degradation that is expected for unstructured RNAs 
(Fig. 4A, lane “I”). A potential small hairpin formed by inverted 5'-CUUG-3' sequences in the 
repeat was not apparent. Interestingly, the addition of Cas6b (Fig. 4A, lane “C”) to the 
probing assay causes, for most crRNAs, a change of the degradation pattern with the 
accumulation of smaller RNA fragments (most prominently e.g., for crRNAs containing 
spacer 10 or 23). Parallel assays with equal amounts of Cas6b storage buffer alone did not 
cause this destabilizing effect on the crRNAs. The crRNA24 was not degraded and the 
crRNA26 exhibits degradation that differs from the degradation pattern of the other crRNAs. 
In the probing reaction of this substrate with Cas6b, the accumulation of smaller RNA 
degradation products was not observed. However, the formation of a distinct larger RNA 
fragment can be seen. A time course experiment using this particular crRNA confirmed this 
observation (Fig. 4B). With longer incubation times, the amount of the large crRNA fragment 
increased while the substrate amount decreased. The degradation patterns for the probing 
reaction without Cas6b remained nearly identical during the investigated time period. RNase 
T1 digests were utilized to identify guanine bases in the RNA in order to pinpoint the sites of 
increased differential RNA stability found for probing with Cas6b (Fig. 4C). The RNase T1 
digestion revealed that most of the accumulated 5'-labeled small RNA fragments have a 
length of 8 - 11 bases indicating the repeat tag of the crRNA. The accumulated crRNA26 
fragment is cleaved between bases 22–23 of the crRNA. This is a very G-rich region of this 
spacer with the highest GC-content of all M. maripaludis spacers. 
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Figure 4. In-line crRNA probing assays. (A) Individual spacer(n) - repeat - spacer(n+1) RNAs were 
generated by in vitro run-off transcription, processed by Cas6b to yield mature crRNAs. The crRNAs 
were 5' labeled with (γ-32p)-ATP and incubated for 16h at room temperature using a mild alkaline 
buffer to aim for partial digestion (lane “I”). Cas6b influence in the probing reaction was determined by 
addition of 20 µM Cas6b (lane “c”), untreated crRNA served as control (“-”). The probing reactions 
were separated by denaturing polyacrylamide gel-electrophoresis (20 %) and visualized by 
autoradiography. (B) A time-course experiment employing crRNA26 was performed taking samples at 
the indicated time spots. (C) Exemplary RNase T1 (Ambion) digests of the indicated crRNAs using 1 U 
of the enzyme were performed to identify specific cleavage of guanine bases and to determine the 
sizes of the RNA fragments. Two enzyme concentrations were tested for crRNA11 (1 U, 0.1 U) 
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Discussion 
Different oligomerization states are reported for members of the Cas6 family of crRNA 
processing endonucleases. While most Cas6 proteins are reported to act as monomeric 
proteins, a non-catalytic Cas6 homolog from P. horikoshii was shown to feature RNA 
sequence-dependent dimerization (Wang et al, 2012). The active site of Cas6 can feature a 
catalytic triad that is also commonly found in tRNA splicing endonucleases (Carte et al, 
2008). These splicing endonucleases always act as multimers with different families that 
form either heterotetrameric (Calvin et al, 2005; Randau et al, 2005a; Tocchini-Valentini et al, 
2005; Yoshinari et al, 2005), homotetrameric (Li et al, 1998) or dimeric (Fujishima et al, 2011; 
Li & Abelson, 2000) assemblies. Our binding assays with M. maripaludis Cas6b and a non-
hydrolysable repeat RNA clearly show two distinct shifts and, together with gel-filtration 
analysis, suggest dimerization of Cas6b upon substrate binding. However, binding assays 
with mature crRNA revealed only a single shift, which suggests monomeric crRNA binding of 
Cas6b after processing. Cas6b dimerization is observed in a state of stalled substrate 
processing, similar to the results obtained for P. horikoshii. Here, the non-catalytic active site 
of Cas6 hinders processing, while in the case of Cas6b, the 2'-deoxy modification of the 
repeat RNA prevents endonucleolytic cleavage. Pull-down assays with either Cas7 or Cas5 
from S. solfataricus did not lead to co-purification of Cas6 proteins, suggesting that Cas6 
does not interact (or interacts only transiently) with these Cascade proteins (Lintner et al, 
2011b). In conclusion, we support a model that requires Cas6b dimerization during repeat 
RNA cleavage. A long CRISPR RNA precursor could potentially facilitate the binding of 
several Cas6b dimers to the various repeat sequences. Finally, Cas6 enzymes might act as 
a transporter to deliver the crRNA to the Cascade complex. Thus, commonly observed 
monomeric Cas6-crRNA complexes might act as a scaffold for Cascade formation around 
the mature crRNA. The processing of pre-crRNAs by Cas6 enzymes is highly dependent on 
the repeat sequence, but it is not fully understood which role spacer sequences play in 
influencing efficient crRNA processing and the total abundance of different crRNAs in the 
cell. Different factors determine which spacer is integrated into a CRISPR array. A crucial 
element is the protospacer adjacent motif (PAM), which is essential for recognition of 
protospacer sequences in the DNA of mobile genetic elements and, therefore, for the 
adaptation of new spacers into the growing CRISPR array (Deltcheva et al, 2011; Makarova 
et al, 2011b). PAM sequences were shown to be very small, only 2 nt (Gudbergsdottir et al, 
2011) or 3 nt (Fischer et al, 2012) in length, and are also needed for the interference step to 
distinguish between self and non-self nucleic acids (Fischer et al, 2012; Gudbergsdottir et al, 
2011; Semenova et al, 2011). In addition, it was shown that the length of the spacer is 
significant. Spacer acquisition assays in E. coli revealed that the majority of newly acquired 
spacers had a length between 32 - 33 nt with only few exceptions of longer or shorter 
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spacers (Yosef et al, 2012). A similar spacer distribution was identified for the three CRISPR 
loci of S. thermophilus (Horvath et al, 2008). Spacer length in M. maripaludis shows an 
analogous pattern with most of the spacers being 36 - 38 nt in length (Table S1). The longest 
spacer is spacer 8, which is the only 40 nt spacer in the investigated CRISPR. Interestingly, 
both spacer - repeat - spacer RNA substrates that contained spacer 8 showed a reduced 
Cas6b processing efficiency, which suggests that spacer sequences or spacer length play a 
role in Cas6b activity. Our comparative analysis of all potential spacer - repeat - spacer 
combinations revealed additional reproducible differences in the efficiency of Cas6b 
processing of the enclosed repeat. However, these differences are often minor and, most 
importantly, do not clearly match with the highly variable crRNA abundance pattern observed 
in vivo (Table S1) (Richter et al, 2012). The crRNAs that are underrepresented in deep-
sequencing data showed no reduced 5'-terminal maturation by Cas6b. However, potential 
sequencing biases in RNA-Seq studies should always be considered. Variable stability of 
crRNAs might also influence the crRNA abundance in vivo. However, our in-line probing 
experiments indicated a rather uniform pattern of crRNA degradation without observing 
stable secondary structure elements within the crRNAs. It was surprising to see that Cas6b 
destabilizes crRNAs, which could e.g., be explained by bending of the phosphate backbone 
upon Cas6b binding. Most retaining RNA degradation products show that the 5'-terminal 
repeat tag is protected from further degradation. In our experiment, the influence of spacer 
sequences on the stability of the RNA is obvious as the single spacer 26 with an unusually 
high GC-content forms a distinct RNA fragment that is protected from further degradation. 
However, crRNA26 appears not to be over-represented in the cell (Table S1). In conclusion, 
these results show that while spacer sequences do have an effect on Cas6b processing and 
Cas6b-crRNA stability, these effects do not fully explain the in vivo crRNA abundance 
patterns. These patterns are suggested to be determined by several factors that include the 
ones we measured with the presented methodology. Additional parameters that could not be 
addressed with the current experimental setup are (1) the establishment of the interaction of 
crRNAs with Cas protein interference complexes in the cell, (2) differential turnover of 
crRNAs depending on their utilization in the cell and (3) different intrinsic stabilities of crRNAs 
after Cas protein interference complex binding. It could be shown for S. solfataricus that the 
abundance of crRNAs bound to the interference Cas protein complex CMR was also very 
diverse (Zhang et al, 2012). Therefore, the distance of the crRNA’s spacer to the promoter 
and the success rate of the loading of crRNAs into a CMR or Cascade complex might have 
the strongest influences on crRNA abundance in the cell. Finally, the sequences of potential 
spacers have a huge impact on the global CRISPR transcription if they contain elements that 
might either serve as promoters or terminators. Recent studies revealed internal promotion of 
CRISPR array transcription (Deng et al, 2012; Richter et al, 2012) suggesting that spacer 
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sequences with promoter elements could be selected for during evolution if the increased 
transcription of crRNAs with older spacers was beneficial. A problematic scenario is the 
possible integration of spacer sequences with transcription termination sequences into a 
CRISPR. Many questions remain regarding the termination signals in archaeal genomes. 
However, one commonly observed feature, are poly-T stretches at termination sites 
(Santangelo & Reeve, 2006; Thomm  et al, 1993). We observed that M. maripaludis and 
many archaea avoid the adaptation of spacer sequences with long poly-T stretches. In 
addition, several long poly-A stretches are found in the newly acquired spacers of the M. 
maripaludis CRISPR. These poly-A stretches specify poly-T stretches in the reverse direction 
and might provide beneficial termination signals for the prevention of anti-crRNA production. 
In addition, repeat sequences appear to have evolved to lack poly-T (more than 3 T bases in 
a row) motifs in Archaea while these are commonly found in bacterial repeats (Kunin et al, 
2007). Careful manual inspection of archaeal repeats identified only two sequences with four 
consecutive T residues while the majority of them (over 300) contained poly-A sequences. 
Future research on the loading efficiency of Cascade complexes, internal promotion and 
termination signal will be required to fully assess the diverse influences that spacer 
sequences can have on crRNA abundance and their effectiveness against viral attacks. 
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Supplementary Materials 
 
Figure S1. Size exclusion chromatography of Cas6b and d(-1) repeat RNA. SDS-PAGE  
analysis revealed the presence of Cas6b in fractions corresponding to two peaks: peak 1 (12  
ml, 13 ml) and peak 2 (15 ml, 16 ml). Calibration of the molecular weight of fractionated  
proteins determined the mass of peak 1 at 69 kDa (Cas6b dimer + d(-1) repeat RNA has a  
mass of 69.2 kDa) and peak 2 at 26.2 kDa (Cas6b monomer has a mass of 28.3 kDa). 
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Table S1. M. maripaludis C5 spacers 
Spacer 
# 
Spacer 
position 
Spacer 
length Spacer sequence 
Relative 
abundance1 
Spacer 
GC (%) 
1 742916 35 TTCTCCTTCCATCTTGAACAGTGTGAGGTAGCAGG 88,4 49 
2 742988 37 ATTAATCCCATAATACTTTTCTAGGTCTGGGCGGAAT 100,0 38 
3 743062 34 TAAAAAAAGAAAAAAGTTAAAAAAGCTAGAATAA 6,6 15 
4 743133 37 AAAAAACAGATTGAAAAATTAACGGCAAAACAATGAA 18,0 24 
5 743207 36 AAAACGAAAGAAGACTCAACAAGCTAGAAAAACAAT 55,2 31 
6 743280 34 CAATTGCTAAGAGTGCACTAATCGCACTAATAAA 22,4 35 
7 743351 35 ATTTTAAGTATGCGATGTACTCGGATTGATAAATT 50,6 29 
8 743423 40 ACGTAGATACGCTTGTTGCTTCAATGGAAAATTCAGAAGG 40,3 40 
9 743500 36 TTTGTGAATCCCATACAAGGGTTACAGCAGTTACAG 35,1 42 
10 743573 37 ATTTATACGACTAGAAGACCGGCAAAAGTGTATACGG 10,0 41 
11 743647 34 AAAATAAAGCAACGGTTATAAGTCCGGTTGCGAT 4,8 38 
12 743718 37 AGCGTCTATATAAGCGGAACTATACGCACTTTCCGGT 21,9 46 
13 743792 37 CGAATGAAACGAGCGAAACAAGTAATAAAAAATCAAG 9,4 32 
14 743866 36 CAGTAAAAACATTTTGATTTATTATTTTGATCCATT 1,7 19 
15 743939 39 CAGTAAAAAAAGTTAATGAAGAAATTACACCAAGTACTT 1,6 26 
16 744015 38 TCGATATAAGCGGAACTATACGCACTTTCCGCTCTTAA 9,1 42 
17 744090 38 TTTTTTTATACGTTTAGTAACAGGGTTAATTCTGTTTA 5,0 24 
18 744165 37 TTTAATTCCCATTCATGGTTTGGATCTGGAATAAATG 2,3 32 
19 744239 38 TTTTGTTCGTGTCTTTTCTTCTCAATAATTCTTTTAAA 4,2 24 
20 744314 37 TTTTTTTATTGTAATCGGTTATACTGTTGTATTCTGT 4,6 24 
21 744388 38 ACAATTTAGATGTTATAGAGTTTTTAAAACAGAATAAA 6,2 18 
22 744463 36 TACAGAATTTACGTGATTTTAATTATGGTATATATT 0,8 19 
23 744536 38 TATTGTCGATTTTATTTCGCTTAACTCTGTCGGATTAT 9,4 32 
24 744611 36 TGATGGAGTCAAAAGGTAAGACTGTTAAATTTCCGG 14,8 39 
25 744684 37 ACCTTGAAAATATAACATATGAGCAAAAAATTGAAAT 3,2 22 
26 744758 38 CCACCGGCGGAGGGCTCTAAAACGAGGGTACTCGAATA 7,2 58 
27 744833 37 CTGATGAAACGAGCGAAACAAACAATAAAAAATCAAG 1,8 32 
 
1 Relative abundance of individual Methanococcus maripaludis C5 crRNAs was calculated 
from RNA-Seq data taken from Richter et al, 2012. The most abundant spacer 2 was set as 
100 and abundances were calculated accordingly.  
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Abstract 
 
Bacteria and Archaea developed a variety of defense mechanisms against viruses including 
the adaptive immune system CRISPR-Cas. This system utilizes small interfering RNAs 
(crRNAs), which can contain unique sequences derived from viral genomes. Together with a 
complex of CRISPR associated proteins the crRNA base pairs with invading nucleic acids 
and mediates immunity (Barrangou et al, 2007; Brouns et al, 2008). CRISPR-Cas systems 
show a broad diversity (Makarova et al, 2011a; Makarova et al, 2011b), which is also 
exemplified in the Cas6 proteins, the enzymes generating mature crRNA (Carte et al, 2008; 
Gesner et al, 2011; Haurwitz et al, 2010; Reeks et al, 2013c; Richter et al, 2012; Sashital et 
al, 2011). Here, we detail a biochemical analysis of the Cas6 homolog Cas6b of subtype I-B 
in M. maripaludis C5. Cas6b is a single turnover enzyme with a binding affinity of 668 nM 
and an observed reaction rate of 0.296 min-1. We identified an important amino acid residue 
(M185) for RNA binding and two additional residues that are involved in crRNA maturation 
(K30 and Y47). Our studies further reveal that the repeat sequence and not the repeat 
structure is important for precursor crRNA processing by Cas6b. 
 
Introduction 
 
CRISPR-Cas is an adaptive prokaryotic defense mechanism against invading nucleic acids 
that recently generated interest as a new genome editing tool (recently reviewed in 
(Charpentier & Doudna, 2013; Horvath & Barrangou, 2013; Richter et al, 2013b)). The 
system is composed of clustered regularly interspaced short palindromic repeats (CRISPR) 
adjoined to a set of CRISPR associated (Cas) genes. The CRISPR array comprises unique 
spacer sequences that intersperse a series of repeats. Spacer sequences can be derived 
from genomes of mobile genetic elements and, as part of the interfering small RNA (crRNA), 
these spacers help to counter a reoccurring attack of these elements. The basic mechanism 
of the CRISPR immunity can be divided into three major steps: i) adaptation of new spacers, 
ii) the maturation of crRNAs and iii) interference with the alien nucleic acid (Barrangou et al, 
2007; Brouns et al, 2008; Horvath & Barrangou, 2010; Jore et al, 2011a; Sorek et al, 2008; 
Terns & Terns, 2011; van der Oost et al, 2009; Westra et al, 2012b). Although the details of 
the adaption process are still not completely understood, it was shown that Cas1 and Cas2 
play a critical role in adaption and that the putative acquisition complex Cascis (CRISPR 
associated complex for integration of spacers) requires only the leader sequence and one 
repeat unit to adapt new spacer sequences (Datsenko et al, 2012; Erdmann & Garrett, 2012; 
Plagens et al, 2012; Swarts et al, 2012; Yosef et al, 2012; Yosef et al, 2013). In Type-I 
systems more information is present for the processing of precursor-crRNA (pre-crRNA), 
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mediated by Cas6 family proteins (Carte et al, 2008; Gesner et al, 2011; Haurwitz et al, 
2010; Reeks et al, 2013c; Richter et al, 2012; Sashital et al, 2011) and the interference step 
in which a complex of different Cas proteins, called Cascade (CRISPR associated complex 
for antiviral defense) together with the mature crRNA marks the invader for degradation by 
Cas3 (Cady & O'Toole, 2011; Howard et al, 2011; Jore et al, 2011b; Lintner et al, 2011b; 
Mulepati & Bailey, 2011; Sashital et al, 2012; Sinkunas et al, 2011; Sinkunas et al, 2013; 
Westra et al, 2012a; Wiedenheft et al, 2011a; Wiedenheft et al, 2011b). While Cascade is a 
complex found in Type-I systems, Type-II systems utilize a single multifunctional protein 
called Cas9 to generate mature crRNAs and to interfere with the alien nucleic acid (Chylinski 
et al, 2013; Deltcheva et al, 2011; Jinek et al, 2012). Two Cascade-like complexes (CMR or 
CSM) are reported for Type-III systems (Hale et al, 2009; Marraffini & Sontheimer, 2010a; 
Osawa et al, 2013; Shao et al, 2013; Shao & Li, 2013; Zhang et al, 2012). 
The three major types of CRISPR-Cas systems were defined by computational analyses and 
differ in their main interfering proteins: Cas3 (Type-I), Cas9 (Type-II) and Cas10 (Type-III). A 
further classification into at least 10 subtypes is based on subtype-specific proteins (e.g. 
Cas6b, Cas8b) (Makarova et al, 2011b). Subtype I-B with its specific proteins Cas8b and 
Cas6b can be found e.g. in Clostridia, methanogens and halophiles. Both in Methanococcus 
maripaludis and in Clostridium thermocellum an I-B system with 8 Cas proteins has been be 
identified. These include the universal Cas1, Cas2 and Cas4 proteins, proposed to be part of 
the spacer acquisition complex Cascis, the four interference complex proteins Cas3, Cas5, 
Cas7, Cas8b and the pre-crRNA processing enzyme Cas6b (Richter et al, 2012). 
The first description of a crRNA maturation protein was published for the metal-independent 
subtype III-B Cas6 of Pyrococcus furiosus (Pf Cas6) (Carte et al, 2010; Carte et al, 2008; 
Wang et al, 2011; Wang et al, 2012). Further characterization of crRNA maturation by Cas6 
family proteins was done for subtype I-E (Cas6e, formerly Cse3) in Escherichia coli and 
Thermus thermophilus (Gesner et al, 2011; Sashital et al, 2011), subtype I-F (Cas6f, also 
known as Csy4) of Pseudomonas aeruginosa (Haurwitz et al, 2010; Haurwitz et al, 2012; 
Sternberg et al, 2012) and subtype I-B (Cas6b) in M. maripaludis C5 and Methanosarcina 
mazei (Nickel et al, 2013; Richter et al, 2013a; Richter et al, 2012). Surprisingly, no Cas6 
homolog is found in subtype I-C. Here, Cas5d appears to take over the functions of both 
Cas6e and Cas5e (Garside et al, 2012; Nam et al, 2012). Cas6 enzymes share similar 
features including a ferredoxin-like fold and the general acid/base mechanism of pre-crRNA 
processing. Considering that the overall sequence identities are very limited, the structural 
similarity of Cas6 enzymes is striking. The sequence differences of these enzymes are most 
obvious in the composition of the catalytic sites. While Pf Cas6 employs a triad of tyrosine, 
histidine and lysine residues (Carte et al, 2010; Wang et al, 2011), Cas6f utilizes a dyad of a 
serine and a histidine residue (Haurwitz et al, 2012). Cas6e activity also relies on the 
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canonical catalytic histidine and additionally a tyrosine has been reported to play a role in 
processing (Gesner et al, 2011; Sashital et al, 2011). Biochemical characterization of Cas6b 
reports the importance of two interchangeable histidine residues (Nickel et al, 2013; Richter 
et al, 2012). Despite their different active site composition and substrate recognition, the 
resulting mature crRNA always consists of a full-length spacer flanked by remaining repeat 
parts forming a distinct 8 nt 5' terminal tag and a gradually trimmed 3' terminal tag. Cas5d 
crRNA maturation on the other hand yields an 11 nt 5' terminal repeat tag (Carte et al, 2008; 
Gesner et al, 2011; Haurwitz et al, 2010; Nam et al, 2012; Richter et al, 2012; Sashital et al, 
2011). The 5' repeat tags are important during the discrimination of self- and non-self DNA 
(Marraffini & Sontheimer, 2010b; Sashital et al, 2012; Westra et al, 2013).  
Cas6 enzymes are often reported to bind their substrates as a monomer (Carte et al, 2010; 
Gesner et al, 2011; Haurwitz et al, 2010; Sashital et al, 2011; Wang et al, 2011). Exceptions 
are found in a non-catalytic Pf Cas6 homolog of Pyrococcus horikoshii (Wang et al, 2012), in 
a dimeric form of Sulfolobus solfataricus Cas6 (Sso Cas6) (Reeks et al, 2013c), in two Cas6e 
variants of T. thermophilus (Niewoehner et al, 2013) and Cas6b of M. maripaludis (Richter et 
al, 2013a), which were observed to bind RNA substrates in dimeric manner. While the 
reported monomeric binding correlates with the proposed wrap-around mechanism, in which 
Cas6 is bound to the long precursor in a bead chain like manner (Wang et al, 2011), the 
dimeric binding supports an individual processing of pre-crRNA by Cas6 dimers before being 
transported to Cascade. Repeat sequences play a critical role for Cas6 binding and also for 
Cas6 processing. Despite their different lengths, the repeats can differ in their secondary 
structures, which are specifically recognized by some Cas6 (Gesner et al, 2011; Haurwitz et 
al, 2010; Sashital et al, 2011; Sternberg et al, 2012). Other studies showed that structures of 
repeats, often formed due to their palindromic nature, do not influence the cleavage reaction 
(Carte et al, 2010; Carte et al, 2008; Wang et al, 2011). In addition to a possible structure of 
repeats, the sequence itself seems to be important not only for binding but also for 
processing by Cas6. The length and individual nucleotides of the sequence showed to be 
critical for binding and cleavage by Cas6 enzymes (Carte et al, 2010; Carte et al, 2008; 
Sternberg et al, 2012; Wang et al, 2011; Wang et al, 2012), while the deletion of some 
sequence stretches, even within the 5' terminal tag, does not influence processing by Cas6 
(Wang et al, 2011; Wang et al, 2012). Some nucleotides seem to have only an influence on 
processing by affecting the binding behaviour of Cas6 (Carte et al, 2010; Sternberg et al, 
2012), whereas other nucleotides were shown to inhibit processing, while binding was still 
possible (Wang et al, 2012).  
In this study we show that Cas6b of M. maripaludis is a single turnover enzyme with an 
observed reaction rate of kobs = 0.296 min-1 and a binding affinity to non-cleavable substrate 
of Kd= 668 nM. We further show that, besides the previously described catalytic histidines 
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(H38 and H40) (Richter et al, 2012), a lysine (K30) and a tyrosine (Y47) are critical for Cas6b 
processing activity. UV-crosslinking experiments with Cas6b that were followed by mass 
spectrometric analysis identified a methionine residue (M185) that has a major influence on 
repeat binding by Cas6b. Mutation of this residue resulted in a two times lower affinity to the 
respective RNA substrate (KD=1.03 µM) compared to the wild-type enzyme. Analyses of 
different repeat mutants showed that the sequence of the M. maripaludis repeat is critical for 
Cas6b recognition and cleavage. Finally, we could show that repeats of an archaeal and a 
bacterial subtype I-B system are interchangeable and only the disruption of individual key 
nucleotides affects the processing reaction by Cas6b. 
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Material and Methods 
 
 
Growth of E. coli 
 
E. coli cells were grown in LB-media with appropriate antibiotics at 37 °C and shaking at 200 
rpm. 
 
Production of Cas6b and mutants 
 
Using genomic DNA of M. maripaludis C5 the cas6b gene was amplified and cloned into the 
vector pET-20b to enable for a protein expression with a C-terminal His-tag. QuikChange 
site-directed mutagenesis was carried out according to the manufacturer’s instructions 
(Stratagene mutations were confirmed by sequencing (MWG Eurofins)). The different Cas6b 
variants were produced in E. coli (Rosetta2 DE3) cells as described previously (Richter et al, 
2012). After growth to an OD578 of 0.6 the protein expression was induced by addition of 
isopropylthio-β-D-galactoside (IPTG) to a final concentration of 0.5 mM. The cells were 
harvested 4 hours post induction and the cell pellet was resuspended in 5 ml lysis buffer (10 
mM Tris-HCl [pH 8.0], 300 mM NaCl, 10 % glycerol and 0.5 mM DTT) per 1 g cells. Lysis 
was carried out on ice with lysozyme (1 mg / g cell pellet) for 30 min. Cell disruption was 
achieved by applying 8 cycles of 30 s sonication (Branson Sonifier 250) and 30 s rest on ice. 
The lysate was cleared by centrifugation (47800 g, 30 min, 4 °C) and subsequently the 
supernatant was loaded onto a Ni-NTA-Sepharose Column (GE-Healthcare) and purified 
using a FPLC Äkta-Purification system (GE-Healthcare). To elute the proteins, a linear 
gradient of imidazole was applied (0 – 500 mM) and the purity of eluted proteins was 
determined by SDS-PAGE and coomassie blue staining. Pure protein fractions were pooled 
and dialysed into lysis buffer following a protein concentration determination by Bradford 
Assay (BioRad). 
 
Generation RNA substrates 
 
M. maripaludis C5 wild-type repeat RNA, its deoxy substitution variant (d-1) and the wild-type 
repeat RNA of C. thermocellum were synthesized by MWG Eurofins. Synthesized RNA was 
5' end labelled using T4 polynucleotide kinase (Ambion) and [γ-32P] ATP (5000 ci/mmol, 
Hartman Analytic) according to the manufracturer’s instructions. The labelling reaction was 
carried out for 1 hour at 37 °C in final volume of 10 µl (1 µl PNK buffer (NEB), 25 U T4 PNK 
(Ambion), 10 pmol RNA). 
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Generation of M. maripaludis repeat variants was achieved either by site-directed 
mutagenesis of a pUC19 vector containing a spacer2 - repeat - spacer3 construct (Richter et 
al, 2012) (G16C, G16C/C25G; Stratagene) using oligonucleotides designed by Agilent’s 
Primer Design tool or by direct synthesis of oligonucleotide pairs with the desired mutation 
(U15A, U32A; MWG Eurofins). Substrates harbouring the repeat variants G16C and 
G16C/C25G were yielded by in vitro run-off transcription after linearization of the vector using 
HindIII. The variants U15A and U32A were also yielded by in vitro run-off transcription, but 
here a hybridization (heating of the mixed oligonucleotide pair for 5 min at 95 °C and slow 
decrease of temperature for 2 hours) of the synthesized oligonucleotides preceded the in 
vitro transcription. In vitro run-off transcription was carried out for 3 hours at 37 °C in a final 
volume of 20 µl using the linear DNA templates described above (40 mM HEPES-KOH [pH 
8.0]; 22 mM MgCl2; 5 mM DTT; 1 mM spermidine; 4 mM UTP, CTP, GTP, ATP; 25 µCi [α-
32P] adenosine triphosphate (ATP) (5000 Ci/mmol, Hartman Analytic) 20 U RNase inhibitor; 1 
µg T7 RNA polymerase; 1 µg linear template). 
RNA labelling reactions were separated by a denaturing polyacrylamide gel electrophoresis 
(8 M Urea; 1 x TBE; 10 % polyacrylamide). Using sterile scalpels the respective bands were 
cut out of the gel in reference to a brief autoradiographic exposure. Elution of the RNA took 
place in 500 µl RNA elution buffer (250 mM NaOAc; 20 mM Tris-HCL [pH 7.5]; 1 mM EDTA 
[pH 8.0]; 0.25 % SDS) over-night shaking on ice. Precipitation of RNA was achieved by 
addition of 2 Vol EtOH (100 %, ice cold) and 1/100 glycogen (Roche) and incubation at – 20 
°C for 1 h. Subsequent to pelleting, the RNA was washed with 70 % EtOH and the dried 
pellet was resuspended in H2ODEPC. 
 
Endonuclease assay 
 
Indicated concentrations of the different Cas6b variants were incubated with the radiolabelled 
RNA substrates in a final volume of 10 µl (250 mM KCl; 1.875 mM MgCl2; 1 mM DTT; 20 mM 
HEPES-KOH [pH 8.0]). Reactions were incubated at 37 °C for the indicated period of time 
and immediately mixed with 2 x formamide buffer (95 % formamide; 5 mM EDTA [pH 8.0]; 
2.5 mg bromophenolblue; 2.5 mg xylene cyanol) and heated at 95 °C for 5 min to stop the 
cleavage reaction. For turnover and kinetic studies of Cas6b a master mix of 5 (50 µl) and 24 
(240 µl) reactions, respectively, was prepared to assure constant reaction conditions. After 
the indicated time period a 10 µl sample was removed and mixed with 2 x formamide buffer 
and heated to 95 °C for 5 min. 
The reactions were loaded on a denaturing polyacrylamide gel (12 %) and run in 1 x TBE at 
12 W for 1.5 hours. Visualization was achieved by phosphorimaging. Substrate processing 
was quantified using ImageQuant software. Mean values of relative processed substrate out 
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of three independent turnover assays were plotted using Origin and standard deviation was 
calculated using Excel. Kinetic values were plotted using Origin and fitted according to 
first-order reactions. Linearization of the data was calculated with Excel and plotted with 
Origin; the slope of the equation equals kobs, the observed reaction rate. 
 
Electrophoretic mobility shift assay (EMSA) 
 
In binding assays the indicated concentrations of either Cas6b wild-type or Cas6b M185A 
were mixed with the radiolabelled (d-1) repeat variant in a final volume of 10 µl (10 mM 
Tris-HCl [pH8.0]; 200 mM KCl; 5 % glycerol; 0.5 mM DTT; 0.5 mM EDTA [pH 8.0]; 1 µg 
BSA). The mixture was incubated at 37 °C for 1 h before addition of 6 x DNA loading dye (4 
g sucrose; 2.5 mg bromophenolblue; 2.5 mg xylene cyanol in 10 ml H2O). A 7 % native 
polyacrylamide gel running in 1 x TBE at 8 W for 2.5 hours was used to separate the reaction 
products. Visualization was achieved by autoradiography and quantification of EMSAs for KD 
value determination was done with ImageQuant. Relative amounts of bound RNA were 
plotted against the used protein concentration and fitted with a hyperbolic equation using 
Origin. Linearization of the data was achieved by plotting the data in a Scatchard-plot in 
which the negative reciprocal of the slope equals the Kd value. 
 
UV induced protein-RNA crosslinking and enrichment of cross-linked peptides 
 
UV crosslinking and enrichment of cross-linked species was achieved as previously 
described (Schmidt et al, 2012). Cas6b and (d-1) repeat RNA were mixed in equimolar ratios 
(1 nmol each) in a total volume of 100 µl of lysis buffer. Formation of complex was achieved 
by incubation on ice for 30 min before being transferred in black polypropylene microplates 
(Greiner Bio-One) and irradiated at 254 nm for 10 min. Following a RNA precipitation 
(described above) the samples were denatured (4 M Urea, 50 mM Tris-HCl [pH 7.9]) and 
digested with Benzonase (Ambion) for 1 h at 37 °C. Proteolysis was performed over-night at 
37 °C using trypsin (Promega). After desalting on a C18 column (Dr. Maisch GmbH, 
Göttingen) the cross-linked peptides were enriched using a TiO2 column (GL sciences). 
Finally, the samples were dried and resuspended in 10 µl solvent (5 % acetonitrile (ACN), 1 
% formic acid (FA)). 
 
Nano-liquid chromatography and MS analysis 
 
5 µl of the cross-linked sample (above) was subjected to a nano-liquid chromatography 
system (Agilent 1100 series, Agilent Technologies) including a C18 trapping column (length: 
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2 cm; inner diameter: 150 µm; flow rate: 10 µl/min; buffer A: 0.1 % FA) in line with a C18 
analytical column (length: 15 cm; inner diameter: 75 µm) (both C18 AQ 120 Å 5 µm, Dr. 
Maisch GmbH). After elution from the trapping column the analytes were separated in the 
analytical column using a gradient of 7 - 38 % buffer B (95 % ACN, 0.1 % FA) with an elution 
time of 33 min (0.87 %/min) and a flow rate of 300 nl/min. 
Online ESI-MS was performed using an LTQ-Orbitrap Velos (Thermo Scientific), operated in 
data-dependent mode using a TOP10 method. The MS scans were recorded in a m/z range 
of 350 – 1600 and for subsequent MS/MS the top 10 most intense ions were selected. 
Fragments, generated by HCD activation (higher energy collision dissociation, normalized 
collision energy = 40), and precursor ions were scanned in the Orbitrap. The resulting 
spectra were measured with high accuracy (< 5 ppm) both at MS and MSMS level. 
 
MS data analysis 
 
MS *.raw files were converted into *.mzML format using msconvert (Kessner et al, 2008). 
Open MS (Bertsch et al, 2011; Sturm et al, 2008) and OMSSA (Geer et al, 2004) search 
engines were employed to analyze the protein-RNA cross-links. High scoring cross-linked 
peptides were manually annotated for confirmation. 
 
Repeat Analysis 
 
RNA structures were predicted using RNAfold (McCaskill, 1990; Schuster et al, 1994; Zuker 
& Stiegler, 1981) at standard settings. Repeat sequences were aligned using VectorNTI 
(Invitrogen) with a ClustalW2 algorithm (Larkin et al, 2007)and a sequence logo of different 
subtype I-B repeat sequences was created with WebLogo using the basic settings (Crooks et 
al, 2004; Schneider & Stephens, 1990).  
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Results 
 
Cas6b is a single turnover enzyme with a fast reaction rate 
 
Endonucleolytic cleavage assays using recombinant Cas6b were employed to determine the 
enzymatic turnover of Cas6b (Fig. 1a). In three independent assays with three different RNA 
to protein ratios and different incubation times, only in an 1:1 ratio, the RNA substrate was 
cleaved with high conversion rates of about 80 %. Decreasing protein concentrations and 
maintaining constant RNA levels (10 nM) showed a significant reduction in substrate 
conversion rate to about 40 % and 15 % for 1:5 and 1:10 ratios, respectively (Fig. 1b), 
indicating a single turnover mechanism of Cas6b. 
Determination of the observed reaction rate (kobs) was performed in time course experiments 
in which the substrate conversion was monitored over 570 s (samples taken every 30 s). The 
assay shows maximum conversion already after 200 s and indicates a very fast reaction rate 
(Fig. 1c). Quantification and plotting of the data shows (Fig. 1d) that 70 % conversion is 
achieved after approximately 200 seconds and stays constant during the remaining 
incubation time. Linearization (small graph inserted in Fig. 1d) of the data was for the data 
obtained for the first 200 seconds after which the plateau of conversion was reached. Three 
independent assays show a substrate conversion rate kobs = 0.296 min-1 ± 0.01 min-1. 
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Figure 1. Cas6b is a single turnover endonuclease. To determine the turnover and reaction rate of 
Cas6b, endonuclease assays were performed with 5' end labelled repeat RNA. (A) Determining the 
turnover, a representative assay using 3 different Cas6b to RNA ratios (1:1, 1:5 and 1:10) incubated 
for 4 different time intervals (5 min, 10 min, 30 min and 60 mins) is shown. Processing occurs in all 
reactions, yet only in the 1:1 ratio a significant conversion rate is observed, indicative for a single 
turnover enzyme. (B) Substrate processing of three independent assays was quantified. (C) One 
representative assay in which 1.5 nM Cas6b with 1 nM repeat RNA were incubated over a time course 
of 570 seconds taking a sample every 30 seconds is displayed. (D) Quantified data was plotted and 
fitted by the first-order rate law. The data obtained for the first 200 seconds of the reactions were 
linearized and in three independent assays the reaction rate kobs = 0.296 min-1 ± 0.02 min-1 was 
determined.  
 
The active site of Cas6b is composed of four active residues 
 
Previous studies identified two interchangeable histidine residues as part of the Cas6b 
catalytic site (Nickel et al, 2013; Richter et al, 2012). A structural model and alignment 
(Richter et al, 2012) was used to deduce further amino acid residues that might be involved 
in the processing reaction of Cas6b. Single mutations of conserved residues in Cas6b did not 
seem to have a significant impact on activity (Tab. 1). Therefore, double mutants were 
introduced by site-directed mutatgenesis. These mutants were analysed using endonuclease 
assays employing M. maripaludis C5 repeat RNA as substrate (Fig. 2a). Of the created 
mutants (Tab. 1), only a mutation of both lysine at position 30 together with a tyrosin at 
position 47 resulted in a significant reduction of conversion to 20 % (Fig. 2b). The mutation of 
two conserverd lysines at position 29 and 30 and the double mutant of K29 and Y47 resulted 
in a Cas6b with wild-type like conversion rates. Together four active residues were identified: 
lysine 29, histidine 38, histidine 40 and tyrosine 47.  
 
Figure 2. A lysine and tyrosine residue are part of the catalytic site of Cas6b. Indicated Cas6b 
mutants were used in endonuclease assays with 5' end labelled repeat RNA. (A) The activities of the 
Cas6b variants are shown in a representative assay. While the two double mutants of lysine 29/lysine 
30 and lysine 29/tyrosine 47 did not show significant differences compared to wild-type (wt) Cas6b, 
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the double mutant lysine 30/tyrosine 47 displays a highly reduced processing activity. (B) Product 
formation by the indicated Cas6b variants was quantified in three independent assays. 
 
It should be noted that several mutants did not yield soluble protein (Tab. 1) and it cannot be 
excluded that these residues might also be involved in the cleavage reaction. 
 
Table 1. Set of different Cas6b mutants. 
 
active site 
mutants 
  binding site 
mutants 
  
mutated 
residue 
soluble 
protein  
active 
protein  
mutated 
residue 
soluble 
protein  
binding 
protein  
R24A yes yes M185A yes (yes) 
Y26A yes yes G187A no - 
K29A yes yes G190A yes yes 
K30A yes yes G203A no - 
Y31A yes yes G205A no - 
H38A yes (yes) G203A/G205A no - 
H38F yes (yes) G211A/G213A no - 
H40A yes (yes)    
H40F yes (yes)    
Y47A yes (yes)    
Y49A no -    
Y49F no -    
K55A yes yes    
Y26A/K55A no -    
K30A/Y47A yes no    
K29A/K30A yes yes    
K29A/Y47A yes yes    
K29A/K30A/
Y47A 
yes no    
Y31/K55 no -    
H38A/H40A yes no    
Y47A/Y49A no -    
Y47A/Y49F no -    
 
 
A methionine residue at position 185 binds to a UUGC motif of a non-hydrolysable 
repeat substrate 
 
It was shown previously, that Cas6b binds to a non-cleavable repeat version with a 
deoxynucleotide substitution (d-1 repeat) and forms dimers (Richter et al, 2013a). 
UV-crosslinking of the d-1 repeat substrate to wild-type Cas6b followed by mass 
spectrometric analysis identified a methionine residue at position 185 that interacts with an 
UUGC sequence motif of the repeat RNA. Interestingly, analysis of the previously introduced 
Cas6b structural model (Richter et al, 2012), shows that the methionine residue is at the 
opposite site of the already identified catalytic residues, indicating two distinct domains for 
cleavage and substrate binding. 
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An approach to generate binding deficient Cas6b mutants by site-directed mutagenesis often 
resulted in insoluble proteins (Tab. 1), especially for mutants in the C-terminal glycine rich 
loop proposed to be important for substrate binding (Haurwitz et al, 2010). However, the 
mutation of the methionine 185 residue yielded soluble protein. Determination of Kd values 
for the wild-type and the M185A mutant of Cas6b were performed by standard EMSAs (Fig. 
3). Binding assays for both Cas6b versions show a gradually inclining amount of shifted 
substrate with increasing amounts of Cas6b, yet the shifts for wild-type Cas6b appear 
already at concentrations as low as 50 nM (Kd of 668 nM ± 29 nM) (Fig. 3a, b) while over 250 
nM are needed to cause a significant RNA substrate shift with the M185A mutant (Kd = 1.03 
µM ± 0.3 µM) (Fig. 3c, d). Scatchard linearization of the quantified data (small graph inserted 
in Fig. 3b, c) was employed to yield KD values of both proteins. An approximately two times 
higher affinity of Cas6b wild-type to its RNA substrate is displayed compared to the mutant, 
confirming the importance of this residue for substrate binding. 
 
Figure 3. A methionine residue plays an important role in substrate binding of Cas6b. EMSAs 
using 5' radiolabelled deoxy repeat RNA incubated with indicated Cas6b variants and concentrations 
were used to determine the substrate binding affinity. (A) Shifting of the substrate starts at Cas6b 
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concentrations of 50 nM and a complete shift of the substrate into a Cas6b (wt):RNA complex is 
reached at a concentration of 2.5 µM. At higher Cas6b concentrations the reported Cas6b dimerization 
(Richter et al, 2013a) was observed to begin. (B, D) Quantified data was plotted and fitted with an 
hyperbolic curve. Linearization was achieved with a Scatchard plot and the Kd, as the negative 
reciprocal of the slope, was determined in three independent assays with Kd,wt = 668 nM ± 29 nM and 
Kd,M185A = 1.03 µM ± 0.3 µM. (C) Higher concentrations of the M185A Cas6b mutant are needed to 
initiate the shift of the RNA substrate (250 nM). Full substrate shift into Cas6b (M185A):RNA complex 
is achieved with comparably high concentrations of 6.5 µM. 
 
The maturation of crRNA by Cas6b tolerates changes in repeat sequence and 
structures 
 
Bioinformatical analysis of different 37 nt long subtype I-B repeats using sequence 
alignments (ClustalW2, (Larkin et al, 2007)) and sequence logo generation (WebLogo, 
(Crooks et al, 2004; Schneider & Stephens, 1990)) revealed several conserved nucleotides, 
predominantly located in the processing region that yields the AUUGAAAC 8 nt 5' terminal 
tag of the mature crRNA (Fig. 4a). The 5' region of the repeat shows a lower conversion 
suggesting that it is less important for Cas6b binding or cleavage. 
Several single nucleotide mutations were introduced into the M. maripaludis C5 repeat 
sequence to evaluate the importance of the repeat sequence and structure for Cas6b 
processing (Fig. 4b,c). A mutation that is expected to resolve the hairpin structure (G16C) 
showed a lower substrate conversion rate compared to the wild-type, indicating a possible 
influence of repeat structure on Cas6b recognition. However, restoring the hairpin structure 
by repairing the Watson-Crick base pairs (G16C/C25G) resulted in a complete loss of 
processing by Cas6b. Two UUGC motifs are found within the repeat sequence. One of these 
motifs is found to be bound by the methionine residue 185 mentioned above. Individually 
changing each of the two UUGC motifs into UAGC, to analyse their effect on processing, 
resulted in cleavable substrates. Furthermore the mutation of uridine 15 to adenine resolves 
the hairpin structure and confirms the lack of structural influences on the processing by 
Cas6b. Interestingly, M. maripaludis Cas6b was able to cleave a wild-type repeat RNA of C. 
thermocellum with slightly reduced activity even though this repeat displays 12 nt changes 
and an altered structure (Fig. 4 c/d). The CRISPRmap tool (Lange et al, 2013) places both 
repeat sequences into superfamily E, however, both repeats have a completely divergent 
predicted structure (Fig. 4c) indicating an influence of the sequence during processing rather 
than an influence of the structure. 
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Figure 4. The influence of the repeat sequence on crRNA maturation by Cas6b. (A) A sequence 
alignment (ClustalW2) (Larkin et al, 2007) and a sequence logo (WebLogo) (Crooks et al, 2004; 
Schneider & Stephens, 1990) of different 37 nt long subtype I-B repeats show a highly conserved 3' 
region while the 5' regions are less conserved between these repeats. (B) In endonuclease assays 
incubating different internally labelled RNA substrates representing several repeat variants (G16C, 
G16C/C25G, U15A and U32A) as well as 5' end labelled M. maripaludis and C. thermocellum 
wild-type (Mm wt and Ct wt) repeat RNAs were incubated with different concentrations of M. 
maripaludis Cas6b (10 µM, 1 µM and 0.1 µM). While the G16C/C25G repeat substrate is not 
processed anymore, all other used substrates are still cleaved by Cas6b indicating a sequence 
influence rather than a structural influence during processing. (C) Structure predictions for the different 
repeat variants were created with RNAfold (McCaskill, 1990; Schuster et al, 1994; Zuker & Stiegler, 
1981). (D) A list of the different used repeat sequences. Altered nucleotides compared to M. 
maripaludis wild-type (Mmar wt) repeat are marked in red. 
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Discussion 
 
Structural and biochemical characterization studies are available for several members of the 
diverse family of Cas6 endonucleases present in the different CRISPR-Cas subtypes (Carte 
et al, 2010; Carte et al, 2008; Gesner et al, 2011; Haurwitz et al, 2010; Haurwitz et al, 2012; 
Nickel et al, 2013; Reeks et al, 2013c; Richter et al, 2013a; Richter et al, 2012; Sashital et al, 
2011; Sternberg et al, 2012; Wang & Li, 2012; Wang et al, 2011; Wang et al, 2012). 
Canonical histidines (e.g. found in Cas6f, Cas6e and Pf Cas6) are a key feature of Cas6 
catalytic sites, as the proposed general acid/base mechanism requires protonation of the 
leaving group by the histidine (Carte et al, 2008). Previous studies identified two histidine 
residues in the catalytic site of Cas6b (Nickel et al, 2013; Richter et al, 2012). The only 
known exception is a Cas6 homolog of S. solfataricus (Sso Cas6) that lacks the canonical 
histidine residiue (Reeks et al, 2013c). However, to stabilize the conformation during the 
reaction, more residues are required. In Pf Cas6 a tyrosine and lysine were reported to 
complete the active center of the enzyme (Carte et al, 2010; Wang et al, 2011). In this study, 
these residues were also identified for Cas6b. Although the composition of the Pf Cas6 and 
Cas6b catalytic sites appear similar, the order of the residues is reversed in Cas6b and two 
histidines seem to complement for each other. Therefore this is indicative for a distinct 
catalytic site and strengthens the hypothesis that Cas6 enzymes can be used to classify their 
respective subtypes (Richter et al, 2012). Until now, all the characterized Cas6 enzymes of 
different subtypes are reported to have different catalytic sites, which might also correlate 
with the respective mode of processing, e.g. the wrap-around mechanism (Wang et al, 
2011), dimerization upon processing (Richter et al, 2013a) or the recognition of repeat 
hairpin structures (Gesner et al, 2011; Haurwitz et al, 2010; Sashital et al, 2011; Sternberg et 
al, 2012). 
We showed that Cas6b of M. maripaludis is a single-turnover enzyme, which is in good 
agreement with other studies, reporting single-turnover reactions for Cas6f (Haurwitz et al, 
2010), Cas6e (Sashital et al, 2011) and Sso Cas6 (Reeks et al, 2013c). However, the 
catalytic activity of Cas6b (0.296 min-1) is about 20-fold lower compared to observed reaction 
rates of Cas6e (4.9 min-1) (Sashital et al, 2011) or Cas6f (3.8 min-1) (Haurwitz et al, 2010; 
Sternberg et al, 2012). Similar reaction rates to Cas6b were reported for the dimeric version 
of S. solfataricus (Sso) Cas6 (0.8 min-1), while the monomeric version shows about 10-fold 
lower conversion rates (0.034 min-1) (Reeks et al, 2013c). Cas6b of M. maripaludis has also 
been reported to form dimers at higher concentrations when supplied with non-hydrolysable 
pre-crRNA substrate (Richter et al, 2013a).  
To be in a measurable window of conversion rate, only very low amounts of Cas6b could be 
used for the kobs determination. These low concentrations, however, might not have 
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promoted the previously reported Cas6b dimerization (Richter et al, 2013a). Assuming that 
the monomeric form of Cas6b is also active, this is a possible explanation for the observed 
lower conversion rate.  
With a substrate affinity of approximately 668 nM, the binding affinity of Cas6b to its 
substrate is significantly lower compared to other Cas6 homologs as the Kd values of Cas6f 
and Cas6e are reported with 50 pM and 3.6 nM, respectively (Sashital et al, 2011; Sternberg 
et al, 2012). One explanation could be a different mode of binding, as both Cas6e and Cas6f 
specifically recognize a RNA hairpin structure of their respective repeats followed by fast 
reaction rates (Gesner et al, 2011; Haurwitz et al, 2010; Sashital et al, 2011; Sternberg et al, 
2012). Unfortunately, no kinetic data exists for Pf Cas6 and other Cas6 members close to 
Cas6b that do not rely on the recognition of a secondary repeat structure. The recognition of 
a hairpin structure of a repeat and the associated fast coordination of the cleavage site into 
the active site could be faster compared to the proposed wrap-around mechanism for 
unstructured pre-crRNAs. This mechanism (Wang et al, 2011) based on sequence rather 
then structure of the repeat may need more time for scanning of putative binding sites as well 
as for coordination of the cleavage site into the catalytic center of the Cas6 enzyme. The 
wrap-around theory is also supported by the distal loci for binding and cleavage within the 
protein, which was reported for Pf Cas6 (Carte et al, 2010; Wang et al, 2011). In agreement 
with this, a methionine residue at position 185, important for binding, is at the opposite site of 
the active center of Cas6b and wrapping of the repeat cleavage site into the active site might 
require additional fine-tuning. As Cas6f, for example, specifically recognizes the structure of 
the repeat and cleaves at the stem of the hairpin (Haurwitz et al, 2010; Sternberg et al, 
2012), the wrap-around hypothesis also gives reasoning for the lower conversion rates 
observed for Cas6b.  
While binding of the substrate always includes several amino acids (e.g. arginine, glycine) it 
seems that binding of a uridine base is important during recognition and the involved amino 
acids differ in the various Cas6 enzymes (Gesner et al, 2011; Wang et al, 2011). Cas6e of T. 
thermophilus for example employs an arginine residue for binding (Gesner et al, 2011), while 
in Cas6b the methionine residue binds the uridine. Mutational studies of repeats associated 
with Cas6e and Pf Cas6 revealed that the loss of this uridine base severely affects binding 
by Cas6 indicating a stronger influence of the repeat sequence (Carte et al, 2010; Sashital et 
al, 2011; Wang et al, 2011). The importance of individual nucleotides within the repeat were 
also shown for Cas6f binding (Sternberg et al, 2012). Here, the 5th nucleotide is crucial for 
binding as it marks the beginning of the hairpin structure. Further analysis, including 
mutations within the hairpin, proved the importance of the hairpin for Cas6f processing. In 
addition, single nucleotides within the stem-loop region that do not affect the repeat structure 
were important for recognition (Sternberg et al, 2012). Mutation of single nucleotides showed 
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similar effects on Cas6b cleavage of repeats, however the crucial influence of the structure 
for both binding and cleavage was not identified. Cas6b was able to cleave a C. 
thermocellum repeat substrate from a bacterial subtype I-B with a distinct predicted structure. 
Cas6 enzymes evolved two different binding sites for recognition of their substrates, one site 
specifically binding to the hairpin and the second site recognizing a 5' terminal segment 
preceeding the hairpin (Niewoehner et al, 2013). While some Cas6 variants seem to have 
both binding sites, studies of Pf Cas6 show that repeat binding occurs 12 nt upstream of the 
processing site indicating that only one of the two binding motifs is apparent in this Cas6 
(Carte et al, 2010; Wang et al, 2011). The performed Cas6b studies confirm this result, as 
the uridine residue identified by UV–crosslinking experiments is located in this proposed 
binding area for Cas6 and no other binding was identified. This residue is highly conserved 
among subtype I-B repeats, which indicates its importance. A specific length of the RNA 
sequence is needed to direct the repeat into the catalytic site of the enzyme. In agreement, 
the distance of the identified binding site to the point of processing within the repeat matches 
the proposed wrap-around mechanism (Wang et al, 2011). 
In conclusion, the data provides evidence for the apparent similarity of Pf Cas6 and subtype 
I-B archaeal Cas6b. The repeat recognition and cleavage activities are proposed to employ 
very similar mechanisms and both active centers feature similar yet reversed catalytic triads. 
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Abstract 
 
CRISPR arrays are transcribed into long precursor RNA species, which are further 
processed into mature, interfering RNAs (crRNAs). Cas proteins utilize these RNAs, which 
can contain spacer sequences derived from viral genomes, to mediate immunity during a 
reoccurring viral attack (Barrangou et al, 2007; Brouns et al, 2008). Different CRISPR-Cas 
types are defined by the presence of different interference complexes in which a large 
subunit plays a major role for target binding mediated by crRNA base complementarity 
(Makarova et al, 2011a; Makarova et al, 2011b). We biochemically analysed the proposed 
large Cascade subunit Cas8b of the subtype I-B CRISPR-Cas system found in 
Methanococcus maripaludis C5 and Clostridium thermocellum. Evaluation of the two Cas8b 
proteins revealed a putative proteolytic cleavage site within the protein resulting in the 
creation of two protein fragments that are proposed to represent the large and small 
Cascade subunit of subtype I-B. Finally, we demonstrate unspecific nucleic acid binding by 
Cas8b and the absence of endonucleolytic cleavage activity. 
 
Introduction 
 
The prokaryotic immune system CRISPR-Cas, composed of arrays of clustered regularly 
interspaced short palindromic repeats (CRISPR) and CRISPR associated (Cas) genes, 
utilizes base complementarity between small interfering RNAs (crRNAs) and target nucleic 
acids to identify and degrade foreign DNA or RNA. Repetitive DNA sequences (repeat) of 
CRISPR arrays are interspersed by unique spacer sequences that can be derived from 
genomes of infecting viruses. These spacers are a part of the crRNAs and confer the 
necessary base complementarity with the target (Barrangou et al, 2007; Bolotin et al, 2005; 
Brouns et al, 2008; Horvath & Barrangou, 2010; Mojica et al, 2009; Mojica et al, 2005; Sorek 
et al, 2008; Terns & Terns, 2011; van der Oost et al, 2009). Mechanistically, the CRISPR-
Cas immunity can be described in three phases: i) acquisition of new spacer sequences 
(Datsenko et al, 2012; Erdmann & Garrett, 2012; Plagens et al, 2012; Swarts et al, 2012; 
Yosef et al, 2012), ii) maturation of crRNAs (Carte et al, 2008; Gesner et al, 2011; Haurwitz 
et al, 2010; Richter et al, 2012; Sashital et al, 2011) and iii) interference with the foreign 
nucleic acids during a reoccurring attack by a ribonucleoprotein complex of Cas proteins and 
mature crRNA (Cady & O'Toole, 2011; Hale et al, 2009; Jore et al, 2011b; Lintner et al, 
2011b; Sashital et al, 2012; Shao et al, 2013; Wiedenheft et al, 2011a; Wiedenheft et al, 
2011b; Zhang et al, 2012). 
Based on the three different proteins Cas3, Cas9 and Cas10, responsible for the degradation 
of the target nucleic acid, the CRISPR-Cas systems were classified into three major types. 
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Grouping of individual Cas proteins led to a classification into at least 10 additional subtypes 
(Makarova et al, 2011b). The Type-I subsystem I-B can e.g. be found in methanogens, 
halophiles and Clostridia. In the archaeon Methanococcus maripaludis C5 and in the 
bacterial organism Clostridium thermocellum a minimalistic I-B system is present, with two 
operons coding for the putative adaption machinery Cascis (CRISPR associated complex for 
integration of spacer) (Plagens et al, 2012) and the interference complex Cascade (CRISPR 
associated complex for antiviral defense) (Richter et al, 2013a; Richter et al, 2012). This 
system comprises the universal Cas proteins Cas1, Cas2 and Cas4, the interference 
proteins Cas3, Cas5, Cas7 and the subtype-specific proteins Cas8b and Cas6b (Richter et 
al, 2012). The large Cascade subunits, represented by Cas8 proteins are some of the most 
diverse components of CRISPR-Cas systems and show only low similarities in their 
proposed Zn-finger and polymerase like domains (e.g. thumb and palm). Cas8 proteins are 
predicted to play a major role during the interference step (Makarova et al, 2011a). This 
stage is the major difference between the three types and reflects the plethora of different 
CRISPR-Cas systems best (Makarova et al, 2011b). A reasonable explanation for this 
diversification is the co-evolution of viruses and their hosts, which led to the development of 
a variety of measures by viruses to penetrate their hosts, e.g. anti-CRISPR proteins (Bondy-
Denomy et al, 2013). 
Type-I systems are found in both, bacteria and archaea, and employ an interference system 
in which Cas3 is the key player. Cas3 contains an HD phosphohydrolase domain and a 
DExH-like helicase domain and subsequent to the recruitment by Cascade unwinds dsDNA 
and degrades the resulting ssDNA in an ATP and Mg2+ dependent manner (Beloglazova et 
al, 2011; Makarova et al, 2011a; Makarova et al, 2011b; Mulepati & Bailey, 2011; Sinkunas 
et al, 2011). Target recognition is mediated by base pairing of the crRNA with the 
complementary strand and results in a displacement of the non-complementary strand 
yielding a Cas3 accessible structure called R-loop (Jore et al, 2011b; Lintner et al, 2011b). 
To avoid self-targeting of genomic DNA, Cascade is able to discriminate between self- and 
non-self targets using two specific sequence motifs. The first motif is the 5' terminal repeat 
tag of mature crRNA, generated by Cas6 family enzymes (Carte et al, 2008; Gesner et al, 
2011; Haurwitz et al, 2010; Richter et al, 2012; Sashital et al, 2011) and the second motif is 
represented by the protospacer adjacent motif (PAM), which is short sequence motif that can 
be located upstream or downstream of a protospacer sequence. Both crRNA and PAM 
sequences must not base pair to ensure discrimination between self- and non-self. 
Additionally, the 2 – 5 nt long PAM sequence serves as motif for Cascade binding (Marraffini 
& Sontheimer, 2010b; Sashital et al, 2012; Westra et al, 2013). Subsequently, a helical 
destabilization enables the invasion of the matching seed sequence of the crRNA. Seed 
sequences are described as the first 8 -10 nt of a spacer sequence that are necessary for 
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successful recognition of the foreign DNA (Semenova et al, 2011). Type I-E Cascade of E. 
coli is the best studied CRISPR interference complex (Brouns et al, 2008; Jore et al, 2011b; 
Wiedenheft et al, 2011a; Wiedenheft et al, 2011b), has a size of 405 kDa and is composed of 
the subunits, Cas6e, Cse1, Cse2, Cas7 and Cas5. While Cas6e processes precursor crRNA, 
Cas7 and Cas5 are tightly bound to the crRNA to protect its degradation. The conservation of 
Cas5, Cas7 and the helicase/nuclease Cas3 suggests a general mechanism of interference 
in Type-I systems, which is supported by studies of the related I-A system with a similar 
Cas7/Cas5 crRNA binding platform (Lintner et al, 2011b; Plagens et al, 2012). The large 
Cascade subunit Cse1 of subtype I-E and the small subunit Cse2 tightly bind their DNA 
target (Jore et al, 2011b; Mulepati et al, 2012; Sinkunas et al, 2013). However, the large 
subunit Cse1 is dispensable in vitro and the resulting sub-complex is able to specifically bind 
ssDNA and dsDNA. The addition of Cse1 enhances target localization, yet the binding 
becomes unspecific (Jore et al, 2011b). Strutural studies of Cse1 of Thermus thermophilus 
indicate an involvement during PAM recognition. In binding studies performed with this Cse1 
variant a loop structure displayed a high specificity towards PAM sequences. (Sashital et al, 
2012). A study of type I-F Cascade of Pseudomonas aeruginosa showed a similar assembly 
of the interference complex compared to the one described for I-E (Wiedenheft et al, 2011a). 
However, I-F systems lack a small Cascade subunit and only a large subunit is reported 
(Makarova et al, 2011a). Similarly to I-E, Csy1 (the I-F large subunit) and Csy2 (Cas5) form a 
heterodimer, which seems to be involved in target recognition and is also located at the 
periphery of the Cascade (Wiedenheft et al, 2011a). Type I systems display a broad variety 
regarding their large Cascade subunit. The subtypes I-A and I-E employ two proteins 
designated as small and large subunit, while the subtypes I-B, I-C and I-F have one gene 
coding for a protein that would be required to combine the functions of the small and large 
Cascade subunit. An exception is apparent in subtype I-D, where a Cas10 homolog is found, 
which additionally to the Cas8 features has a HD nuclease domain that seems to be 
reminiscent to the Type-III systems (Makarova et al, 2011a). Although Type-III systems also 
employ a large ribonucleoprotein complex for target interference (Hale et al, 2009; Osawa et 
al, 2013; Shao et al, 2013; Zhang et al, 2012), no genes coding for a small and large subunit 
are found in Type-III systems, which are thought to be the progenitor of Type-I systems 
(Makarova et al, 2011a; Makarova et al, 2011b). As Type-II systems only rely on one large 
multifunctional protein (Cas9) for interference and no large or small subunit of an interference 
complex are found (Chylinski et al, 2013; Deltcheva et al, 2011; Jinek et al, 2012), it seems 
that the presence of a small subunit is special for Type-I systems. The different large 
subunits of Type-I systems (Cse1, Csy1, Cas10d and Cas8) do not share high sequence 
similarity, but with an RRM fold and the putative Palm and Thumb domains, they have some 
features in common, which seem to correlate with their function in target binding and 
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recognition (Makarova et al, 2011a). The subtype I-B large subunit of Methanothermobacter 
thermautotrophicus (Nar71) has been analysed biochemically (Guy et al, 2004). Nar71 was 
proposed to be a novel nuclease-ATPase of a putative thermophilic DNA repair system, as 
the CRISPR-Cas immune system was not yet described. The protein was shown to bind 
Holliday junctions, flayed and flapped DNA structures. Furthermore, a strand specific 
nuclease activity towards 3' flapped structures was observed in the presence of ATP. The 
addition of ATP also resulted in DNA unwinding activities (Guy et al, 2004). Additional 
information is needed to evaluate the possible conserved functions of the different large 
Cascade subunits (e.g. Cas8b, Cas8a, Cas8c). 
In this study we present the recombinant production of the subtype I-B specific protein Cas8b 
of M. maripaludis C5. We demonstrate that the purification of two different Cas8b proteins of 
the bacterial representative C. thermocellum and the archaeon M. maripaludis C5 results in 
two fragments. The similar sizes of the fragments would correlate with a proteolytic cleavage 
into the large and small Cascade subunit comparable to Cse1 and Cse2 of E. coli Cascade. 
Edman sequencing of the smaller fragment identified the cleavage site within the full length 
Cas8b between an asparagine and a methionine residue. The initial biochemical 
characterization of Cas8b of M. thermautotrophicus, Nar71, showed nuclease and helicase 
functions of the protein (Guy et al, 2004). Experiments using the purified Cas8b of M. 
maripaludis C5 and CRISPR-Cas adapted flayed and flapped substrates (DNA/RNA) as well 
as ssDNA, dsDNA and ssRNA substrates, did not display the reported cleavage activity. 
However, the protein exhibits nucleic acid binding activity, which is in agreement with the 
putative role within Cascade. 
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Material and Methods 
 
Growth of E. coli 
 
All E. coli cells used for cloning and expression were grown in LB–medium with the 
appropriate antibiotics at 37 °C shaking at 200 rpm. 
 
Production of Cas8b and mutants 
 
The cas8b genes MmarC5_0771 (Cas8b) and Cthe_3201 (Ct Cas8b) were amplified from 
genomic DNA isolated from Methanococcus maripaludis C5 or Clostridium thermocellum 
(ATCC 27405), respectively. To yield a C-terminal His-tag the genes were cloned into 
pET-20b vector, while MmarC5_0771 additionally was cloned in to pET-Duet1 to facilitate 
expression with an N-terminal His-tag. A sequence alignment of various Cas8b of different 
organisms was prepared with VectorNTI (Invitrogen) using the ClustalW2 algorithm (Larkin et 
al, 2007). Site-directed mutagenesis to generate cas8b mutants was performed according to 
the manufacturer’s protocol of QuikChange site-directed mutagenesis (Stratagene). 
QuikChange primers were designed with the QuikChange Primer Design tool (Agilent) and 
synthesized by MWG Eurofins. Mutations were confirmed by sequencing (MWG). 
Expression of the Cas8b variants was facilitated in E. coli (Rosetta2 DE3) cells by induction 
of protein expression using a final concentration of 0.5 mM isopropylthio-β-D-galactoside 
(IPTG) after the cells reached an OD578 of 0.6. Cells were harvested after 4 hours and the 
pelleted cells were resuspended in 5 ml lysis buffer (10 mM Tris-HCl [pH 8.0]; 300 mM NaCl; 
10 % glycerol and 0.5 mM DTT) per 1 g cells. The cells were lysed with lysozyme (1 mg/g 
cells) incubated on ice for 30 min before being disrupted by sonication (8 x 30 sec, Branson 
Sonifier 250). The lysate was cleared by centrifugation (47800 g, 30 min, 4 °C) and 
supernatant was applied to a Ni-NTA-Sepharose column (GE-Healthcare) and purified using 
a FPLC Äkta-Purification system (GE-Healthcare). Elution of the column bound protein was 
achieved by a linear imidazole gradient (0 – 500 mM). SDS-PAGE and coomassie blue 
staining determined the purity of proteins. Pure protein samples were pooled and dialyzed 
into lysis buffer containing only 100 mM NaCl for further purification steps. In additional steps 
Cas8b of M. maripaludis C5 was purified using a cation exchange column 
(Heparin-Sepharose, GE-Healthcare) and a gradient of NaCl (0 – 1000 mM). SDS-PAGE 
and coomassie blue staining verified the purity of the eluted protein before pooled samples 
were subjected to dialysis into lysis buffer. Final purification was performed by size-exclusion 
chromatography applying the protein sample to an analytical Superdex column (200 10/300 
GL, GE-Healthcare). The molecular weight of the collected fractions was determined by 
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comparison to a calibration curve of the column with molecular weight markers (Kit for 
Molecular Weights, Sigma-Aldrich). The final protein concentration was determined by 
Bradford assay (BioRad). 
 
Generation of DNA and RNA substrates 
 
A repeat variant with a deoxynucleotide substitution at the 29th nucleotide to prevent 
processing by Cas6b was synthesized by MWG. DNA oligonucleotides used to generate 
flapped, flayed and R-Loop like structures were manually designed to have complementary 
sequences and were synthesized by MWG. Cas6b processing of unlabeled 
spacer1 - repeat - spacer2 precursor crRNA yielded mature crRNA2 as described previously 
(Richter et al, 2013a).  
The indicated substrates were 5' end labelled using T4 polynucleotide kinase (Ambion) and 
[γ-32P] ATP (5000 Ci/mmol) in a total volume of 10 µl for synthesized oligonucleotides (10 
pmol RNA/DNA, 1 µl PNK buffer (NEB), 25 U T4 PNK (Ambion)) and 20 µl for crRNA2 (15 µl 
RNA, 2 µl PNK buffer, 25 U T4 PNK). Labelled oligonucleotides and crRNA2 were separated 
using a 10 % denaturing polyacrylamide gel (8 M Urea, 1 x TBE) running in 1 x TBE at 10 W 
for 1.5 hours. After visualization by autoradiography bands were cut out accordingly and 
DNA and RNA species were eluted in 500 µl elution buffer (250 mM NaOAc; 20 mM Tris-HCl 
[pH 7.5]; 1 mM EDTA [pH 8.0]; 0.25 % SDS) over night shaking on ice. After addition of 2 Vol 
100 % ice cold EtOH and 1/100 glycogen (Roche) the DNA and RNA species were 
precipitated for 1 h at -20 °C, pelleted and subsequently washed with 70 % EtOH. 
Flapped, flayed and R-Loop structures were generated by hybridization of radiolabelled 
oligonucleotides with their respective unlabelled counterparts. The corresponding 
oligonucleotides were mixed with a slight excess of unlabelled oligonucleotides to assure 
complete hybridization of the labelled species. The final reaction volume of 10 µl was heated 
to 95 °C for 5 min followed by a 2 hour cooling step to facilitate proper hybridization of 
complementary sequences.  
 
Endonuclease Assay 
 
Endonucleolytic cleavage assays employed varying indicated Cas8b concentrations, which 
were mixed with the specified radiolabelled substrates. Reactions without ATP (20 mM 
HEPES-KOH [pH 8.0]; 1 mM DTT; 5 mM MgCl2) and with ATP (20 mM HEPES-KOH [pH 
8.0]; 1 mM DTT; 5 mM MgCl2; 10 mM ATP) were brought to 10 µl final volume and incubated 
at 37 °C for 30 min. To define a possible cleavage of a single strand within the flapped or 
flayed substrates, only one strand that was used in the hybridization reaction was 5' 
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endlabelled. To analyse each individual strand for potential cleavage, the labelled strand was 
changed in different hybridization reactions. Separation of DNA species was achieved by a 
denaturing polyacrylamide gel (8 M Urea, 1 x TBE, 15 % acrylamide) followed by 
visualization with autoradiography. 
In order to yield mature crRNA for 5' end labelling, an unlabelled spacer1 - repeat - spacer2 
precursor RNA was processed by Cas6b. Full processing of the substrate was achieved by a 
reaction time of 1 h with 15 µM Cas6b (250 mM KCl; 20 mM HEPES-KOH [pH 8.0]; 1.875 
mM MgCl2; 1 mM DTT). 
 
Electrophoretic mobility shift assay (EMSA) 
 
The indicated concentrations of Cas8b were mixed in binding buffer (10 mM Tris-HCl [pH 
8.0]; 200 mM KCl; 5 % glycerol; 0.5 mM DTT; 0.5 mM EDTA [pH 8.0]; 1 µg BSA) with the 
particular substrate and incubated at 37 °C for 1 h to facilitate binding. The reactions were 
immediately mixed with 6 x DNA loading dye (4 g sucrose; 2.5 mg bromophenol blue; 2.5 mg 
xylene cyanol in 10 ml H2O) and applied to a native polyacrylamide gel (1 x TBE, 7 % 
acrylamide) running in 1 x TBE at 7 W for 3 hours. Visualization was achieved via 
autoradiography. 
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Results 
 
Recombinant Cas8b is purified as two fragments 
 
The genes of M. maripaludis C5 Cas8b (MmarC5_0771, Mm Cas8b) and C. thermocellum 
Cas8b (Cthe_3201, Ct Cas8b) were cloned into pET-20b vector to yield a C-terminal His-tag. 
Addtionally, Mm Cas8b was cloned into pET-Duet1 vector to obtain a N-terminal His-tag. The 
respective Cas8b variants were produced and subsequently purified via Ni-NTA affinity 
chromatography (Fig. 1a), which always resulted in elution fractions containing two protein 
fragments of approximately 60 kDa and 15 kDa size for the C-terminal tagged Cas8b. 
Further purification steps, including cation exchange chromatography and size-exclusion 
chromatography (Fig. 1c) generated cleaner protein fractions. The elution profile of the size-
exclusion chromatography run showed one peak with an estimated size corresponding to the 
calculated size of full-length Cas8b (theoretical MW: 76.6 kDa, Fig. 1c). However, two bands 
were observed by SDS-PAGE (Fig. 1a, right panel). To prevent proteolytic cleavage, 
expression tests (e.g. using minimal medium or protein purification with supplemented 
protease inhibitors) were performed but did not change the protein fragmentation pattern 
(data not shown). In addition, Ct Cas8b expression and purification was analysed as well and 
indicated a nearly identical cleavage pattern during SDS-PAGE, with two bands of 
approximately 60 kDa and 15 kDa. Taken together this fits with the calculated full-length Ct 
Cas8b (theoretical MW: 71.5 kDa, Fig. 1b). To exclude, that the small band observed during 
SDS-PAGE is enriched due to the C-terminal His-tag, the tag was cloned to the N-terminal 
end, which would then result in a loss of the small band. Again two fragments were 
observed, but the smaller band was reduced in size likely due to the missing His-tag (Fig. 
1b). Mass spectrometric analysis of the small fragment of the C-terminal tagged Mm Cas8b 
purification identified peptides of the C-terminal end of Cas8b, further indicating that the 
obtained results for Cas8b purification are not displaying artifacts of the purification 
procedure. An alignment (Fig. 1d) of different Cas8b variants of various organisms 
(ClustalW2, (Larkin et al, 2007)) reveals the predicted Zn-finger domain (Makarova et al, 
2011a). Cas8b shows only very low sequence conservation. However, the two CxxC-motifs 
(Fig. 1d, upper part) are highly conserved and the entire C-terminal end of the alignment 
(Fig. 1d, lower part) shows a higher sequence similarity indicative for an important function of 
this protein region. The calculated size of this C-terminal part (16.4 kDa) of the protein 
correlates with the examined size of the small fragment of the Cas8b purifications (Fig. 1a,b). 
An N-terminal Edman-Sequencing (in collaboration with AG Lochnit, Gießen) of 10 amino 
acid residues of the small fragment (boxed sequence in the bottom alignment of Fig. 1d) 
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additionally determined the putative cleavage site within the full-length Cas8b between an 
asparagine residue and a methionine residue. 
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Figure 1. Purification of M. maripaludis (Mm) and C. thermocellum (Ct) Cas8b. (A) SDS-PAGE of 
Cas8b elution fractions with the different used chromatography procedures (Ni-NTA affinity, cation 
exchange (Heparin) and size-exclusion) indicated. Cas8b with a N-terminal tag His-tag always purifies 
in two fragments of roughly 60 kDa and 12 kDa (theoretical MW: 76.6 kDa) (B) SDS-PAGE of protein 
purifications of different recombinant Mm Cas8b (either with N- or C-terminal His-tag) and a 
recombinant Ct Cas8b with C-terminal His-tag. The three variants show purification of two fragments 
of 60 kDa and approximately 15 kDa for the C-terminal version and 60 kDa and roughly 12 kDa 
fragments for the N-terminal tagged version. (C) Size-exclusion elution profile of N-terminal tagged 
Mm Cas8b (main graph) and calibration of the size-exclusion column (small boxed graph). (D) 
ClustalW2 sequence alignment of Cas8b representatives (Larkin et al, 2007). The top part shows the 
putative Zn-finger domain with two CXXC motifs and the lower part depicts the C-terminal part 
showing a higher similarity compared to the overall sequence identity. Amino acids that were identified 
via Edman-Sequencing of the Mm Cas8b C-terminal fragment are displayed by a box within the 
alignment. Conserved residues are shown with black background while grey background highlights 
similar amino acid residues. 
 
Cas8b shows no endonucleolytic cleavage activity 
 
Studies with another Cas8b homolog (Nar71) of M. thermautotrophicus revealed a structure 
specific cleavage activity of the protein correlating with a postulated function in a novel kind 
of DNA repair system (Guy et al, 2004). With the knowledge of the association of Nar71 with 
a CRISPR-Cas system, this putative function was re-investigated using Mm Cas8b and 
substrates designed to mimic structures that are predicted to appear during CRISPR-Cas 
immunity (flapped and flayed DNA structures). Based on the experimental setup of the Nar71 
studies (Guy et al, 2004), we were not able to confirm the reported cleavage activity for 
Cas8b in reactions that were carried out either with supplemented or without supplemented 
ATP. The DNA strands (Fig. 2a) that were used to generate the structures, were not 
processed (Fig. 2b) by Cas8b. Further assays with single stranded RNA and DNA also did 
not show any cleavage activity of Cas8b under the tested conditions (data not shown). 
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Figure 2. M. maripaludis Cas8b does not exhibit endonucleolytic cleavage activity. (A) 
Oligonucleotides designed for hybridization are displayed. Complementary sequence parts that 
hybridize with each other are shown by underlined and italic sequences. (B) Structures formed by 
hybridization are indicated below. Cas8b cleavage activity was determined with endonuclease assays 
using flapped and flayed DNA structures with alteration of the 5' labelled strand (marked by an 
asterisk). The upper panel shows a denaturing polyacrylamide gel of an assay without supplemented 
ATP and three decreasing concentrations of Cas8b (6 µM; 3 µM and 1 µM). In the lower panel the 
same reactions are shown with supplementation of ATP (10 mM), separation of the reaction was 
achieved by denaturing polyacrylamide gel electrophoresis. Cleavage activity was not observed under 
the tested conditions. 
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Cas8b binds nucleic acids unspecifically 
 
Binding of Cas8b to different nucleic acid substrates was assayed by EMSA studies. Cas8b 
was shown to bind ssRNA, ssDNA, dsDNA and R-loop mimicking structures in an unspecific 
manner (Fig 3). Size-exclusion chromatography of a Cas8b:RNA complex shows a 
monomeric binding behaviour in assays performed with d-1 repeat RNA (data not shown). 
Competitive assays using either unlabelled d-1 repeat RNA or unlabelled and unspecific 
yeast RNA showed non-specificity of the binding reaction as the labelled RNA substrate is 
not shifted when higher yeast RNA concentrations were used (Fig. 3c). Cas8b also bound 
R-loop structures that were designed to should mimic structures generated during an 
interference event in which Cas8b would act as big Cascade subunit, without showing major 
preferences to any of the used substrates (Fig. 3d). In additional experiments we aimed to 
elucidate possible functions in PAM recognition that are reported for the large Cascade 
subunit Cse1 (Sashital et al, 2012) (substrate sequences are shown in Fig. 3a). However, 
Cas8b did not display a favoured binding to a TTC PAM containing substrate (PAM reported 
in (Fischer et al, 2012)) when compared to a non-PAM sequence (data not shown).  
	   92	  
 
Figure 3. Unspecific nucleic acid binding by M. maripaludis Cas8b. (A) Substrates for EMSAs 
and oligonucleotides designed for hybridization are shown. Complementary sequence parts are 
depicted by underlined and italic sequences. (B) A native polyacrylamide gel of an EMSA using 5' end 
labelled d-1 repeat RNA and decreasing Cas8b concentrations (17.5 µM – 2.5 µM) shows a high 
shifting RNA:Cas8b complex. A reaction of RNA incubated in binding buffer (C) served as negative 
control and a reaction of Cas6b incubated with RNA conduced a positive binding control (CC). (C) 
Competition of the Cas8b:RNA shift with unlabelled d-1 repeat RNA (1 µM – 10 nM) and unlabelled 
yeast RNA (1 µg – 10 ng) shows decreasing amounts of shifted labelled RNA indicative for an 
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unspecific binding reaction. (D) Binding assays of different R-loop mimicking structures. The left panel 
shows binding to flapped and flayed DNA arrangements and the right panel depicts binding to flapped 
and flayed RNA structures. Hybrids formed by base complementarity are shown below the assays with 
small roman numerals marking the used oligonucleotide and asterisks highlighting labelled strands. 
Cas8b was able to bind to all tested structures.  
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Discussion 
 
CRISPR-Cas interference complexes have been described for subtype I-E in E. coli and T. 
themophilus, subtype I-F in P. aeruginosa (Jore et al, 2011b; Sashital et al, 2012; Westra et 
al, 2012a; Wiedenheft et al, 2011a; Wiedenheft et al, 2011b) and also for Type II systems 
(Chylinski et al, 2013; Deltcheva et al, 2011; Jinek et al, 2012). Only little information was 
obtained for Type III systems (Hale et al, 2009; Osawa et al, 2013; Shao et al, 2013; Zhang 
et al, 2012) since a complete complex to investigate the underlying details is still not 
available. Similarly, the complete assembly of different Cascade-like complexes is lacking 
e.g. for subtype I-A systems. However, sub-complexes have been reported for an archaeal 
I-A system of Sulfolobus solftaricus (Lintner et al, 2011b; Reeks et al, 2013a; Reeks et al, 
2013b). Studies of the E. coli Cascade showed that the complex is composed of Cas7, Cas5 
and Cas6, proteins that can also be found in M. maripaludis. In addition to these three 
proteins, the I-E Cascade also possesses one large subunit (Cse1) and a homo-dimer of a 
small subunit (Cse2) (Jore et al, 2011b). Analysis of the genetic organization of the cas 
genes of subtype I-B reveals that there is no gene coding for a small Cascade subunit. 
Amongst the Type-I systems, only subtypes I-E (Cse1 and Cse2) and I-A (Cas8a and Csa5) 
have a small and large subunit, while in the other systems only one protein is found and 
thought to combine the functions of both subunits (Jore et al, 2011b; Makarova et al, 2011a; 
Reeks et al, 2013a). No biochemical data exists for the interference complexes of the two 
subtypes I-C and I-D. Subtype I-C, however, appears to be similar to the I-B systems as they 
share a resembling genetic organization and the Cas8c gene arrangement (putative 
Zn-finger, Palm and Thumb domains) suggest an evolutionary relationship (Makarova et al, 
2011a). The large subunit Cas10d of the I-D systems is very different to all other Type-I 
systems and is reminiscent of Type-III systems, as Cas10d, in addition to the conserved 
Cas8 domains (Zn-finger, Palm and Thumb), has a N-terminal HD domain (Makarova et al, 
2011a). Here, we present data for an archaeal Cas8b protein of M. maripaludis, the putative 
large subunit of a subtype I-B Cascade. The observed purification pattern of Cas8b into two 
fragments seems to be a feature of Cas8b proteins as two representative enzymes of 
different organisms and a variant with a different tag loacation of Mm Cas8b resulted in the 
same cleavage pattern. Bioinformatic analyses of Type-I large subunits show that the small 
subunit appears to be C-terminally fused to the large subunit resulting in the Cas8b protein 
(Makarova et al, 2011a). With respect to these analyses and to our results, we propose that 
in subtype I-B a proteolytic cleavage yields the small and the large subunit of the I-B 
Cascade. It seems that this cleavage so far is restricted to I-B systems, since no such 
cleavage is reported for the large subunit Csy1 of the I-F Cascade investigated in P. 
aeruginosa, which is also lacking a small subunit protein (Wiedenheft et al, 2011b). Our 
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results pinpoint the cleavage site within Cas8b to a region prone for proteolytic cleavage by 
aspartic proteases. Features of these proteases (e.g. Pepsin, Cathepsin) are a general two 
domain structure with two highly conserved aspartate residues in the N-terminal domain 
(Szecsi, 1992). Although our alignment does not show strongly conserved aspartate residues 
it is apparent that there is an accumulation of aspartate residues in the N-terminal protein 
region. Furthermore it is not a necessity to have two completely conserved aspartate 
residues as e.g. a retroviral protease of HIV is a heterodimer with each monomeric unit 
supplying one of the two aspartic protease domains (Graves, 1991; Toh et al, 1985). Next to 
the cleavage site, within Cas8b, a conserved region of the C-terminal end is found, which 
might contribute a recognition site for a protease. Proteolytic cleavage of proenzymes to yield 
active forms of enzymes has been described for many proteins. For example Protein Kinase 
C is activated by proteolytic cleavage of Ca2+ dependent Protease I (Kajikawa et al, 1983; 
Kishimoto et al, 1983; Takai et al, 1979). Also various other human systems use activation of 
proteins that are similar, for instance trypsin activation is achieved by proteolytic cleavage of 
trypsinogen by an enteropeptidase (Desnuelle & Gabeloteau, 1957; Liener, 1960; Rovery & 
Desnuelle, 1954). However, activation does not necessarily have to be performed in trans. 
Autocatalytic cleavage of proteins has been reported for several cases in which e.g. an 
N-terminal nucleophile is responsible for the processing. This would also be one putative 
mechanism for Cas8b. In this reaction, e.g. in the case of the glutamine PRPP 
amidotransferase (GAT), a cysteine residue takes the role of the active nucleophile for 
self-processing (Brannigan et al, 1995). In Cas8b four cysteine residues are conserved in 
two CxxC motifs and e.g. might take part in an autocatalytic cleavage. However, the CxxC 
motifs can also be part of a cysteine switch (Springman et al, 1990; Van Wart & Birkedal-
Hansen, 1990) in which conserved cysteine residues can interact with Zn2+ ions. If zinc is 
bound to the cysteine residues the protein is in an inactive state. However, an active site with 
the motif HExxHxxGxxH that is a feature of cysteine metalloproteases (Springman et al, 
1990; Van Wart & Birkedal-Hansen, 1990) cannot be identified in the Cas8b alignment. 
The presented proteolytic mechanisms display only a few instances of different processing 
reactions to yield active proteins and show a possibility of regulating downstream processes 
after transcription and translation. These kinds of feedback regulations help to fine-tune 
active protein species to not disturb the cellular protein equilibrium. Although Cas8b might 
not necessarily follow one of the described processing pathways, our results suggest a 
potential for Cas8b to undergo post-translational cleavage to yield the large and small 
Cascade subunit.  
In a first biochemical characterization of a Cas8b homolog of M. thermautotrophicus (Nar71), 
a nucleic acid cleavage activity and strand displacement for flapped and flayed DNA 
structures was reported. The authors suggested a novel DNA repair system in thermophiles 
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(Guy et al, 2004). However, in experiments using similar substrates based on the 
CRISPR-Cas immune system, Cas8b of M. maripaludis did not show any of those activities. 
The substrates were similar to the flayed and flapped DNA structures used in the Nar71 
studies (Guy et al, 2004), but the designed oligonucleotides contained spacer sequences 
and putative PAM sequences instead of random sequences. Considering their size, a 
sequence identity of only 14.5 % of both proteins is very low and surprisingly the two CxxC 
motifs that are usually conserved between Cas8b sequences are not found in Nar71. This 
suggests two different forms of Cas8b since it is also not reported that Nar71 purifies into two 
fragments (Guy et al, 2004). Therefore, Nar71 might exhibit different functions. The binding 
activity that both proteins share might be needed for R-loop formation and stabilization. The 
lack of specificity of nucleic acid binding is in agreement with studies in which a subtype I-E 
Cascade sub-complex missing the big subunit Cse1 showed more specific binding compared 
to a full Cascade that exhibited unspecific DNA binding behaviour. However, Cse1 of E. coli 
alone was not able to bind DNA and only Cascade combinations with the small subunit Cse2 
enabled binding (Jore et al, 2011b). However, in another study, Cse1 of T. thermophilus was 
suggested to be involved in PAM recognition (Sashital et al, 2012). Therefore, the chosen 
PAM for our Cas8b analysis, based on another subtype I-B study (Fischer et al, 2012), may 
not be correct and a future screening for the proper PAM sequence should be used to 
analyse the PAM-specificity of Cas8b.  
The nucleic acid binding shown by both, Nar71 and Mm Cas8b, lacked any specificity, which 
may be only apparent in the context of a complete Cascade. Therefore, it might be that the 
assembly of Cas8b into the interference complex might be required to reveal the native 
function of the protein.  
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Conclusion 
 
CRISPR-Cas systems show a broad diversity with different described types and subtypes 
(Makarova et al, 2011b). Although the general aspects and mechanisms of the three major 
types are very similar, the underlying details can vary significantly between the subtypes.  
The adaption step is proposed to be conserved between the different types, as all systems 
seem to employ a similar complex (Cascis) formed by the universal proteins Cas1 and Cas2 
(Erdmann & Garrett, 2012; Fineran & Charpentier, 2012; Plagens et al, 2012; Swarts et al, 
2012; Yosef et al, 2012).  
The processing step, which yields mature crRNA, is similar amongst Type-I systems. All 
subtypes use a Cas6 homolog to process pre-crRNA yielding a mature form of the interfering 
RNA (Gesner et al, 2011; Haurwitz et al, 2010; Reeks et al, 2013c; Richter et al, 2012; 
Sashital et al, 2011). One exception is found within subtype I-C in which no Cas6 homolog is 
present and Cas5d is responsible for pre-crRNA processing (Garside et al, 2012; Nam et al, 
2012). The acid/base chemistry that is applied by the Cas6 enzymes appears to be 
conserved. However, the details of substrate recognition and processing by Cas6 enzymes 
differ between subtypes. This study provides the identification of the subtype I-B 
endoribonuclease Cas6b of M. maripaludis, which processes pre-crRNA into mature crRNA. 
With the support of the results obtained in this work, a new classification of Cas6 enzymes 
based on their mode of substrate recognition is proposed. Furthermore it is proposed, that 
the differences of Cas6 enzymes can be used to distinguish different subtypes. 
The interference step is the most diverse stage of CRISPR-Cas immunity with regard to 
participating complexes and modes of target recognition. Type-I systems employ an 
interference complex called Cascade (CRISPR associated complex for antiviral defense), 
which recognizes the invading nucleic acid via crRNA base pairing and prepares it for 
degradation by Cas3. Subtype I-E of E. coli is the best studied Type-I system and the 
Cascade is reported to be composed of Cas5, Cas7, Cas6 and the large and small Cascade 
subunits, Cse1 and Cse2, respectively (Jore et al, 2011b; Westra et al, 2012c; Wiedenheft et 
al, 2011a). Amongst the different Type-I systems only the subtypes I-E and I-A possess 
genes coding for a small and large Cascade subunit, while in the other systems one protein 
appears to combine the functions of both subunits. In this study we report the identification of 
proteolytic cleavage of the large Cascade subunit Cas8b of the subtype I-B system present 
in M. maripaludis and C. thermocellum and propose a novel mechanism to yield the small 
and large subunits of Cascade. 
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An evolutionary link between Cas6 endoribonucleases of different CRISPR-Cas 
subtypes 
 
All studied Cas6 enzymes share some basic features, e.g. a ferredoxin-like fold or the metal 
independent processing of pre-crRNA. In addition, the cleavage reaction always yields 
mature crRNA with a 5' terminal repeat tag of 8 nucleotides (Carte et al, 2008; Gesner et al, 
2011; Haurwitz et al, 2010; Richter et al, 2012; Sashital et al, 2011). Even though the Cas6 
activities are similar, the sequence identity of these proteins is limited and mechanistic 
differences became apparent between the studied homologs. While Cas6e and Cas6f show 
a very high affinity towards their substrate and specifically recognize a hairpin structure 
within the repeat (Gesner et al, 2011; Haurwitz et al, 2010; Sashital et al, 2011; Sternberg et 
al, 2012), Pf Cas6 and Cas6b do not seem to rely on a structural recognition motif of their 
substrates. Instead a sequence motif located 12 nt upstream of the processing site appears 
to influence binding (Carte et al, 2010; Carte et al, 2008; Wang et al, 2011; Wang et al, 
2012). Additionally, Cas6b showed a comparable low affinity towards its substrate, which 
might correlate with the wrap-around mechanism proposed for Pf Cas6 (see Fig. 1) (Wang et 
al, 2011). The wrap-around mechanism describes a model in which several Cas6 enzymes 
are bound along the pre-crRNA in a bead chain like manner, wrapping the RNA around the 
enzyme. As this mechanism is not based on secondary structures, the missing structural 
elements that highlight the binding sites could delay tight binding, as scanning for the 
recognition motifs and coordination of the repeat cleavage site into the catalytic center might 
take more time and result in less affine binding. The lower processing rate measured for 
Cas6b in comparison to the observed reaction rates of Cas6e and Cas6f (Gesner et al, 2011; 
Sternberg et al, 2012) is difficiult to explain by this mechanism since a chain of multiple Cas6 
units could enable multiple cleavage events along a long pre-crRNA transcript.  
Cas6 enzymes also differ in their catalytic site composition. The first identified and 
characterized Cas6 enzyme, Pf Cas6, harbors a catalytic triad composed of a tyrosine, an 
histidine and a lysine residue (Carte et al, 2010; Carte et al, 2008; Wang et al, 2011; Wang et 
al, 2012). Studies to identify the catalytic site of Cas6e show that only two residues (tyrosine 
and histidine) are involved in crRNA maturation (Gesner et al, 2011; Sashital et al, 2011). A 
catalytic dyad (histidine and serine) is also described for Cas6f (Haurwitz et al, 2010). The 
residues involved in the catalysis performed by Cas6b are the same as in Pf Cas6, but their 
order is reversed to lysine, histidine and tyrosine. Additionally, not one but two conserved 
histidine residues play a major role in Cas6b pre-crRNA processing (Richter et al, 2012). 
Whereas the composition of the active site shows variations, one constant is the canonical 
histidine, which is found in all of these reported enzymes and is required for target 
protonation (Carte et al, 2008). One exception to prove the rule is a Cas6 homolog of S. 
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solfataricus, which does not rely on the canonical histidine. Here the protonation of the target 
is performed by a catalytic site that is composed of three lysine residues and one arginine 
(Reeks et al, 2013c).  
Cas6 sequence similarities are very low but a structural model of Cas6b (Richter et al, 2012) 
aligns very well with the crystal structure of Pf Cas6 (Wang et al, 2011). This structural 
conservation and the similarities in crRNA processing indicate that both Cas6 proteins might 
be evolutionary linked. Bioinformatical analysis of the three CRISPR-Cas types suggest that 
Type-III systems are the progenitors of the Type-I and –II systems. Evidential for this 
proposal are the presence of a Cas10 homolog in Type-I systems (Cas10d in I-D) and the 
high similarities between Cas8 proteins of Type-I and Cmx1 proteins of Type-III (Makarova et 
al, 2011a). Studies in Methanosarcina mazei further report that Cas6 enzymes of a Type I-B 
and a Type III-B system independently show identical processing patterns with a consensus 
repeat substrate (Nickel et al, 2013). Additionally, it was shown that Type–III systems lack a 
Cas1 gene and therefore usually pair with at least one subtype I-A or I-B system (Makarova 
et al, 2011a; Makarova et al, 2011b). This additionally implies a possible functional 
connection between Type-I and Type-III systems. Further evidence for this link of the two 
systems is provided by a non-catalytic Type I-A Pf Cas6 homolog of Pyrococcus horikoshii, 
which shares a sequence identity of 75 % with the III-B Cas6. This enzyme is also able to 
form dimers (Wang & Li, 2012) similar to Cas6b, which can form dimers with an uncleavable 
repeat substrate (Richter et al, 2013a). Furthermore, the binding site within the protein is 
found to be distal to the catalytic site in both Pf Cas6 and Cas6b (Wang et al, 2011; Wang et 
al, 2012), which is indicative for the proposed wrap-around mechanism and would separate 
both proteins from the mechanism found e.g. in Cas6e and Cas6f. Therefore, we propose 
two classes of Cas6 enzymes (Fig.1), one that specifically recognizes repeat structures 
(Cas6e, Cas6f) and a second class that is based on a sequence dependence (Pf Cas6, 
Cas6b). However, to confirm the similarities between Cas6b and Pf Cas6, a crystal structure 
of Cas6b is needed. 
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Figure 1. A proposed classification of Cas6 enzymes. Based on the mode of substrate recognition 
two classes of Cas6 enzymes are described. Class I Cas6 enzymes (e.g. Pf Cas6 and Cas6b) do not 
rely on secondary structures of their substrates and employ the proposed wrap-around mechanism. 
The spacer sequences help to guide the repeat sequences around multiple Cas6 units to mediate a 
bead chain like binding. Enzymes belonging to Class II (e.g. Cas6e and Cas6f) specifically recognize 
a stem loop structure of the repeat and facilitate cleavage at the base of the hairpin. 
 
The large Cascade subunit Cas8b – two for the price of one? 
 
The basic assembly of Type-I interference complexes appears to be conserved. Studies 
performed with Cascade complexes of the subtypes I-E and I-F suggest the universal 
presence of Cas5, Cas6 and Cas7 proteins (Jore et al, 2011b; Wiedenheft et al, 2011a; 
Wiedenheft et al, 2011b). However, differences can be found regarding the presence of a 
large and small Cascade subunit. While Cascade of subtype I-F does not employ a small 
subunit and only a large subunit is present (Wiedenheft et al, 2011b), the I-E Cascade is 
composed of a large and a small subunit (Jore et al, 2011b; Wiedenheft et al, 2011a). The 
occurrence of small and large subunits within Type-I systems differs, subtypes I-A and I-E 
possess genes coding for both subunits, whereas the subtypes I-B, I-C and I-F only have 
one gene coding for a large protein, which is likely required to combine the function of both, 
the small and the large subunit. Subtype I-D represents an exception with Cas10d, a large 
subunit with an HD domain that is reminiscent of the Type-III Cas10 enzymes (Makarova et 
al, 2011a; Makarova et al, 2011b).   
Analysing Cas8b, the large subunit of the subtype I-B system of M. maripaludis, we observed 
a distinct proteolytic cleavage event of the protein. This cleavage within the C-terminal end of 
the protein is conserved in another Cas8b of C. thermocellum and we speculate that the 
proteolytic activity could create protein fragments that might function as the large and small 
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subunit. Additional evidence for this proposal is found in bioinformatic analysis of Cas8 
proteins, which suggest that the small subunit is C-terminally fused to the large Cascade 
subunit (Makarova et al, 2011a). Large and small Cascade subunits are thought to be 
involved in PAM recognition (Sashital et al, 2012), target binding and R-Loop stabilization 
(Jore et al, 2011b; Makarova et al, 2011a; Makarova et al, 2011b). Biochemical analyses of 
Nar71, a Cas8b homolog of M. thermautothrophicus, showed that Cas8b is a nuclease with 
ATPase properties. Furthermore, this protein was able to bind Holliday junctions, as well as 
flayed and flapped DNA structures. However, without the knowledge about CRISPR-Cas the 
protein was proposed to be part of a novel DNA repair system of thermophiles (Guy et al, 
2004). Analyses of Cas8b of M. maripaludis with similar substrates that may occur during 
CRISPR-Cas interference did not show nucleic acid cleavage activity and revealed 
unspecific DNA binding properties. The large subunit Cse1 of E. coli was not able to shift 
DNA substrates and only within Cascade and in combination with the small subunit Cse2 a 
non-specific shift of DNA was observed (Jore et al, 2011b). In contrast, studies with Cse1 of 
T. thermophilus using DNA substrates with and without PAM sequences revealed substrate 
binding based on PAM recognition (Sashital et al, 2012). These results confirm the predicted 
role of the large subunits during PAM recognition. The isolated Cas8b was tested for PAM 
recognition but did not show specificity towards any of the used substrates. Future screening 
of additional PAM sequence candidaters might be necessary. Additionally, future studies will 
focus on a completely assembled I-B Cascade to study if the functions of large and small 
Cas proteins are revealed in the context of the protein complex. In this study we established 
a Cas6b approach to create various crRNAs in vitro, which will be used to load the studied 
Cascade complexes. 
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